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Cognitive flexibility refers to how individuals adapt their behaviour to changes in the envi-
ronment. Although important for survival and wellbeing, cognitive flexibility is impaired in a
wide range of neurological and neuropsychiatric disorders, including Parkinson’s Disease and
Obsessive-Compulsive Disorder (OCD). Optimal flexibility is known to depend on dopamine
(DA) neurotransmission in the central nervous system, but the precise mechanism and brain
loci underlying the effects of DA on flexible decision-making remain unclear.
In this thesis, cognitive flexibility was inferred in experimental rats by evaluating their
performance on a reversal-learning task involving a simple discrimination between rewarded
and non-rewarded stimuli. During reversal, subjects must adapt and respond to the formerly
non-rewarded stimulus whilst ignoring the initially rewarded stimulus. Learning on this task
thus requires constants shifts in behaviour in response to positive (rewarded) and negative
(non-rewarded) feedback. The overarching hypothesis of my thesis is that DA modulates
reversal learning performance by signaling positive and negative reward prediction errors
(RPE) within the direct (rewarded) and indirect (non-rewarded) pathways, respectively.
To investigate this hypothesis, I used a range of experimental approaches to interrogate the
neuromodulation of the direct and indirect pathways by DA. In Chapter 3, I found dissociable
effects of D1 and D2 receptor antagonists during different stages of serial visual reversal
learning when administered into the nucleus accumbens shell. In Chapter 4, I used a recently
developed valence-probe visual discrimination task to dissociate different components of
reversal learning and tested the extent to which these were dependent on D2 receptors. We
found that the D2 agonist quinpirole impaired reversal learning when given systemically, an
effect that depended on decreased sensitivity to negative feedback, but improved performance
when given directly into the nucleus accumbens. In Chapter 5, the synaptic location of
D2 receptors involved in the modulation of reversal learning was evaluated. Using a post-
synaptic probe compound (an adenosine 2A receptor antagonist) evidence is presented for a
vi
predominately post-synaptic locus underlying the effects of D2 agents on reversal learning.
Finally, in Chapter 6, an in-vivo optogenetics intervention was used to simulate activity in
the mesoaccumbal and nigrostriatal circuits during reversal learning. Here, activation of
the mesoaccumbal, not nigrostriatal, circuit modulated reversal learning on trials when the
expected reward was omitted.
Taken together, these original results provide support for a dissociable role of DA re-
ceptors and striatal subregions in learning from positive and negative feedback in reversal
learning. These findings expand our understanding of the neural circuit mechanisms under-
lying cognitive inflexibility and highlight potential therapeutic targets to improve flexible
decision making in PD, OCD and a range of other brain disorders.
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Cognitive flexibility refers to the skill to adapt behaviour to sudden changes in the environ-
ment. Since cognitive flexibility is assessed by observed behaviour, it is often referred to as
behavioural flexibility when assessed in experimental animals. Eslinger and Grattan (1993)
described behavioural flexibility as "the ability to shift avenues of thought and action in order
to perceive, process and respond to situations in different ways". Behavioural flexibility is
an emergent property of efficient executive functioning that serves many independent, but
interacting, cognitive control processes including attention, working memory, inhibition, and
shifting, which are necessary for adaptive behaviour in novel or unfamiliar environments
(Dajani and Uddin, 2015).
Despite flexible behaviour being important for everyday life, this capacity is often re-
stricted in a number of neurological and neuropsychiatric disorders, including schizophrenia
(Leeson et al., 2009), obsessive-compulsive disorder (OCD) (Remijnse et al., 2013), Parkin-
son’s disease (Cools et al., 2001), and substance use disorder (Ersche et al., 2011). Such
cognitive impairment is often treatment-resistant or even worsens with pharmacotherapy
(Pallanti et al., 2004). To find treatments for these patients, it is critical to understand the
pathophysiology and neural mechanisms of impaired behavioural flexibility.
The neural substrates of behavioural flexibility are most commonly assessed in humans
and other animals using reversal learning tasks. In such tasks, an initially acquired action-
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outcome (A-O) association (e.g. responding to stimulus A in an operant chamber) is paired
with a rewarded outcome, while responding to stimulus B is paired with lack of reward.
When the discrimination is successfully learnt according to a criterion, the reward contin-
gencies are reversed such that stimulus A is no longer rewarded and vice versa. Optimal
reversal performance requires the A-O association to be flexibly updated to facilitate the
density of rewarded outcomes (Izquierdo et al., 2017; Izquierdo and Jentsch, 2012; Nilsson
et al., 2015). A difficulty in disengaging from a previously rewarded stimulus that is now
unrewarded reflects rigid behaviour (Fineberg et al., 2010; Izquierdo and Jentsch, 2012;
Nilsson et al., 2015). The associative structure of reversal learning is deceptively complicated
with fluctuations in behaviour dependent on A-O learning, together with stimulus-outcome
(S-O) and stimulus-response (S-R) learning. In addition, several cognitive processes are
recruited to enable adaptive learning in new conditions, comprising associative learning,
response selection and inhibition, decision-making, working memory, and attention.
The brain substrates that underlie behavioural flexibility have been vigorously pursued in
recent years (Izquierdo, 2017). Accumulating evidence from rodents, non-human primates
and humans has linked inflexible behaviour in reversal learning to dysfunction within the
cortico-striatal circuitry, involving connections to the dorsal and ventral striatum in rodents
(Boulougouris et al., 2007; Dalton et al., 2016; McAlonan and Brown, 2003), with widely
researched modulatory contributions from dopamine (DA) and serotonin (5-HT) (Clarke
et al., 2004, 2011).
1.1.1 The relevance of cognitive flexibility research for neuropsychi-
atric disorders
Neuropsychiatric and neurological disorders have long been studied but we still lack a
comprehensive understanding of their underlying neural mechanisms, as well as broad and
efficient treatments. Symptom heterogeneity, complexity and co-morbidities commonly ob-
served in mental disorders, represent a challenge in psychiatry to appropriately diagnose and
treat patients. Neurocognitive endophenotypes (i.e. measurable biomarkers correlated with a
cognitive illness), have therefore received much attention within the last decade (Fineberg
et al., 2010; Flint and Munafò, 2007; Robbins et al., 2012) in which behavioural inflexibility
has been proposed as an endophenotype for a host of heterogeneous neuropsychiatric disor-
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ders including OCD, schizophrenia, and Parkinson’s disease (Gillan et al., 2016; Robbins
et al., 2012).
Splitting heterogeneous disorders into cognitive endophenotypes can promote trans-
lational research across species, enabling us to better dissociate commonalities between
disorders and optimise diagnosis. This could explain apparent comorbidities across disorders,
and more importantly, lead to tailor-made pharmacological and behavioural treatments with
a transdiagnostic application (Robbins et al., 2012). Indeed, the National Institute of Mental
Health (NIMH) has recently endorsed the new strategy of focusing on behavioural constructs,
rather than symptoms and disorder classifications stated by the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5) (Association, 2013) in clinical and preclinical re-
search. The existence of an inflexible endophenotype shared by a range of heterogeneous
cognitive disorders suggests a common neural mechanism that could potentially be targeted
for drug remediation (Fineberg et al., 2010; Godier and Park, 2014; Izquierdo et al., 2017;
Romera-Garcia et al., 2020).
For instance, OCD is a heterogeneous disorder characterised by maladaptive patterns of
repetitive and inflexible behaviour and cognition. Deficits in cognitive flexibility have been
reported in individuals with OCD and their unaffected first-degree relatives during reversal
learning (Chamberlain et al., 2007; Gruner and Pittenger, 2017; Gu et al., 2008). During
reversal cognitive tests, the orbitofrontal cortex (OFC) and the striatum show attenuated
responsiveness, suggesting they are key brain regions in modulating the symptoms underly-
ing the behavioural impairment and being key in the neurobiological mechanism of OCD
(Remijnse et al., 2006). Schizophrenia is a disorder characterised by accentuated positive
or psychotic symptoms alongside deficits in emotion, motivation and cognition (Waltz and
Gold, 2016). Specially the latter has been associated with low goal-directed performance
due to slow acquisition of adaptive behaviour and flexible responses following a change
in contingencies (Morris et al., 2015; Waltz and Gold, 2016). Consistent with this clinical
observation, decreased cognitive flexibility is found in reversal learning tasks after impair-
ments in the cortico-striatal circuit (Leeson et al., 2009; Morris et al., 2015; Reddy et al.,
2016). Individuals with schizophrenia also perform poorly on outcome devaluation tasks
commonly used to assess habitual behaviour (Morris et al., 2015). Parkinson’s disease affects
the initiation and control of movements, motivation and reward-seeking behaviour (Borek
et al., 2006). A classic neuropathology of this disease is the degeneration of DA cells in the
substancia nigra pars compacta (SNc) impairing both tonic and phasic DA signalling in its
efferent targets (Dauer and Przedborski, 2003). In consequence, individuals with Parkinson’s
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disease experience poor levels of performance in reversal learning (Peterson et al., 2009),
which can be altered depending on DA medication (Cools et al., 2001).
Understanding the neural mechanisms underlying these behaviours and subprocesses is
crucial to shed light into the aetiology of neuropsychiatric disorders and contribute to finding
effective treatments.
1.2 Reversal learning
Reversal learning is a widely used procedure to assess cognitive flexibility and has been
broadly used to investigate aberrant cognitive processing associated with neuropsychiatric
disorders (Fig. 1.1). Reversal learning measures the ability to adapt behaviour to a reversal
in reinforcement contingencies. Initially, subjects are trained to discriminate between two
(or more) stimuli or locations, one of which is associated with reward, whereas the other
one is not. After successfully discriminating both options by reaching a criterion level of
performance, contingencies reverse, so that the previously rewarded stimulus is now non-
rewarded, and vice versa. Subjects are then trained to reach the criterion again. This next
phase requires acquiring a strategy to solve the task during initial discrimination, which must
be inhibited or extinguished when reversal occurs to prevent perseverative (i.e. incorrect)
responses. Once the old strategy is extinguished, subjects need to acquire a novel association
to be rewarded in the new conditions. That is, reversal learning requires a shift in valence
between stimuli or locations that have previously been associated with a specific outcome
(e.g. delivery of reward). Importantly, reversal learning can consist in a reversal of all type of
cues (e.g. visual, spatial, odorant, textural), but the choosing options remain constant.
1.2.1 Reversal learning
Reversal learning paradigms can be used in multiple species, including rodents (Graybeal
et al., 2011), non-human primates (Clarke et al., 2007), and humans (Cools et al., 2007),
and therefore have inherent translational utility to resolve the neural and psychological
mechanisms of cognitive flexibility.
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Fig. 1.1 Illustration of the reversal-learning task using touchscreens in rodents, monkeys and
humans. Adapted from Izquierdo et al. (2017).
In rodents, reversal-learning procedures often performed in operant chambers comprising
levers, apertures for nose poke responses, or a touch-sensitive screen – although mazes have
also been adopted (Bari et al., 2010; Dalton et al., 2014; Shah et al., 2019). Reversal learning
can use purely spatial stimuli, like lever or response apertures, or incorporate visual and
auditory cues (Boulougouris et al., 2007; Castañé et al., 2010). Touchscreens are mainly
used to test visual-discrimination reversal learning since they offer a wider variety of stimuli,
but they can also test spatial strategies (Alsiö et al., 2019; Mar et al., 2013; Oomen et al.,
2013). Touchscreen testing is analogous to the procedures used in the Cambridge Automated
Neuropsychological Test Automated Battery (CANTAB) (Robbins et al., 1994; Sahakian
et al., 1993), a set of computerised neuropsychological tests developed to assess cognitive
flexibility in humans.
In non-human primates, the tasks used are similar to those used in rodents, but in general
monkeys are able to solve more reversals than rodents within the same time period (Dalton
et al., 2014; Horst et al., 2019). In addition, modified versions of the Wisconsin General Test
Apparatus (WGTA) can be implemented in monkeys to investigate reversal learning. In the
WGTA, two wells are presented and covered by an object. One of the two wells contains
a reward, which the monkeys discover by removing the correct object. Similarly, it can be
tested by using visual stimuli or cards (Jones and Mishkin, 1972; McAlonan and Brown,
2003; Walker et al., 2009).
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In humans, including healthy volunteers and patients, reversal-learning tests follow
the same basic design as the tests mentioned above; i.e. the simultaneous presentation of
two stimuli, one of which is associated with reward, while the other one is not. Stimuli
are normally presented on a touchscreen or form letters or symbols on a keyboard, where
subjects must register their choices. Although tasks are similar across species, the main
difference in humans relies on the type of reward, which is often feedback on the correctness
of their choices or through receipt of real or hypothetical monetary rewards, instead of food
incentives as in the case of experimental animals. Thus, in humans, stimuli are generally
conditioned reinforcers rather than primary reinforcers.
Reversal learning paradigms are usually either (1) deterministic (P(reward|choice) =
1 or P(reward|choice) = 0), or (2) probabilistic (0.5 < P(reward|choice) < 1 or 0 <
P(reward|choice) < 0.5) in nature. Probabilistic strategies slow down learning and re-
duce the development of simple strategies, such as win-stay and lose-shift, since subjects
must integrate the history of choices and outcomes to choose which stimulus is more likely
to deliver reward. Depending on the particular task configuration, it is also possible for a
single reversal over multiple sessions or multiple reversals within the same session (Alsiö
et al., 2019).
Reversal learning performance is typically assessed by the number of reversals achieved
or by the number of errors versus correct responses made before reaching the discrimination
criterion. The tendency of subjects to perseverate on the previously rewarded stimulus (now
non-rewarded) is a further variable of interest, that reflects a failure to disengage from the
previous strategy. Trial-by-trial responses to positive and negative feedback can also be
assessed by calculating win-stay and lose-shift probabilities (Alsiö et al., 2019; Bari et al.,
2010; Dalton et al., 2014).
More recently, trial-by-trial computational models have attempted to simulate how sub-
jects learn about environmental contingencies and translate reward representations into action
(Daw, 2009; Niv et al., 2012). These models have highlighted latent variables such as
learning rate, the tendency to explore or exploit stimuli according to learned reinforcing
properties, and ‘stickiness’ – the likelihood to respond on the same stimulus as in previous
trials regardless of its rewarding value.
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1.2.2 Other paradigms to test cognitive flexibility
In addition to reversal learning, other paradigms have been developed to assess cognitive
flexibility, including attentional set shifting, task switching and the ability to suppress
automatically elicited responses.
Attentional set shifting falls in the same category as reversal learning in terms of changes
in reward contingencies: once subjects have learned an initial discrimination, contingencies
shift, so that what was previously positive is now negative and vice versa. However, the main
difference in attentional set shifting and strategy shifting is that the shift occurs between
different dimensions or perceptual categories e.g. from visual to spatial. These tasks
allow for intradimensional and extradimensional shifts. In intradimensional tests, the set of
stimuli changes, but not the relevant stimulus dimension (e.g. if the first set was based on
discrimination visual stimuli, the shift will incorporate novel choice options within the visual
domain. In extradimensional tests, not only the set of stimuli shifts, but also the reinforced
dimension (e.g. if the first set of stimuli were visual, now they might be auditory).
As in reversal learning, attentional set-shifting paradigms have been developed across
species (Eagle et al., 2008; Roberts et al., 2007). In humans, one of the most prominent tasks
to assess the ability to shift is the Wisconsin Card Sorting Test (WCST). The WCST consists
of presenting to the subject a number of stimulus cards with certain shapes and colours.
Subjects are asked to match these cards according to a specific stimulus aspect. Attentional
set-shifting tasks for animals have been developed based on the WCST and using sets of
stimuli belonging to multiple sensory dimensions (e.g. odorant, visual, spatial, auditory)
(Birrell and Brown, 2000; Garner et al., 2006).
Another paradigm used widely to evaluate cognitive flexibility is task switching. It con-
sists of changing the stimulus-response set following an external cue. This is a fundamental
difference from reversal learning and attentional set shifting, in which changes are not cued,
hence subjects need to explore the conditions to detect the change and develop a new strategy
to solve the task. This paradigm is mostly used in humans, as it recruits higher-level neural
substrates for cognitive control (Monsell, 2003; Sohn et al., 2000).
Finally, the assessment of inhibitory control over prepotent or habitual responses is
another category of tasks used to evaluate cognitive flexibility. An example of these paradigms
is the stop-signal reaction task (SSRT). Subjects train to respond to a set of stimuli but then
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are required to stop following a signal, which assesses action inhibition or the ability to
flexibly inhibit a pre-planned physical response (Eagle et al., 2008). The Go/No-go task
allows for measuring waiting impulsivity and inhibitory control. The paradigm involves
two-choice discrimination with the presentation of a series of stimuli accompanied with “go”
cues, which signal the need to respond to the stimulus, or with “no-go” cues, which require
not to respond to the stimulus. If the frequency of go cues is larger than no-go cues, subjects
might develop a prepotent tendency to respond, which must be inhibited when no-go cues
are presented. Similarly, if conditions reverse, subjects must inhibit previous responses and
develop new strategies (Costantini and Hoving, 1973; Mishkin and Pribram, 1955; Syed
et al., 2015).
1.3 Psychological substrates of reversal learning
Predicting when and where a reward might occur allows humans and other animals to
initiate and adapt their responses to optimise the number of rewards received (O’Doherty,




The study of classical conditioning has its origins in the 19th century with Ivan Pavlov,
who studied how animals, including humans, learn by association. Classical or Pavlovian
conditioning refers to learning to associate an unconditioned stimulus (US) that elicits a
biological response (unconditioned responses; UR) with a previously neutral stimulus that
becomes a conditioned stimulus (CS). As result of learning this association, the CS alone
comes to elicit the behavioural response originally associated with the US – the conditioned
response (CR). This form of learning enables the subject to predict outcomes and exhibit
preparatory or anticipatory behaviours. Importantly, in a Pavlovian conditioned procedure,
there is no causal association between the animal’s responses and the environmental outcome,
but learning originates from repeated presentation (Mackintosh, 1974). The most common
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association during this conditioning is the stimulus-response association (S-R), in which the
CS is directly associated with the UR.
Instrumental conditioning
Instrumental or operant conditioning was first described by Burrhus Frederic Skinner as
“any and every voluntary behaviour that acts upon the environment to create a response”
(Skinner, 1938). This means that subjects exert control over events through a causal and direct
link between their actions and subsequent outcomes. Two associative processes underlie
instrumental behaviour: goal-directed actions and habitual behaviour.
Goal-directed actions are based upon knowledge of the contingency between actions and
outcomes, so-called A-O associations, and the incentive value of those outcomes (Balleine
and Dickinson, 1998; Cardinal and Everitt, 2004). Goal-directed processes dominate instru-
mental learning and behaviour in early stages of training, and are relatively flexible according
to the needs fulfilled by particular outcomes.
As training progresses, actions become reflexive and less flexible in nature, eventually
coming under the control of habitual processes. Habitual behaviours are based on S-R
associations, which are sensitive to contiguous pairing of a specific action and reinforcer, as
opposed to a causal relationship (Balleine and Dickinson, 1998). In opposition to Pavlovian
S-R associations, instrumental S-Rs are created through positive or negative reinforcement,
rather than associative learning.
Given the existence of multiple strategies to control behaviour, the question arises for
their existence. In other words, if humans and other animals can behave in a goal-directed
manner, why are less flexible behaviours required? The most compelling explanation is that
each strategy offers a different trade-off between accuracy, speed, experience, and efficiency.
Goal-directed behaviours guide the subject towards reliably achieving a goal, but flexibility is
cognitively demanding and its implementation is relatively slow. In contrast, stimulus-driven
behaviours may sometimes fail to meet an organism’s current needs, but can be deployed
quickly and require less computational resources (O’Doherty, 2011). Thus, a switch between
strategies allows for the selection of the most economical strategy.
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1.3.2 Discrimination learning processes
Solving a discrimination task requires the subjects to learn the value of each choice, forming
accurate A-O associations (Izquierdo, 2017). However, during cognitive flexibility tasks such
as reversal learning, the previous positive contingencies become negative, and vice versa.
Successful reversal performance requires adjusting behaviour based on the representations
of A-O contingencies. Following reversal, the stimulus associated with the reward (CS+),
becomes associated with the lack of reward (CS-). To overcome this shift, a subject must stop
responding to the original CS+, now CS-, a process opposed by perseverance. In contrast, the
original CS- becomes the CS+, thus requiring the subject to start responding to the original
CS-, a process opposed by learned non-reward.
Perseverative behaviour
Perseveration refers to the inappropriate repetition or maintenance of an action despite the
absence or cessation of the original stimulus or outcome; or in cognitive terms, due to an
incorrect abstract relationship between stimuli and goals (Garner et al., 2006). Perseverating
on a specific action – linked to habitual behaviour – might be beneficial to achieve efficient
and rapid responding. However, excessive perseverance is also maladaptive and underlies
neuropathological disorders such as OCD (Serpell et al., 2009).
Typically, perseveration is framed as the inability to overcome reinforced associations,
which in cognitive flexibility tasks corresponds to excessive approach to a previous CS-
(Nilsson et al., 2015). To assess perseveration in reversal learning, the most common
approach is to classify incorrect responses after stimuli reversal into early and late errors. It
is widely assumed that the number of incorrect responses in early stages reflects the strength
and stability of the old association and can therefore is an index of perseverative behaviour
(Jones and Mishkin, 1972).
Learned non-reward
Learned non-reward emerges from the association of the CS with ‘no US’ (i.e. no reward).
Following a contingency shift, learned non-reward interferes with the formation of a new
strategy to optimise rewarded outcomes. An increased avoidance towards the original CS-
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limits exploration of rewarding possibilities. In two-choice reversal learning tasks, the
inability to overcome a non-rewarded association has also been named learned avoidance
(Clarke et al., 2007) or learned irrelevance (Boulougouris et al., 2008).
Research has also focused on how learning is shaped by reinforced and non-reinforced
outcomes, which ultimately guide responding. A growing number of studies has confirmed
that some neurological disorders show an altered sensitivity to positive or negative feedback,
which alter how learning is shaped. For example, one of the most prominent distortions in
patients with major depressive disorder is abnormal sensitivity to negative feedback (Beats
et al., 1996; Elliott et al., 1997; Rygula et al., 2018). Suffering from a bias towards negative
feedback negatively skews the way that environmental information is processed (Elliott et al.,
1997; Hales et al., 2014). The negative perception may lead to increased attention to received
negative feedback and impair subjects’ ability to perform in tasks that require cognitive
flexibility, as well as impairing their wellbeing and daily experience (Elliott et al., 1997).
The neural mechanisms underlying such impairment are unclear. Hence, understanding the
mechanisms by which relevant cognitive biases are perceived and maintained is an important
goal in the context of novel treatment development.
1.4 Neuroanatomical basis: the striatum
The basal ganglia are fundamental information processors in the mammalian brain. They
consist of a group of subcortical forebrain and midbrain nuclei implicated in a broad range of
behaviours, including movement, action selection, and reinforcement learning (Humphries
and Prescott, 2010).
Fig. 1.2 Illustration of striatal subregions on coronal sections at 1.70, 1.60, 1.20 and 0.70
mm from Bregma. Abbreviations: dorsomedial (DMS), dorsolateral striatum (DLS), nucleus
accumbens core (NAcC), nucleus accumbens shell (NAcS). Adapted from Paxinos and
Watson (1998).
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Fig. 1.3 Diagram of the rat cortico-striatal circuit and its role in behavioural control. The
schematic illustrates the proposed role of the dorsolateral striatum (DLS) in habitual be-
haviour, the dorsomedial striatum (DMS) in goal-directed actions, and the nucleus accum-
bens (NAc) in attributing vigour and directing orientation, approach or avoidance responses.
Colour gradient indicates the gradient of afferent projections and topography (Voorn et al.,
2004). Tapered arrows represent input convergence. Dorsostriatal output divides into the di-
rect D1R-expressing pathway (with a disinhibitory effect, +), and the indirect D2R-expressing
pathway (with an inhibitory effect, -). Ventrostriatal output also consists on D1R- and D2R-
expressing MSNs, but their segregation between direct and indirect pathways is less cate-
gorical (dash line). Projections from the ventral tegmental area (VTA) and substantia nigra
pars compacta (SNc) are mainly dopaminergic and represented with red arrows. The table
displays characteristic features of the different control systems of behaviour. Table abbrevia-
tions: stimulus (S), context (C), outcome (O), response (R). Circuit abbreviations: nucleus
accumbens shell (NAcS), nucleus accumbens core (NAcC), substantia nigra pars reticulata
(SNr), dorsal hippocampus (dH), ventral hippocampus (vH), pallidum (P), entorhinal cortex
(ENT), subthalamic nucleus (STN), basolateral amygdala (BLA), central nucleus of the
amygdala (CN). Neocortex abbreviations: infralimbic cortex (IL), prelimbic cortex (PL),
orbitofrontal cortex (OFC), parietal cortex (PP), cingulate gyrus (CG), sensorimotor cortex
(SMA). Adapted from Gruber and McDonald (2012).
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1.4.1 Anatomical heterogeneity
The striatum in rodents is an anatomical and functional heterogeneous structure, which is
typically subdivided into the dorsal and the ventral striatum (Fig. 1.2). The dorsal striatum
can be further subdivided into the dorsomedial (DMS) and dorsolateral striatum (DLS). The
ventral striatum mainly consists of the nucleus accumbens (NAc), which can be anatomically
segregated into the NAc core (NAcC) and the NAc shell (NAcS) based on inputs and
immunohistochemical markers (Zahm, 1999).
The striatum receives major inputs from glutamatergic and dopaminergic neurons. Gluta-
matergic inputs mainly arise from cortical regions, as well as thalamic and limbic regions.
Cortical efferents innervate the striatum following a dorsomedial-ventrolateral topographical
organisation (for review see (Haber, 2016)). The DMS receives inputs from associative
regions, including projections from more dorsal regions of medial prefrontal cortex (mPFC),
orbitofrontal cortex (OFC), primary motor and somatosensory cortices, as well as amygdala,
thalamus, and DA midbrain systems, including the substantia nigra pars compacta (SNc)
(Wall et al., 2013) (Fig. 1.3). Conversely, the DLS is innervated by sensorimotor cortices,
thalamus, and DA midbrain systems (Burke et al., 2017). Conversely, the NAc receives
projections from the prefrontal cortex (PFC), including the OFC, amygdala, thalamus, mid-
brain DA system [mainly, ventral tegmental area (VTA)], and the laterodorsal tegmentum
(Berendse et al., 1992; Berendse and Groenewegen, 1990; Boeijinga et al., 1993; Ikemoto,
2007). The NAcS and NAcC receive inputs from the infralimbic cortex (IL) and the pre-
limbic cortex (PL) (Keistler et al., 2015; Sesack et al., 1989; Vertes, 2004). Dopaminergic
innervation into the NAc has a mediolateral topography within the NAcC and NAcS. DA
neurons in the posteromedial VTA generally project to the ventromedial striatum, including
the NAcS, whereas anteromedial VTA efferents largely project to the ventrolateral striatum,
including the NAcC, but also in part the NAcS (Ikemoto, 2007).
The NAcC and NAcS have other defining features that further enable their differentiation.
In rats, the NAcC has a higher cell density (Meredith et al., 1992) and higher DA and 5-HT
metabolism (Deutch and Cameron, 1992) compared with the NAcS. In addition, there is
recognised variation in the density of afferents and efferents in the two NAc subregions
(Salgado and Kaplitt, 2015), with the NAcS receiving a denser input of glutamatergic inputs
than the NAcC (Mingote et al., 2019).
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1.4.2 Cellular heterogeneity
Striatal neurons can be classified into two main subgroups: medium spiny neurons (MSNs)
and interneurons. MSNs are the primary cell type in both dorsal and ventral regions, making
up over 90% of total striatal neurons. These are GABAergic (γ-aminobutyric acid) inhibitory
neurons that receive excitatory cortical efferents (Tepper and Bolam, 2004). MSNs also
receive dopaminergic modulatory input from the SNc or the VTA via the nigrostriatal and
mesolimbic loops. This dopaminergic input can have different modulatory effects depending
on the targeted MSNs pathway: direct and indirect pathways.
The direct and indirect pathways are the two main channels of information flow through
the basal ganglia, and are constituted by two principal types of MSNs (Gerfen et al., 1990)
(Fig. 1.4). The direct pathway originates from a subpopulation of MSNs expressing DA D1
receptors (D1R), which are Gs-coupled receptors. These receptors increase neuronal activity
by activating adenylate cyclase signalling that catalyses the conversion of cytosolic adenosine
triphosphate (ATP) into cyclic-adenosine monophosphate (cAMP). D1R expressing neurons
project directly from the striatum to the substantia nigra pars reticulata (SNr), also sending
projections to the internal part of the globus pallidus (GPi). The indirect pathway originates
from the subpopulation of MSNs expressing dopamine D2 receptors (D2R), which are
Gi-coupled receptors. These receptors reduce cell activity by inhibiting adenylate cyclase
signalling via their G-coupled protein. Neurons belonging to the indirect pathway indirectly
innervate the SNr by projecting from the striatum to the external part of the globus pallidus
(GPe). GPe neurons release GABA to the subthalamic nucleus (STN), and finally the STN
sends glutamatergic projections to the SNr. These output nuclei modulate the thalamus,
which in turn sends input to the cortex, closing the cortico-striato-thalamo-cortical loop (for
review see (Haber, 2016)) (Fig. 1.4).
Direct and indirect striatal MSNs also express additional distinctive opiate peptides.
The direct pathway, expressing D1R, also contains substance P and dynorphin, whereas
the indirect pathway, expressing D2R, co-expresses enkephalin. These neuropeptides are
hypothesised to modulate dopaminergic input to the striatum (Steiner and Gerfen, 1998).
Although the segregated view of striatal outputs is widely accepted, it is also an over-
simplification. For example, extensive reciprocal connections exist within the basal ganglia,
including projections from the globus pallidus (GP) back to the striatum (Bevan et al., 1998).
Within the same striatum, MSNs send dense axon collaterals to other MSNs modulating their
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activity (Burke et al., 2017; Tunstall et al., 2002). Hence, MSNs belonging to the direct and
indirect pathways can influence the output from the other pathway, following the so-called
process of “lateral inhibition”. Recently, the division of MSNs DA receptors subtypes has
been questioned, since it might not involve a complete segregation (Cazorla et al., 2014).
The dichotomy of direct and indirect pathways also seems to hold more for the dorsal, but
less so for the ventral striatum, where the proportion of MSNs expressing both D1R and D2R
is higher (Bertran-Gonzalez et al., 2008; Matamales et al., 2009), and D1R- and D2R-MSN
projection targets are less segregated (Kupchik et al., 2015).
Fig. 1.4 Direct and indirect pathways in the dorsal and ventral striatum. A) Direct pathway in
the dorsal striatum expresses D1R, coupled to Gs protein, and project to the globus pallidus
pars interna (GPi) and substantia nigra (SN). B) Direct pathway in the ventral striatum
expresses D1R and predominantly projects to the SN from the nucleus accumbens core
(NAcC), and ventral tegmental area (VTA) from the nucleus accumbens shell (NAcS). C)
Indirect pathway in the dorsal striatum expresses D2R and projects to the globus pallidus
pars externa (GPe), which projects directly or via the subthalamic nucleus (STN) to SN. D)
Indirect pathway in the ventral striatum expresses both D1R and D2R, and projects from the
NAcC to the dorsolateral part of the ventral pallidum (VP), which projects to the STN and
reaches the SN; or from the NAcS to the ventromedial part of the VP, sending GABAergic
projections to the VTA. Adapted from Soares-Cunha et al. (2016).
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1.4.3 Role of the striatum in learning
Anatomic segregations also lead to functional dissociations. In general terms, the dorsal
striatum plays a role in motor planning, action selection and S-R habit learning, whereas the
NAc is involved in regulating motivated behaviour and reward-related learning (Isomura et al.,
2013), although these functions can also overlap. Thus, the stronger input from the limbic
cortex and VTA, rather than SNc, into the NAc makes it the region where information about
reward and motivational drive are integrated to guide behavioural performance (Mogenson
et al., 1980), as opposed to the dorsal striatum’s role in sensorimotor integration (Robbins
and Everitt, 1992).
The dorsal striatum has been suggested to play a role in cognitive flexibility due to its
implication in goal-directed actions and habitual behaviours. Specifically, the DLS mediates
habitual, whereas the DMS regulates goal-directed behaviours (Brigman et al., 2013; Corbit
et al., 2014; Yin and Knowlton, 2006). Yin and colleagues found that lesions of the DLS
disrupt habit formation in instrumental learning, whereas outcome expectancy is preserved
(Yin et al., 2004). They also observed that DLS lesions impair performance in an outcome
devaluation task, which is a commonly used task to assess habitual behaviours. Conversely,
lesions to the DMS had no effect on behaviour in this paradigm (Yin et al., 2004). Similarly,
DLS DA-depleted rats became sensitive to reward-devaluation and incapable of forming S-R
habits in an operant conditioning task (Faure et al., 2005).
The DMS is necessary for the acquisition and expression of A-O instrumental learning.
Lesions of the posterior part of the DMS during pre-training stages blunt sensitivity to both
contingency and outcome degradation (Yin et al., 2005). It has also been observed that
lesions of the DMS before and after training impair sensitivity to devaluation and degradation
contingencies, which highlights the importance of the DMS (especially its posterior part)
in both acquisition and expression of A-O associations (Yin et al., 2005). In addition, in-
vivo recordings during behavioural shifting showed that the DMS (together with the OFC)
becomes more engaged, and the DLS less engaged, when behaviour shifts to goal-directed
responding, showing that both regions dynamically encode the shift between goal-directed
actions and habitual behaviours (Gremel and Costa, 2013).
Conversely, the NAc does not seem to be required for goal-directed or habitual behaviours,
since excitotoxic lesions of this structure leave performance intact, but it does appear to
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regulate these behaviours by integrating limbic information (Cardinal et al., 2002); for
example, in processing reward-related stimuli.
Human imaging studies show that both the dorsal and ventral striatum are recruited
during reversal-learning tasks, and lesions in the basal ganglia impair performance in this
form of cognitive flexibility (Cools et al., 2002; Rogers et al., 2000). Lesions in the DLS
impair late phase of reversal learning (Brigman et al., 2013). Similarly, DLS lesions disrupt
habit formation in instrumental learning, while maintaining outcome anticipation (Yin et al.,
2004). In contrast, lesions of the DMS in rats impair various forms of reversal, while leaving
unaffected the retention of the initial discrimination (Clarke et al., 2008; Ragozzino and
Choi, 2004). This effect was suggested to be due to a failure in suppressing perseverative
responses to previous reward contingencies (Castañé et al., 2010). Indeed, blocking the
DMS in marmosets produces perseverative behaviour, leading to impaired reversal-learning
performance, in a similar manner to OFC lesions (Clarke et al., 2014, 2008).
In contrast to the dorsal striatum, the role of the ventral striatum in cognitive flexibility
is controversial. Lesions in this region did not alter reversal learning, latency to collect the
reward, number of omissions or locomotor activity (Castañé et al., 2010), but the ability
for set-shifting tasks was affected in rats (Floresco et al., 2009). It has been suggested that
the NAc is more involved in complex forms of behavioural flexibility involving changes in
strategies, but it does not appear to make a critical contribution to simpler forms of these
processes, such as visual discrimination or reversal learning (Castañé et al., 2010; Floresco
et al., 2009; Kehagia et al., 2010). Nevertheless, lesions in the NAcS in rats impaired
performance in a probabilistic reversal learning task, while lesions in the NAcC affected
reward collection latencies but not overall performance (Dalton et al., 2014).
1.5 Neurochemical basis: dopamine
DA, or 3-hydroxytyramine, was discovered over 60 years ago as the precursor of nora-
drenaline (Montagu, 1957). Shortly thereafter, Carlsson and colleagues showed that DA
concentration in the striatum was higher than in the rest of the brain, even if its concentration
of noradrenaline was low, indicating that DA was not only a precursor, but also a neuro-
transmitter in its own right (Carlsson et al., 1958). Subsequently, DA has been intensively
investigated due to its demonstrated role in a multitude of brain functions, including learning,
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memory, motivation, and emotional behaviours, which has had a significant impact in the
applied fields of neurology, psychiatry and psychopharmacology (Iversen and Iversen, 2007).
1.5.1 Dopaminergic nuclei and projections
DA, together with adrenaline and noradrenaline, constitute the monoamine neurotransmitter
family of the catecholamines, which are organic compounds with a catechol and a side-chain
amine. Catecholamines are synthesised from the amino acid l-tyrosine and different enzymes
catalyse its transformation into each of the above neurotransmitters. The primary cytoplas-
matic synthetic pathway of DA involves the transformation of l-tyrosine into L-DOPA via
tyrosine hydroxylase (TH) and L-DOPA into DA via DOPA decarboxylase. Extracellular DA
can be reuptaken by the DA transporter (DAT). After its cytoplasmatic synthesis or reuptake,
DA is accumulated into vesicles via the vesicular monoamine transporter 2 (VMAT2) (Fig.
1.7). These enzymes may work as neuromarkers for DA neurons. However, molecular
heterogeneity exists between different DA cell subpopulations (Morales and Margolis, 2017).
While various cellular compartments of DA neurons express high levels of TH – and this
is therefore often used to detect DA neurons –, some TH positive neurons lack expression
of VMAT2 or DAT or co-release other neurotransmitters, like glutamate (Li et al., 2012;
Morales and Margolis, 2017).
The neuronal soma that produce DA are localised in a small number of regions. In the
mammalian brain, there are nine DA-producing nuclei, from A8 to A16 (Fig. 1.5; (Björklund
and Dunnett, 2007). From these, three are located in the midbrain – A8, A9 and A10 –, with
the A9 (SNc) and A10 (VTA) receiving the most attention due to their role in reinforcement
learning and reward processing (Tritsch and Sabatini, 2012).
The three major dopaminergic pathways are the nigrostriatal, mesolimbic, and the meso-
cortical (Fig.1.5). The tuberoinfudibular pathway is a fourth system that merges from the
arcuate or infundibular nucleus in the tuberal region of the hypothalamus and innervates the
median eminence, attached to the infundibulum. Unlike the other pathways, it modulates the
release of hormones in the blood, such as prolactin (Weiner and Ganong, 1978), but will not
be discussed further in this thesis.
Although this standard segregation of these pathways is well accepted, it is an over
simplification. Neurons from the SNc also send axons to the limbic system and the cortex.
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Fig. 1.5 Dopaminergic nuclei and projections of interest of the rat brain in sagittal view. Nine
major cell groups are represented in navy blue. Projections of interested are also illustrated:
nigrostriatal (light blue), mesolimbic or mesoaccumbal (light grey-blue), and mesocortical
(grey-blue). Adapted from Björklund and Dunnett (2007).
In addition, despite these pathways being anatomically and functionally different, their cell
bodies are intermingled in the VTA and SN (Björklund and Dunnett, 2007). Within the basal
ganglia, it is not only the striatum that receives dopaminergic inputs form the midbrain –
which processes DA signalling via the direct and indirect pathways discussed above -, but also
the GP, ventral pallidum and STN (Hassani et al., 1997; Lindvall and Björklund, 1979). Thus,
downstream effects of basal ganglia signalling extend further than the dorsoventral striatal
influence (or caudate-putamen in primates), allowing for a more complex and comprehensive
influence on the regulation of the circuitry. See below for further details on the striatal
dopaminergic network modulating cognitive flexibility.
1.5.2 Dopamine spike firing and release
DA neurons exhibit two distinct modes of firing activity: tonic and phasic (Goto et al., 2007;
Grace, 1991). Understanding the specific functions that DA mediates depends fundamentally
on phasic versus tonic activity, which governs DA release dynamics and synaptic sites of
action.
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Tonic firing refers to slow and spontaneous firing that is driven by changes in membrane
conductance mediated by glutamatergic inputs (Grace and Bunney, 1984; Grace and Onn,
1989) and GABAergic inhibition (Grace and Bunney, 1979). Importantly, when DA neurons
are tonically activated, release of DA exceeds the synaptic cleft and spills into the extracellular
space. Tonic extracellular DA levels depend on the number of DA neurons that spontaneously
spike in a tonic manner (Grace, 1991) and results in small concentrations varying over
time e.g. 4-20 nM within the striatum (Keefe et al., 1993; Parsons and Justice, 1992).
Although these concentrations are too low to have an effect on post-synaptic neurons, they
are sufficiently high to modulate the activity of pre-synaptic receptors (i.e. autoreceptors)
that regulate release of DA into the synaptic space (Grace, 1991, 2000). Thus, elevated tonic
firing can attenuate phasic DA signalling (Grace, 1991).
Phasic firing, in contrast, refers to sharp changes in firing rate – bursting activity –
leading to large changes in DA release. DA release under these conditions depends on
glutamatergic excitatory innervations from a number of brain regions, including the STN
and the pedunculopontine tegmentum (Floresco et al., 2003; Futami et al., 1995; Smith and
Grace, 1992). Phasic DA release is of high amplitude (e.g. hundreds of µM to nM), transient
and powerful (Goto et al., 2007; Grace, 1991). However, DA is quickly removed from the
synaptic cleft via high affinity uptake that limits the diffusion of DA into the extracellular
space. Phasic signalling is proposed to be the primarily involved in reinforcement learning
(Schultz et al., 1997), which is discussed in more detail below.
1.5.3 Dopamine as a teaching signal
Reward prediction errors
Seminal work from Schultz and colleagues (Schultz et al., 1997) provided insight into the
mechanisms that promote learning resultant from reward prediction errors (RPEs). RPEs
refer to the contrast between learnt expectations and actual outcomes, and are used to update
current beliefs and adjust behaviour (Fig. 1.6). Using electrophysiological recordings in
the midbrain of macaque monkeys, Schultz and colleagues demonstrated that in a task were
a cue would predict the delivery of reward, DA firing rate would increase in response to
an unpredicted reward. If animals were over-trained, they would learn to associate a CS
as predictor of reward, and DA neurons would shift from firing upon presentation of the
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reward to firing upon presentation of the cue. In addition, receiving a larger reward than
expected would transiently increase dopaminergic firing rate (i.e. induce a burst), causing a
so-called positive RPE. In contrast, a smaller reward would pause tonic firing (i.e. induce a
dip), causing a negative RPE. If the reward did not differ from expectation, DA signalling
would remain unchanged (Schultz, 2013; Schultz et al., 1997). Therefore, DA is involved in
reinforcement learning, especially when expectations are violated.
Since the proposal that midbrain DA neurons signalling encodes RPEs was first suggested,
it has been widely confirmed using different behavioural paradigms (Tobler et al., 2003;
Waelti et al., 2001), rewards with distinct properties or dimensions (Lak et al., 2014), and
across species (Cohen et al., 2012; O’Doherty et al., 2006; Takahashi et al., 2016). Further,
a causal link between neuronally encoded RPEs and reinforcement learning has recently
been reported. Thus, it has been shown that timed inhibition of DA activity disrupts learning
(Hamid et al., 2016) whereas hyper-activation of DA neurons with in-vivo optogenetics to
generate an artificial positive RPE increases cue-driven reward-seeking behaviour (Steinberg
et al., 2013). In contrast, inhibition of DA neuronal activity, that simulates an artificial
negative RPE, is sufficient to impair associative learning (Chang et al., 2015). In agreement
with these results, DA transmission also provides a prediction error signal during reversal
learning, transiently decreasing in response to errors following a shift in response-outcome
contingencies, and increasing after unexpected rewards when animals start interacting with
the previously unrewarded stimulus (Klanker et al., 2015; Verharen et al., 2018).
Fig. 1.6 Illustration of reward and reward prediction error (RPE) signals. Before learning,
dopaminergic neurons signal a positive RPE in the presence of an unconditioned stimulus
(US; reward). After learning, the conditioned stimulus (CS; e.g. cue) predicts the delivery
of reward and dopaminergic neurons signal a positive RPE paired with the CS, not the US.
When reward is omitted after learning, activity of dopaminergic neurons is depressed at the
time when the US was expected (i.e. a negative RPE). Adapted from Verharen (2018).
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Model of the basal ganglia
As previously discussed, midbrain DA neurons send dense projections to the striatum, where
RPE signals are processed via the direct and indirect pathways, expressing D1R and D2R,
respectively (see section 1.4.2). Due to their G-coupled protein, post-synaptic D1R are
sensitive to bursts in DA signalling. Thus, positive associations leading to positive RPEs are
strengthened via D1R within the direct pathway. In contrast, post-synaptic D2R are sensitive
to transient dips in DA transmission, so that negative associations leading to negative RPEs
might be weakened via D2R within the indirect pathway (Frank et al., 2004; Yapo et al.,
2017).
Frank and colleagues’ proposed a model for this segregation. In seminal work, they
observed that reinforcement learning was altered in Parkinson’s patients only after they
had taken their dopaminergic medication (Frank et al., 2004). They tested patients using
a probabilistic selection task based on a two-choice visual discrimination, which could
be solved either by learning to approach the positive stimulus, or to avoid the negative
stimulus. They found that patients had a selective decline in learning from losses. A
proposed explanation was that over-physiological states of DA hindered learning from
negative feedback by leaving D2R-expressing striatopallidal neurons insensitive to dips in
DA, thereby blocking learning from negative feedback. In contrast, diminished levels of DA
would hypothetically prevent D1R-expressing nigrostriatal cells from detecting DA burst
firing, thus blunting learning from positive feedback (Cox et al., 2015; Frank et al., 2004).
Consequently, to identify the specific role of different DA pathways in reversal learning,
it is important to differentiate between learning from positive and negative feedback, or
behaviours approaching the positive stimulus from behaviours avoiding the negative stimulus.
1.5.4 Dopaminergic receptors
Receptors subtypes
The existence of multiple types of DA receptors was first proposed in 1976 (Cools and Van
Rossum, 1976). At least five distinct subtypes of DA receptors, D1R, D2R, D3, D4 and D5
receptors (D3R; D4R; D5R) have been described (Surmeier et al., 2007, 1996) and classified
into two families: D1-like receptor, encompassing D1R and D5R; and D2-like receptors,
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encompassing D2R, D3R and D4R. The classification was established based on the genomic
organisation of DA receptors, but primarily on the G protein they are coupled to: D1-like
are Gs-coupled, leading to activation of the neuron, while D2-like receptors are Gi-coupled,
which inhibits neuron, as reviewed in section 2.2.2. D2R can be subdivided based on two
distinct isoforms that arise from alternative gene splicing: D2R short (D2S) and long (D2L)
variants (Giros et al., 1989), which differ in their localisation and function (Centonze et al.,
2004).
The receptors subtypes also differ in their baseline affinity states. Affinity is defined as
the strength of the intermolecular force between the receptor and its ligand (in this case,
DA). For high-affinity receptors, the ligand takes longer to dissociate from the receptor
than for low-affinity receptors. This affects the concentration of ligand required to saturate
occupation of a receptor: low-affinity receptors require larger concentrations than high-
affinity receptors. D2-like receptors have greater affinity than D1-like receptors (Richfield
et al., 1989). Hence, D2-like receptors are considered to be more sensitive to low levels
of DA, while D1-like receptors are more easily activated by phasic DA changes (Richfield
et al., 1989) – although the high-affinity of D2-like receptors has recently been challenged
(Yapo et al., 2017). This differentiation has given rise to behavioural models linking D1-like
receptors with reward learning and D2-like receptors with overall motivational levels (Missale
et al., 1998). However, recent studies show that D2-like receptors are sensitive to pauses and
phasic increases in DA neuron firing and release (Marcott et al., 2014).
Within the central nervous system (CNS), D1-like receptors are present in higher density
in the striatum, SNr, and olfactory bulb (De Keyser et al., 1988). A lower level of expression
has been reported in the entopeduncular nucleus, cerebral aqueduct, ventricles, with even
lower expression in the dorsolateral PFC, cingulate cortex and hippocampus (Boyson et al.,
1986; Savasta et al., 1986). D2-like receptors are mainly expressed in the striatum. They
are also present in the GPe, cerebral cortex, amygdala, and pituitary gland (De Keyser et al.,
1988; Jackson and Westlind-Danielsson, 1994).
Functional interactions of DA receptors in the striatum
Within the striatum, D1R and D2R are found throughout the region in elevated density, from
dorsal to ventral subregions (Gerfen et al., 1990; Matamales et al., 2009; Surmeier et al.,
2009). D5R are present in low levels in MSNs, but are highly expressed in interneurons
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(Rivera et al., 2002). D3R and D4R are expressed in low levels in the dorsal striatum (Mrzljak
et al., 1996; Surmeier et al., 1996). There is also significant expression of D3R, but not D4R,
in the NAc (Mrzljak et al., 1996; Richtand et al., 1995).
Although the segregation of striatal MSNs between direct and indirect pathways has been
widely accepted, the separate distribution of D1R and D2R within this anatomical dichotomy
is less clear. Much work has been done to distinguish whether these receptors are expressed
in different MSNs or co-expressed in the same neurons (Aizman et al., 2000; Surmeier et al.,
1992, 1996). In the dorsal striatum, only a minority (i.e. 5%) of neurons co-express D1R
and D2R and it is widely accepted that the D1R and D2R defined MSNs project to the
SNr and GPe, respectively, following the direct and indirect pathway segregation (Surmeier
et al., 1996). Neurons expressing D1R, D2R or co-expressing both account for the totality of
MSNs. However, D1-like and D2-like receptors do not appear to be that well separated. For
example, it has been reported that some D2R-expressing MSNs also contain D5R, and a high
number of D1R-expressing MSNs (i.e. up to 70%) contain D3R and/or D4R. Nonetheless, as
previously mentioned, D3R, D4R, and D5R are present in a much lower level than D1R and
D2R (Surmeier et al., 1996).
In the ventral striatum, the dissociation is further complicated in relation to the dorsal
striatum. On one hand, the MSN population co-expressing D1R and D2R is higher, being 6%
in the NAcC and 17% in the NAcS (Bertran-Gonzalez et al., 2008; Matamales et al., 2009).
On the other hand, a comparatively higher number of cells also express D3R. Double-staining
studies have estimated that 33% of D2R-expressing MSN in the NAc (NAcC and NAcS)
co-express D3R, compared to 22% in the NAcC and 54% in the NAcS (Le Moine and Bloch,
1996; Schwartz et al., 1998).
Less is known about post-synaptic receptors in interneurons. Cholinergic interneurons
express D5R and D2R, but not D1R (Bertran-Gonzalez et al., 2008; Rivera et al., 2002). It is
unknown if D3R and D4R are present in striatal interneurons. It has also been suggested that
GABAergic terminals originating from interneurons express D2R (Bertran-Gonzalez et al.,
2008).
Pre-synaptically, D2R-like receptors are expressed on glutamatergic (Hsu et al., 1995),
GABAergic (Guzmán et al., 2003), cholinergic (Pisani et al., 2000), and dopaminergic
(Benoit-Marand et al., 2001) axon terminals in the striatum. Some studies suggest that D2R
are mainly expressed pre-synaptically, act as autoreceptors, and belong to the D2S isoform.
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In contrast, D2R expressed in post-synaptic neurons belong to the D2L isoform (Usiello et al.,
2000), although recent studies suggest post-synaptic D2R can also belong to the D2S isoform
(Gantz et al., 2015). Exclusively in the NAc, D1-like receptors have also been observed
pre-synaptically on glutamatergic terminals (Dumartin et al., 2007).
Despite the complexity of the distribution of DA receptors in the striatum, D1R- and
D2R-expressing neurons present morphological and dendritic excitability differences, and
D1R and D2R receptors represent the greatest population of expressed receptors, both in
the dorsal and ventral striatum (Day et al., 2008; Gertler et al., 2008; Richtand et al., 1995).
Therefore, they are still classified as D1R- and D2R-dominant MSNs. Consequently, from
this point forward, D1-like and D2-like receptors will be referred to as D1R and D2R,
respectively.
Interaction of D2R and adenosine receptors
Adenosine is considered to be a neuromodulator in the CNS, where it regulates neuronal
excitability and neurotransmitters release via its four subtypes of G-protein-coupled receptors:
A1, A2A, A2B and A3 (Borea et al., 2018). Whereas adenosine A2A (A2AR) and A2B
receptors preferably interact with Gs proteins, A1 and A3 interact with Gi proteins.
Adenosine A1 receptors are present in nearly all brain areas and suppress neuronal
excitability (Borea et al., 2018). In contrast, A2AR are almost exclusively found in DA-rich
areas – such as the striatum –, where they promote neuronal activation (Borea et al., 2018;
Vontell et al., 2010). Adenosine A2B and A3 receptors are mainly expressed in the peripheral,
and have therefore received less attention in research on cognition (Daly et al., 1983; Dixon
et al., 1996; Zhou et al., 1992).
One of the most important roles of adenosine is to induce a brake in the CNS. This
inhibitory function is largely modulated by the activation of one subtype of receptors: A2AR,
which are specifically expressed in striatopallidal neurons in the striatum (DeMet and Chicz-
DeMet, 2002; Ferré, 2008) (Fig. 1.7). These neurons not only express the highest density of
D2R in the brain, but also the highest density of A2AR of any other neuron type or brain
area (Ferré, 2008). It is well documented that adenosine exerts its function in MSNs from the
indirect pathway through intermolecular interactions between A2AR and D2R, which form
receptor heteromers. This shared localisation, combined with evidence that A2AR and D2R
26 Introduction
have an antagonistic inter-relationship, implicates adenosine in functions associated with DA
signalling (Ferré, 2008; Furlong et al., 2017; Nunes et al., 2013; Santerre et al., 2012).
Fig. 1.7 Illustration of D2R-mediated pre- and post-synaptic signalling in neurons. At
the pre-synaptic cell, D2R mainly belong to the short isoform (D2S), where they regulate
synthesis and release of dopamine (DA). D2S regulates DA synthesis by phosphorylating (P)
tyrosine hydroxylase (TH), which transforms tyrosine into L-DOPA, the DA precursor. Pre-
synaptically, D2S also modulate activity of the DA transporter (DAT). At the post-synaptic
cell, D2R mainly belong to the long isoform (D2L), although D2S can also be present. Post-
synaptically, D2R form heteromers with adenosine 2A (A2A) receptors (A2AR). Whereas
D2R are coupled to Gi protein and inhibit adenylyl cyclase (AC), A2AR are coupled to Gs
and activate AC. Following the AC downstream cellular pathway, D2R activation leads to
cell inhibition, whilst A2AR lead to cell activation. D2R can also act via calcium (Ca2+) or
G-independently via β -arrestin2.
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1.5.5 Role of DA in reversal learning
DA regulates synaptic plasticity in brain areas noted for modulating reversal-learning perfor-
mance: the cortex and the striatum (Cagniard et al., 2006; Calabresi et al., 2007), encodes
RPEs (Schultz, 2013), and dopaminergic interventions affect different forms of learning
(Steinberg et al., 2013). Striatal DA plays a key role in modulating reversal learning, as
shown by induced non-perseverative impairments in reversal learning following DA depletion
in the striatum in marmosets (Clarke et al., 2011, 2007).
Further research supports the central involvement of DA in reversal learning (Izquierdo
et al., 2017). Increases in striatal DA levels following methylphenidate administration
improve reversal learning in humans (Clatworthy et al., 2009). In rats, Klanker and colleagues
showed that DA levels increase in the ventromedial striatum in response to unexpected
rewards in a spatial reversal-learning task (Klanker et al., 2013), suggesting that striatal DA
modulates its performance.
DA receptors subtypes have been differentially involved in mediating reversal learning.
Many studies have investigated the potential role of each subtype in this form of behavioural
flexibility. Systemic administration of a D1R agonist impaired early stages of visual reversal-
learning task on touchscreens in mice (Izquierdo et al., 2006). It has been proposed that
the circuit innervating the NAc from the basolateral amygdala mediates this effect, since it
enhances behaviours related to reward via D1R (Stuber et al., 2010). Indeed, local infusions
of a D1R antagonist into the NAcC improved performance during the early phase of visual
serial reversal learning tested on touchscreens (Sala-Bayo et al., 2020).
Systemic administration of D2R agonists impaired spatial reversal learning in rodents,
whereas D2R antagonists did not affect reversal performance (Boulougouris et al., 2009).
Low DA availability is related to poor performance in rodents (Laughlin et al., 2011), non-
human primates (Groman et al., 2011), and humans (Jocham et al., 2009). D2R antagonism,
but not D1R, in the DMS and DLS impairs reversal learning performance at different stages
in a complementary manner i.e. the manipulations in the DMS affect mid stages, whereas of
the DLS affect overall performance, including early and late stages (Sala-Bayo et al., 2020).
A cumulative piece of work indicates that reversal learning relies on optimal balance of D2R
function. D2R functional balance has canonically been referred to as an inverted U-shaped
function of DA, or a triphasic effect of D2R agents, showing that both low and high levels of
DA function lead to cognitive impairments, and behavioural improvements may be found in
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an optimal level in between both extremes in DA signalling (Horst et al., 2019; Yerkes and
Dodson, 1908).
1.6 Thesis overview
1.6.1 Summary and aim
Cognitive flexibility refers to how individuals adapt their behaviour to changes in the envi-
ronment. Although important for survival and wellbeing, cognitive flexibility is impaired in
a wide range of neurological and neuropsychiatric disorders, including Parkinson’s disease
and OCD. Optimal flexibility is known to depend on DA neurotransmission in the CNS.
During reversal, subjects must adapt and respond to the formerly non-rewarded stimulus
whilst ignoring the initially rewarded stimulus. Learning on this task thus requires constant
shifts in behaviour in response to positive (rewarded) and negative (non-rewarded) feedback.
Although the concepts of reward prediction, learning and flexible behaviour have been
associated with DA, the precise mechanism and brain loci underlying the effects of DA on
flexible decision-making remain unclear. Many unanswered questions reflect the present
inability to tie these aspects of its function together, a likely consequence of an imprecise
level of investigation at the brain and behavioural levels. These questions include: what brain
subregions and receptors modulate cognitive flexibility? Do they modulate reversal learning
in a complementary and dynamic manner? Which stages or cognitive subprocesses does DA
modulate? How are positive or negative feedback signals integrated within the striatum? Do
RPEs causally modulate reversal learning performance? If so, via what neuronal projections
and in what cognitive subprocesses?
Thus, the main aim of my thesis is to provide more refined insights into the above
questions, with the overarching hypothesis that DA modulates reversal learning performance
by signalling positive and negative RPEs within the direct (rewarded) and indirect (non-
rewarded) pathways, respectively.
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1.6.2 Outline
In this thesis, cognitive flexibility was inferred in experimental rats by evaluating their per-
formance in reversal-learning tasks involving a two-choice discrimination between rewarded
and non-rewarded stimuli. To investigate the main hypothesis described above, I used a range
of experimental approaches to interrogate the neuromodulation of the direct and indirect
pathways by DA.
Chapter 2 describes the general methods, including methodology common to at least two
experimental chapters.
Chapter 3 aims to elucidate the dissociable effects of D1R and D2R in the NAcS during
reversal learning. I used a serial visual reversal-learning task and local administration of
D1R and D2R antagonists while animals performed a serial visual reversal-learning task to
assess the role of this region and receptors in different phases of reversal learning.
Chapter 4 aims to determine the role of D2R in reversal learning and their influence in
modulating learning from positive or negative feedback. The recently developed valence-
probe visual discrimination task (Alsiö et al., 2019) was used to dissociate different compo-
nents of reversal learning and investigated the extent to which these were dependent on D2R
systemically or locally in the NAcC and NAcS.
Chapter 5 aims to determine the synaptic location – pre- or post-synaptic – of D2R
involved in the modulation of reversal learning. I used a post-synaptic probe compound (an
A2AR antagonist) in a spatial probabilistic reversal-learning task in combination with D2R
agents to test if the effects of D2R agonism in reversal learning were selectively mediated by
striatopallidal D2R.
Chapter 6 aims to dissociate the role that RPEs generated in the nigrostriatal or mesolim-
bic pathways have in modulating reversal-learning performance. In-vivo optogenetics was
used to stimulate the activity in both circuits during specific time points in a spatial prob-
abilistic reversal-learning task to investigate the causal link between bursts of DA firing,




This chapter describes methodology common to more than one experimental chapter. All
other methods specific to individual experiments or further specifications to the methods
given in this chapter are provided in the relevant chapter.
2.1 Subjects
Subjects were male Lister Hooded rats, housed in groups of four under temperature- and
humidity-controlled conditions and a 12:12h dark cycle. Rats were allowed a minimum of
7 days of acclimatization to the animal facility before any procedure began. All rats were
∼300 g at the beginning of training and were maintained at 90% of their free-feeding weight
by food restriction (19 g/day of Purina chow). Water was provided ad libitum in the home
cage.
In Cambridge, all experimental procedures were subject to regulation by the United
Kingdom Home Office (project License 70/7548) according to the Animals (Scientific Proce-
dures) Act 1986 Amendment Regulations 2012 following ethical review by the University of
Cambridge Animal Welfare and Ethical Review Body (AWERB).
At Boehringer Ingelheim, Germany, all experiments were performed in accordance with
EU and German animal experiment legislation, under the license VVH-18-040-G granted by
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local authorities, and under the direct supervision of Boehringer Ingelheim internal animal
welfare officer.
2.2 Apparatus
2.2.1 Touchscreen operant chambers
The behavioural apparatus consisted of 28 touchscreen operant chambers (modified from
Med Associates, Georgia, VT, USA), each measuring 29 × 31 × 24 cm with Plexiglas
ceiling, front door and back panel. The floor was stainless steel bars separated by one cm
from each other with a tray underneath. Access was through a hinged sidewall, secured with
a latch during testing. Each chamber was equipped with a fan, house light (3 W), pellet
dispenser, and magazine with light and photocell nose poke detector. The opposite wall was
replaced with an infrared touchscreen monitor (29 × 23 cm).
2.2.2 Lever pressing chambers
The behavioural apparatus were eight operant chambers (Med Associates, Georgia, VT,
USA), each enclosed within a sound-attenuating wooden box fitted with a fan for ventilation.
Each chamber measured 31.4 × 25.4 × 26.7 cm with a Plexiglas ceiling, front door, and back
panel. On one side of the chamber, a food magazine was centrally located and equipped with
a light and photocell nose-poke detector. A pellet dispenser was connected to the magazine
to deliver the reward: 45 mg sucrose pellets (5TUL, TestDiet, USA). Two retractable levers
and a cue light above each lever flanked the magazine. On the same wall, a house light (3 W)
was located to illuminate the chamber. The floor was made of stainless bars, each separated
by one cm with a tray underneath. Access was through a hinged sidewall, secured with a
latch during testing. The ceiling had a centered 5 cm diameter hole to allow electrical cables
into the chamber.
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2.3 Behavioural procedures
This section is divided between the visual reversal learning tasks, tested using touchscreen
operant chambers at the University of Cambridge, and the spatial probabilistic reversal
learning tested using lever-based operant chambers at Boehringer Ingelheim, Germany. In all
the experiments, animals were tested once each day, 5-7 days a week, until completion of
the study. Behavioural training started at least 2 days after food restriction. Before being
exposed to the behavioural test chambers, rats received ∼30 sugar pellets in their home cage.
2.3.1 Visual reversal learning
Visual reversal learning was tested in touchscreen operant chambers. Performance required
pre-training stages, training in visual discrimination, training in reversal learning and, finally,
testing in the reversal-learning task (Fig. 2.1). Two different visual tasks were used: 1) serial
reversal learning and 2) valence-probe visual discrimination (VPVD) task. Both tasks share
pre-training, visual discrimination training, and the majority of the reversal-learning training
stage. For this reason, the description of these tasks is common for both until the final stages
of training and testing.
Training stages
Pre-training
The purpose of the pre-training sessions was to ensure that animals touched a start box at
the bottom of the touchscreen, which in later stages would initiate the trial. Completion of
this phase required approximately 2 weeks (Fig. 2.1A).
Rats were initially trained to touch the screens with daily sessions of 60 min or 100 trials.
Pre-training consisted of five stages with gradually increased difficulty (Fig. 2.1B). Briefly,
in stage 1, a large white horizontal square ‘start-box’ (15 × 9 cm) was presented in the
bottom centre of the screen, and touching it was associated with reward (45 mg sucrose pellet;
TestDiet 5UTL; Sandown Scientific, Middlesex, UK). The size of the ‘start box’ decreased
throughout the stages until measuring 3 × 4 cm in stage 3. In stages 1-3, animals were
moved to the next stage when reaching 100 responses/rewards per session.
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Fig. 2.1 Figure caption on following page.
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Fig. 2.1 Overview of the touchscreen reversal-learning paradigm. A) Experimental timeline of
the behavioural procedure, including pre-training stages, visual discrimination (VD), training
in the relevant version of the reversal-learning task, surgeries and recovery when required
by the experiment, baseline (BL) and behavioural testing with the relevant manipulation.
B) Pre-raining stages. In stages 1-3 the white box decreases in size with stage level and
becomes the start box. In stages 4 and 5 either the horizontal or the vertical stimulus is
presented following touching the start box from stage 3. Stimuli are placed pseudo-randomly
left/right. C) Representation of the stimuli presented during VD and initial, shared stages of
reversal learning training. D) Flowchart of the visual discrimination and reversal task. E)
Representation of a rat performing in the operant chambers.
In stage 4, touching the white box was not reinforced but led to the presentation of a
visual stimulus (vertical or horizontal bars) with a pseudo-random spatial location, presented
on the left or right of the touchscreen. The same stimulus was not displayed on the same
side for more than three consecutive trials to avoid side-bias. Responding to the stimulus
was reinforced, whereas the blank side led to the illumination of the house-light for a 5 s
time-out (TO) period. After collecting the reward, an inter-trial interval (ITI) of 5 s was
imposed. During stage 5, stimuli were presented slightly higher than in previous stages to
avoid accidental touches e.g. with the tail. The criterion to move from stages 4 and 5 was ≥
80% of correct responses per session.
Visual discrimination training
Following pre-training stages, subjects were trained on a visual two-choice discrimination
task (Fig. 2.1D). In this version of the task, touching the square ‘start box’ triggered the
simultaneous presentation of two stimuli (i.e. vertical and horizontal bars), placed pseudo-
randomly on either the left or right side of the screen (Alsiö et al., 2015). The ‘start-box’ was
used to ensure a central position of the animal before the choice phase. Responses to one
stimulus (i.e. CS+) were associated with reward and collecting the reward initiated the next
ITI. In contrast, responses to the other stimulus (i.e. CS-) were not rewarded and led to a
house light-signalled TO. The response window after stimulus presentation was set to 10 s,
after which the trial was deemed an omission and led to a new ITI. The session ended after
250 trials, 50 rewards or 1 h, whichever came first.
Criterion for discrimination learning was set at 24 correct responses out of 30 consecutive
trials. Once acquired within any session, rats were given a retention session with the same
reward contingencies to ensure they had reliably acquired the visual discrimination.
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Reversal learning training
Following acquisition of visual discrimination, animals were trained on the serial visual
reversal learning task (Fig. 2.1C, E)). After the discrimination and retention sessions,
contingencies reversed so the previous CS+ was then CS- and vice versa. Rats were required
to respond to the new CS+ until reaching the discrimination criterion (≥ 24/30 correct
responses). After reaching criterion, an extra retention session was run.
Following reversal training, animals were tested in either the serial reversal-learning
task (see section 1.3.2) or the valence-probe visual discrimination (VPVD) reversal task
(see section 1.3.3). For the serial reversal-learning task, but not the VPVD task, additional
reversals were given until rats were able to attain the discrimination criterion within three
daily sessions. A retention session was run before each reversal and after reaching the
criterion (Fig. 2.1D), both in training and testing.
Serial reversal learning task
When animals met the criterion of completing a reversal within 3 sessions, they underwent
surgery for cannula implantation. Following recovery from surgery, and prior to testing, rats
were tested with a single reversal learning session as a baseline to ensure stable serial reversal
performance. The following session was a retention session, followed the following day by a
reversal session. Stimulus-outcome conditions were reversed prior to the reversal session, so
that the previous rewarded stimulus was now non-rewarded and vice versa. Animals were
tested on multiple sessions until reaching the discrimination criterion (> 24/30 correct trials)
within one session. A retention session was ran the following day. This process was repeated
for each drug and dose of each Latin-square (LSQ) or crossover design. In serial reversal
learning, the effects of each dose of drug were tested using a within-subject’s design. Each
reversal, including retention sessions, lasted seven days or less.
VPVD task
Studies in patients with neurological disorders have established alterations in adapting
behaviour on the basis of positive and negative feedback, including subjects with depression
or with Parkinson’s disease off-medicine (Elliott et al., 1997; Frank et al., 2004). The typical
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touchscreen visual discrimination procedures require the subjects to discriminate between
CS+ and CS- (Brigman et al., 2013; Horner et al., 2013). The recently developed VPVD
task (Alsiö et al., 2019) is based on two-choice visual discrimination and reversal learning,
but extends the traditional framework by introducing a third probe neutral stimulus (C50/50)
that is rewarded 50% of the times (Fig. 2.2). By examining animals’ performance on these
‘probe trials’, it is possible to determine the impact of positive and negative association on
task performance.
Fig. 2.2 Overview of the trial types and trial structure in the VPVD reversal task. A) Regular
two-choice trials during both visual discrimination (VD; A+ > B-) and subsequent reversal
learning (A- < B+) are alternated with probe trials. During such trials, a third neutral stimulus
that is rewarded 50% of the times (C50/50) is presented against the positive or the negative
stimulus. B) Illustration of a possible set of trials presented during the session. The order
and combination of stimuli are pseudo-randomised, including probe trials, although these are
never presented during the first trial.
Following reversal learning training, standard discrimination trials (CS+ vs CS-) were
interleaved with the third probe neutral stimulus (C50/50, “Diamonds”). That is, C50/50 was
optimal over CS- but not over CS+ (Fig. 2.2A). Each probe trial was randomly presented
once every eight trials (2/8 probe trials in total), although never on the first trial (Fig. 2.2B).
The remaining six trials were standard discrimination to ensure animals’ learning was mainly
driven by the deterministic conditions. No omissions were allowed in this task in order to
ensure rats had completed the probe trials. Instead, a tone was presented every time a trial
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was rewarded. Rats trained for five sessions on the same CS+ and CS- during the training
reversal above (i.e. “Horizontal” vs “Vertical”) in combination with the C50/50 stimulus.
After completing the discrimination, they were trained on the same conditions but with a
novel pair of stimuli (“Forward slash” vs “Backslash”, counterbalanced across rats). CS+
and CS- were referred to as A+ and B- during visual discrimination. Training continued
for a minimum of 5 sessions and was extended for those animals that did not reach 80%
correct on the standard trials (A+ > B-). Next, rats ran a retention session preceded by
vehicle infusions (baseline). On the following day, rats were matched for stimulus-reward
contingencies, performance on the baseline day and during reversal training and were pseudo-
randomly allocated to a drug group. The stimulus-reward contingencies were reversed for
the deterministic stimuli (A- < B+) at the beginning of the session and the reversal phase
continued for 10 days. The C50/50 stimulus value remained the same. A summary of the task
is shown in Table 2.1.
2.3.2 Spatial probabilistic reversal learning
Training stages
Animals were first habituated to the chambers for 15 min with three sugar pellets placed in
the magazine before the start of the session. In all stages (Table 2.2), trials began with the
illumination of the magazine light. Animals were then trained in stage 01 or ‘conditioning’,
which consisted of 60 min sessions of 40 trials to learn that pressing the lever delivered a
reward pellet. Both levers were presented simultaneously, and if one of them was pressed,
three pellets were delivered; if not, only one pellet was delivered. The criterion to move to
the next stage was the completion of 40 trials. All the following training stages consisted of
sessions of 60 min or 120 trials, whichever came first, and incorporated an inter-trial interval
(ITI) of 10 sec, a time-out (TO) of 5 sec after an incorrect response, and a limit hold (LH)
of 30 sec, after which levers were retracted and the trial was considered as an omission.
Criterion to move to the next stages was the attainment of ≥ 80 correct trials. In the next
stage, stage02 or ‘must press’, animals were trained to press the lever to receive a reward
by receiving one pellet when one of the two levers was touched, or none if not. After 60
trials, the preferred lever was retracted to force animals to press the adjacent lever and so not
develop a side bias. The following stage, stage03 or ‘must initiate’, had the same set-up as
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Table 2.1 Summary of the VPVD task stages, including stimuli presented, expected duration
and purpose of the stage. When required, surgeries are performed in between achieving
criterion for the first discrimination in the VPVD task and the beginning of the second
discrimination. Training is achieved with “Horizontal”/”Vertical” bars as A+ and B-, which
are rewarded 100% and 0% of the times. To train in the VPVD task, a new third stimu-
lus (“Diamonds”) is introduced, which is rewarded 50% of the times. For testing, a new
set of A+/B- stimuli is introduced to avoid behavioural artefacts due to previous experi-
ences with the stimuli. The animals are trained in a second discrimination using “Forward
Slash”/”Backslash”, which follow the same principal as the previous vertical and horizontal
bars. Diamonds stimulus remains unaltered
the previous one but animals had to nose poke into an empty magazine to initiate the trial. A
light in the food magazine was flashed to indicate the difference from pellet delivery, which
was indicated with a steady light. The last training stage was stage04, a one-sided version
of the full task. The aim was to avoid side-bias and that both levers could be rewarded in
a probability basis. For this, both cue lights would turn on and after 3 sec, only one of the
levers came out, which was rewarded 80% of the times. After 30 consecutive trials, the levers
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shifted. At least two sessions reaching criterion (≥ 80 correct trials) were required to move
to probabilistic reversal learning (PRL) task training.
Table 2.2 Overview of the training stages in the PRL task, including habituation (Stage00),
the four learning stages (Stage01-Stage04), and the full version of the task (StageV01).
Probabilistic reversal learning
PRL procedures, although are recent, have been widely used to study flexible behaviour in
rodents and humans (Bari et al., 2010; den Ouden et al., 2013; Ineichen et al., 2012). PRL
paradigms often involve the release of probabilistic feedback, so that the correct choice is
spuriously punished, and the incorrect choice is spuriously reinforced (Fig. 2.3B).
The procedures used in the present study (Fig. 2.3) were modified from those described
in (Bari et al., 2010) for the use of retractable levers instead of nose poking holes. Daily
sessions consisted of 200 trials or 60 min, whichever came first, including ITI of 10 sec, TO
of 5 sec and LH of 10 sec.
At the start of each session, one of the two levers was randomly selected to be optimal or
suboptimal. Sessions began with two free pellets in the magazine and illumination of the
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Fig. 2.3 Overview of the PRL task. A) Illustration of the rats performing in the lever-pressing
operant chambers. After eight consecutive correct trials on the optimal lever (CS+; 80%
rewarded), conditions reverse, so that the previously optimal lever is now suboptimal (CS-;
20% rewarded), and vice versa. B) Flowchart of the PRL task.
magazine light. After nose poking, the magazine light was extinguished and the two cue
lights turned on indicating that three seconds later the levers would be available. A response
to the optimal lever delivered a single reward pellet on 80% of the trials, whereas a response
to the suboptimal lever gave reward on only 20% of the trials. A failure to press a lever
within the LH led to their retraction and termination of the trial, which was noted as an
omission. After eight consecutive correct trials (i.e. pressing the optimal lever regardless
of it being reinforced or not), the contingencies were reversed, so that the previous optimal
lever was now suboptimal and vice versa (Fig. 2.3A). This pattern was repeated over the
session. Animals were trained until they could achieve at least three reversals per session
over three consecutive sessions. Once this criterion was met, rats underwent testing.
2.4 Surgeries
Surgical procedures were performed following standard stereotaxic techniques for cannula
implantation (Chapters 3 and 4) and expression of viral vectors (Chapter 6). Methods for
viral vector infusion studies are presented in Chapter 6.
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Rats were anaesthetised using isoflurane in 5% oxygen and secured in a stereotaxic
frame fitted with atraumatic ear bars. Anesthesia was maintained at 2.5% isoflurane. Baytril
(1 mg/kg; 100 mg/ml; Bayer, Germany) and metacam (1 mg/kg; 5 mg/ml; Boehringer
Ingelheim, Germany) diluted in distilled water 1:1 were injected subcutaneously prior to
surgery.
2.4.1 Cannula implantation
Specifications of guided cannulas and coordinates are included in each chapter.
Flat skull was ensured by measuring DV from lambda and Bregma. Coordinates were
according to Paxinos and Watson (1998). Four metal screws and dental cement secured the
guide cannulas to the skull. Obturators were introduced in the guide cannulas and protected
with a dust cap. After surgery, animals were single-housed, received metacam orally (1.5
mg/ml at 1 mg/kg) during three days post-surgery, and allowed ≥ 7 days of recovery.
2.5 Drug microinfusions
After a baseline session, animals received a mock infusion, consisting of introducing the
injectors to the guide cannula without infusion of liquid. The injectors were connected to the
lines with filtered saline to prevent air entrance to the brain. The day prior to testing, they
received a retention session preceded by an infusion of vehicle to allow habituation to the
infusion procedure (vehicle composition described in each chapter including infusions i.e.
Chapters 3 and 4). During infusions, rats were placed on the lap of the researcher and were
gently restrained. Animals were infused bilaterally with a total volume of 0.5 µl/side over
2 min. Injectors (Plastics One, 28-gauge, USA) were left in place 1 min before and after
the infusions, and rats were placed in their home cages before putting them in the operant
chambers to test the behavioural effects of each drug. Timings and injectors’ extension below
the guide cannula are specified in each experimental chapter. Doses were pseudo-randomised
depending on baseline performance on the day prior to testing.
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2.6 Histologies for cannula tip placement
Following completion of the behavioural procedures, animals were anaesthetised with a lethal
dose of pentobarbitone (∼2 ml; Boehringer Ingelheim, Germany) and perfused transcardially
with 0.01 M phosphate buffer saline (PBS) followed by 4% paraformaldehyde (PFA). Brains
were removed, post-fixed in PFA for 24 h and dehydrated in 30% sucrose in 0.01 M PBS.
Brains were sectioned coronally at 60 µm. They were then mounted, stained with cresyl
violet and cover slipped to verify injector-tip placements within inside the NAcC or the
NAcS. Only animals with correct cannula placement were included in the analysis.
2.7 Statistical methods
Statistical tests were performed with R, version 1.2.1335 (RStudio Inc). The main dependent
variables analysed are specified in each chapter. Normality was confirmed with a quantile-
quantile plot (Q-Q plot). For repeated measures variables, sphericity was checked with the
Mauchly’s test for sphericity and corrected with Greenhouse-Geisser when required.
Data were then subjected to ANOVA or Linear Mixed-Effects Model analysis using the
lmer package in R. When significant interactions were found, analysis was followed by post-
hoc pairwise comparisons using the emmeans package in R. If any number of comparisons
were made among the set of groups, a Tukey’s procedure was used to correct p-values. Instead,
if treatment groups were compared against a control group, Dunnett’s test was applied to
correct p-values. Experiments in the VPVD task considered dose as a between-subject effect.
In the PRL task, reversible treatments (e.g. drug doses and light conditions in optogenetics)
were analysed as within-subjects, whereas irreversible manipulations (e.g. opsin-expressing
groups) were analysed as between-subjects factors. Significance was considered at α = 0.05.

Chapter 3
Accumbal dopamine D1 and D2
receptors differentially modulate distinct
phases of serial visual reversal learning
3.1 Introduction
Converging evidence from reversal learning tests implicates DA as an important modulator of
such flexible behaviour. For instance, systemic blockade or agonism of D2R impairs reversal
learning in vervet monkeys and rats (Boulougouris et al., 2009; Lee et al., 2007), while D2R
knockout mice show deficiencies in initial visual discrimination and in reversal learning
(Kruzich and Grandy, 2004). In contrast, pharmacological activation of D1R impaired early
phases of reversal learning (Izquierdo et al., 2006), whereas D1R antagonism did not alter
reversal learning performance (Lee et al., 2007). In healthy humans, repeated variations in the
DA transporter gene, DAT1, have been linked to performance during the early, perseverative
phase of reversal learning, when prior beliefs about the stimulus-reward outcomes still guide
behaviour, whereas accuracy during later phases, when new learning takes place, showed no
such link (den Ouden et al., 2013).
The main subregions of the dorsal striatum, namely the caudate nucleus and the putamen
in primates and the DMS and DLS in rodents, have also been differentially linked to reversal
learning. Recent evidence suggests that pharmacological inactivation of the putamen and
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caudate nucleus differentially affect serial visual reversal learning in marmoset monkeys
(Jackson et al., 2019). D2R availability in these subregions of vervet monkeys is associated
with reversal learning performance (Groman et al., 2011). Importantly, previous research of
ours, presented in Dr Leanne Young’s thesis (Young, 2019), showed a complimentary role of
the DMS and DLS depending on the phase of reversal learning: early, mid or late (Sala-Bayo
et al., 2020). D2R antagonism into the DMS increased errors to reach criterion to complete
reversal in the mid phase, whereas D2R antagonism into the DLS increased overall errors,
especially in the early and late phases. In contrast, D1R antagonism in these regions did not
affect reversal-learning performance. However, less is known about the role of these two
receptors in the ventral striatum.
Previous studies have shown that increased dopaminergic tone in the NAc, or infusions of
a D2R agonist (quinpirole) into this area impaired reversal learning in rats, whereas infusions
of a D1R agonist (SKF81297) disrupted set-shifting by increasing perseverative behaviour
(Haluk and Floresco, 2009). Lesions of the NAc disrupted initial stimulus discrimination and
reversal learning (Annett et al., 1989; Taghzouti et al., 1985), including spatial, but not visual,
reversal learning in monkeys (Stern and Passingham, 1995), and pharmacological inactivation
impaired probabilistic learning in rats (Dalton et al., 2014). However, other studies report no
effect of NAc interventions on such flexibility (Castañé et al., 2010; Schoenbaum and Setlow,
2003).
This discrepancy may be explained by the heterogeneity of the NAc with the NAcC
and NAcS often being suggested to play opposite roles in modulating behaviour, and con-
tributing differentially to e.g. attention (Corbit et al., 2001; Floresco et al., 2006) and
impulsivity-related behaviours (Besson et al., 2010; Economidou et al., 2012; Sesia et al.,
2008). For instance, inactivation of the NAcS impaired probabilistic reversal performance
in rats, identifying a key role for this nucleus in using probabilistic reward feedback to
facilitate discriminative learning and flexibility, whereas inactivation of the NAcC, while
not affecting performance accuracy did cause a general slowing of approach toward the
response levers (Dalton et al., 2014). Previous results from the lab (Sala-Bayo et al., 2020)
reported that infusions of a D2R antagonism (raclopride) into the NAcC selectively improved
performance in reversal learning by reducing the number of errors to reach criterion in the
early, perseverative phase. In contrast, no effect on reversals was observed when blocking
D1R within this region.
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Taken together, this evidence suggests that elevated DA activity in the ventral striatum
leads to impaired reversal learning. However, the role of D1R and D2R in the NAcS in visual
reversal learning or of their involvement in its different learning phases is unknown.
3.2 Aims, approaches, and hypotheses
The aim of this study was to investigate whether D1R and D2R in the NAcS differentially
affect reversal learning, and on the different phases of reversal learning. To achieve this
goal and better understand such dissociations, I explored the behavioural effects of local
administration of a D2R antagonist and a D1R antagonist using a serial visual reversal-
learning task on touchscreen operant chambers. It was hypothesised that the role of DA
receptors in the NAcS would be different, perhaps complementary to the improvement in
reversal performance observed in the early phase when antagonising D2R in the NAcC.
3.3 Methods
All experiments were performed at the Department of Psychology, at the University of
Cambridge, UK.
3.3.1 Subjects
Animals were kept under the conditions specified in Chapter 2 (see section 2.1). A total of
22 male Lister-Hooded rats (Charles River, UK) were used for this study. Rats were housed
in groups of four, but single-housed following implantation of guide cannulas. The number
of animals used for each drug and region is shown in Fig. 3.1B.
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Fig. 3.1 Experimental design. A) Behavioural training and testing protocol. The rewarded
stimulus is represented as a + and the unrewarded stimulus as a -. Stimuli were vertical or
horizontal bars and were counterbalanced as CS+ or CS- across rats. B) Dose distribution
across reversals (Rev) and targeted coordinates for the NAcS. The n column includes sub-
group and final group size for the different DA receptors antagonists: raclopride (D2R) and
SCH23390 (D1R). The same rats received both drugs, although one had to be excluded before
administration of SCH23390. Doses are presented as µl/µl. AP and ML were measured
from bregma and DV from dura. C) Flowchart of the testing procedure and phases of reversal
learning. Phases depended on performance within sessions. After reversal, during the early
phase performance was lower than 11 correct trials out of a set of 30 trials, as animals tended
to perseverate on the previously CS+, now CS-. After some trials, performance improved,
and animals reached the so-called mid, intermediate or random phase, before reaching the




Rats were initially trained to respond to touchscreens operant chambers. See Chapter 2
(section 2.3.1) for details on pre-training stages.
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Visual discrimination training
After the initial training stages, subjects were trained on a visual two-choice discrimination
task. See Chapter 2 (section 2.3.1) for details on visual discrimination training.
3.3.3 Serial visual reversal learning
Following acquisition of visual discrimination, animals were trained in serial visual reversal
learning. See Chapter 2 (section 2.3.1).
3.3.4 Surgeries
Bilateral 22-gauge guide cannulas (PlasticsOne, Sevenoaks, UK) were implanted in the
NAcS (n = 22). following standard stereotactic techniques. For more details see Chapter 2
(section 2.4). Coordinates for NAcS guides were AP +1.6, DV -1.9 and ML ± 0.75 (Fig.
3.1B).
3.3.5 Drugs
The DA D2R antagonist raclopride (Tocris Bioscience, Bristol, UK) and the D1R antagonist
SCH23390 (Sigma-Aldrich, Dorset, UK) were dissolved in physiological saline. The drugs
were infused into the NAcS at the doses of 0, 0.1 and 1 µg/µ l of raclopride and 0 and 1 µg/µ l
of SCH23390. Aliquots were frozen at -80°C in the quantities required for each testing day.
3.3.6 Microinfusions
Intracerebral infusions took place according to the procedure described in Chapter 2 (see
section 2.5). Doses of raclopride were administered in a LSQ design and of SCH23390 in a
cross-over design. Although all doses order for each rat were randomized and controlled for
baseline performance, all animals were infused with raclopride first and received SCH23390
infusions only after the raclopride LSQ was completed (i.e. whereas the individual doses
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within each experiment was counter-balanced, we did not counter-balance between raclopride
and SCH23390). On average, each animal received 4 sessions with infusions per reversal
cycle (vehicle on retention and three days of drug dose or vehicle during reversal), thus
around 12 infusions in the raclopride LSQ, and eight infusions in the cross-over study for
SCH23390.
Injectors from PlasticOne (28-gauge, USA) extended 5 mm below the guide (final DV –
6.9). The injectors were left in place for 1 min both prior to and after the infusion. Rats were
returned to their cage for 5 min before the start of the session.
3.3.7 Histologies
See Chapter 2 (section 2.6) for details on histologies.
3.3.8 Data analysis
See Chapter 2 (section 2.7) for details on statistical analysis. In this chapter, the main depen-
dent variables were the number of errors and trials to criterion (≥ 24/30 correct responses).
Omissions, latencies to respond and latencies to collect the reward were additionally analysed.
Data from each reversal were collapsed over days. Trial outcomes were classified in three
different phases: early, mid or late, depending on the performance over a running window
of 30 consecutive trials. If animals had a significant bias (binomial distribution probabili-
ties) towards the previously positive stimulus (< 11/30 correct responses), performance was
considered to belong to the early phase, in which animals exhibited mainly perseverative
responses. If their performance instead showed a significant preference for the currently
rewarded stimulus (> 19/30 correct responses) it was considered as the late phase, in which
animals moved closer to criterion for learning the reversed contingency. Performance in-
between these thresholds was classified as intermediate or mid-phase, prior to acquisition of
the new learned association. Data from all trials after the rats had reached the final learning
criterion (≥ 24/30 correct responses) were excluded from the analysis.
To ensure normality, errors were square-rooted and latencies log-transformed. Data were
then subjected to Linear Mixed-Effects Model analysis with the lmer package in R. For
each region, the model contained two fixed factors (dose, phase) and one factor (subject)
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modeled as a random slope to account for individual differences between rats across phases
(i.e. individual learning curves). When significant two-way dose × phase interactions were
found, analysis was followed by post-hoc Dunnett’s corrected pairwise comparisons.
3.4 Results
3.4.1 Histology
The ventral-most locations of injectors are included in Fig. 3.2. Rats were excluded from the
study if the injector cannulas were positioned outside the target areas (n = 3). Final group
sizes with verified injector positions for each of the drug groups and targeted coordinates are
shown in Fig. 3.1B.
Effects of intra-striatal infusions of the D2R antagonist raclopride and the D1R antag-
onist SCH23390
Analysis for both raclopride and SCH23390 treatments substantiated that the effect of drugs
varied across phases of the reversal task. Fig. 3.2 shows that whereas local infusions of the
D1R antagonist SCH23390 improved early to mid stages in reversal learning, no effects were
observed with the D2R antagonist raclopride into the NAcS.
Analysis on the number of errors committed after SCH23390 infusions identified a signif-
icant dose × phase interaction after NAcS infusions (F2, 31.997 = 25.516, p < 0.001). Post-hoc
analyses showed that D1R antagonism into the NAcS selectively decreased perseveration in
the early phase compared with the vehicle condition (p < 0.001; Fig. 3.2C), and followed a
trend in the mid phase (p = 0.054). In contrast, there was a dose × phase interaction for errors
after local infusions of raclopride (F4,63.005 = 3.813, p = 0.008), but pairwise comparisons
revealed that no dose differed from the vehicle-control group (Fig. 3.2B). There was thus no
significant effect of raclopride when infused into the NAcS.
Effects on trials to criterion were similar to the ones from errors showed above. Infusion
of SCH23390 decreased the total amount of trials to reach criterion. Mixed-Effects Model
showed a significant dose × phase interaction (F2,32 = 20.323, p < 0.001). Post-hoc analysis
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Fig. 3.2 D1R antagonism improves reversal-learning performance in the early phase. A)
Injector tip placements. Closed circles represent rats that received both raclopride and
SCH23390; open circles represent rats that received only raclopride. B) Example of bilateral
injector tip placement. C) Errors to criterion by phase – early, mid and late – after the D2R
antagonist, raclopride, in the NAcS. D) Errors to criterion by phase – early, mid and late –
after the D1R antagonist, SCH23390, in the NAcS. Errors until reaching criterion of a high
performance (> 24/30 correct responses) are collapsed over reversals. Data shown as mean
± SEM. # p ∼0.05; * p < 0.05 vs vehicle treatment.
revealed this effect was due to the infusion of drug during the early phase (p < 0.001), tending
to persist in the mid phase (p = 0.086). No effects were observed after infusion of raclopride.
Table 3.1 shows that in the NAcS, neither SCH23390 nor raclopride affected the number
of omissions (dose × phase: F2, 35.007 = 2.112, p = 0.136; F4, 72 = 0.830, p = 0.511).
SCH23390 infusions also prolonged the latencies to collect the reward and to respond to
the stimuli regardless of the phase (dose in collect: F1, 31.062 = 99.382, p < 0.001; dose in
respond: F1, 31.082 = 7.838, p = 0.009). Raclopride had no effect on these variables (Table
3.1).
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Table 3.1 Effects on omissions and latencies to respond or to collect the reward after D1R
antagonist SCH23390 or D2R antagonist raclopride into the NAcS. Doses are presented as
µg/µ l; latencies in ms. Data are shown as mean ± SEM. a p < 0.01 vs vehicle treatment; b p
< 0.001 vs vehicle treatment.
3.5 Discussion
This study demonstrates dissociable effects on visual serial reversal learning of D2R and D1R
antagonists locally infused into the ventral striatum depending on different learning phases of
the task (i.e. the early, perseverative phase versus new learning phases). An important overall
finding was that whereas D1R antagonism into the NAcS improved early stages of reversal
learning (Fig. 3.3 for visual interpretation), D2R antagonism failed to alter behaviour. This
shows the existence of different roles of DA receptor signalling within the accumbal structure
when stimulus-reward contingencies change.
This work was the continuation of my BSc project embedded in Dr Leanne Young’s PhD
(Young, 2019), in which we investigated the effect of the same DA receptors antagonists,
raclopride and SCH23390, into the DMS, DLS and NAcC (Sala-Bayo et al., 2020). Briefly,
and in opposition to the effect in the NAcS, we observed an impairment in the mid phase after
D2R antagonism into the DMS, whereas it was observed across all phases, including early
and late, when into the DLS. No effects were detected after D1R antagonism, suggesting a
complementary role of these regions in modulating reversal learning via D2R. In the NAcC,
blocking D2R improved performance during early phases of reversal learning, whereas D1R
antagonism did not alter the amount of errors to reach criterion, in contrast to what we
observed when targeting the NAcS.
These findings increase our understanding of the neural mechanisms modulating cognitive
flexibility, and are in general consistent with previous data on humans with Parkinson’s
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Fig. 3.3 Representation of the potential effects of D1R antagonism in NAcS MSNs. A)
Baseline signalling by D1R- and D2R-expressing MSNs. DA is released by pre-synaptic
neurons expressing D2S as auto-receptors. DA can join D1R and D2R (mainly D2L) in
post-synaptic neurons and activate their signalling cascade. A2AR co-express with D2R
in post-synaptic neurons. B) Interpretation of the effect of D1R antagonism by SCH23390.
The antagonist may join D1R and block their downstream signalling, resulting in lower cell
activation, and decreased pathway signalling, which improved reversal learning performance
by enhancing learning in early perseverative stages.
disease (Cools et al., 2007; Dagher and Robbins, 2009) indicating that excess DA activity
may often be detrimental for reversal performance in the NAc, whereas intact DA function
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in the dorsal striatum is necessary for efficient reversal learning, as supported by data from
non-human primates (Clarke et al., 2011; Groman et al., 2011).
Considering not only the NAcS results, but also the NAcC findings presented in Dr
Young’s thesis (Young, 2019) and in Sala-Bayo et al. (2020), the positive changes in reversal
performance after local infusions relied on both the accumbal subregion and the subtype of
DA receptor, and they were selective for the early phase of reversal learning. Whilst D1R
antagonism in the NAcS reduced the number of perseverative errors, this improvement was
only found after D2R antagonism in the NAcC. This double dissociation refines previous
studies revealing for example that elevated dopaminergic levels in the NAc impair rever-
sal learning (Verharen et al., 2018), and that D2R agonism in the NAc is detrimental for
behavioural flexibility (Haluk and Floresco, 2009; Verharen et al., 2019). This might be
relevant for the DA overdose hypothesis of pathologic cognitive impairments associated
with dopaminergic drug treatment in Parkinson’s disease (Swainson et al., 2000), since our
data indicate that such effects are modulated by D1R in the NAcS and D2R in the NAcC.
Nonetheless, since the antagonists employed here only block endogenous DA, our data also
indicate that DA signalling at D1R in the NAcS and D2R in the NAcC supports perseverative
responding in visual reversal learning, maybe by inadequately maintaining the previous
stimulus-reward association (Flagel et al., 2011) or Pavlovian conditioned approach (Fraser
et al., 2016). Inactivation of the NAcS can also improve numerous forms of behavioural
flexibility, including spatial reversal learning (Aquili, 2014; Castañé et al., 2010; Dalton et al.,
2014), latent-inhibition (Weiner et al., 1996), and attentional set-shifting (Floresco et al.,
2006); our data suggest that these effects could be regulated by D1R-expressing neurons.
When interpreting the results from this set of experiments it is important to bear in
mind that all rats first completed the LSQ investigating the effects of D2R antagonism with
raclopride, and were later tested in a second LSQ studying the effects of D1R antagonism
with SCH23390. It is possible that extra training (≥ 3 reversals) could have affected
animals’ performance in the task by facilitating their reversal skills, or that the number of
received infusions (≥ 12 infusions of raclopride) could have altered the results of subsequent
SCH23390 infusions. Moreover, although SCH23390 is often used to target D1R, it also has
agonist affinity at the serotonin 5-HT2C receptor (Millan et al., 2001), which could contribute
to the observed effects in reversal learning. Nonetheless, previous studies have suggested that
5-HT2C receptor manipulation in the NAc has no impact on reversal-learning performance
(Boulougouris and Robbins, 2010). Perhaps more importantly, the D2R antagonist used also
has strong D3R antagonism properties, which are further discussed in Chapter 7.
56 Accumbal dopamine D1 and D2 receptors in reversal learning
The present chapter adds evidence to the distinct role of DA striatal receptors in modu-
lating reversal learning at specific stages. Together with the dorsal striatal results presented
by Sala-Bayo et al. (2020), the present findings imply that visual reversal learning recruits
sequential processing in ventral striatal and then dorsal striatal domains. In addition, the
present results support the DA overdose hypothesis, which could explain cognitive impair-
ments following striatal excesses of DA. These phenomenon could be differentially driven by
learning from positive or negative feedback, a sensitivity that is often altered in DA-related
cognitive disorders (Tremblay et al., 2002). Thus, the following chapters will investigate how
different brain regions, receptors, and cellular pathways regulate learning from positive or
negative feedback in reversal learning.
3.6 Conclusions
The current study elucidates the involvement of DA in reversal learning and suggests that
striatal DA receptors differentially modulate this form of behavioural flexibility. Using a serial
visual reversal learning task in touchscreen operant chambers, I show that infusions of D1R,
not D2R, antagonist into the NAcS improves reversal learning in early perseverative stages
of reversal. These results enhance our understanding of the neural circuits underlying visual
reversal learning and could be relevant for cognitive inflexibility in DA-related disorders,
such as Parkinson’s disease (Cools et al., 2007), OCD (Denys et al., 2004) or substance use
disorder (Volkow et al., 2009).
Chapter 4
Effects of dopamine D2-like receptor
activation on learning from negative
feedback in a reversal-learning task:
systemic versus intra-accumbens drug
administration
4.1 Introduction
DA is hypothesised to facilitate cognitive flexibility by signalling RPEs. As discussed in
Chapter 1, the RPE theory postulates that midbrain DA signals the discrepancy between the
expected outcome and the actual experience (Schultz, 2013; Schultz et al., 1997). As seen in
Chapter 3, DA differentially modulates reversal learning depending on, not only the striatal
subregion and DA receptor, but also on the reversal phase, which may inform about how
animals are learning from discrepancy between reward expectancy and delivery.
In rodents and primates it has been shown that the firing rates of DA neurons within the
VTA vary according to the expected reward. That is, firing rates increase in response to
unexpected reward (positive RPE), and decrease in response to an unexpected lack of reward
(negative RPE) or remaining unchanged if the outcome matches the prediction (Schultz
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et al., 1997). This error prediction signal is thought to be processed by downstream brain
regions involved in updating reward expectations and fine tuning future reward-seeking
behaviour (Schultz, 2019). In support to this hypothesis, studies using in-vivo optogenetics
show that VTA activation or inhibition bidirectionally simulate positive and negative RPEs,
respectively, and affect Pavlovian reward learning (Chang et al., 2015; Steinberg et al., 2013).
Experimental approaches using chemogenetics (i.e. DREADDs) have revealed that activation
of the VTA to NAc pathway decreases the sensitivity of rats to losses (Verharen et al., 2018)
while Klanker and colleagues (Klanker et al., 2015) observed varying levels of DA release
in the NAc during different trials on a reversal learning task in rats, consistent with RPE
signalling.
As discussed in Chapters 1 and 3, the model of the basal ganglia simulates how DA
modulates approach and avoidance learning via the direct and indirect pathways of the
striatum (Frank et al., 2004). However, this model has not been tested in the context of
reversal learning depending on both positive and negative feedback for optimal reward
outcome. It is also unknown whether impaired D2R function in the NAc is necessary and
sufficient to interfere with reversal learning through effects on negative feedback (i.e. reward
omission).
As described in Chapter 3, while the NAc has been demonstrated to be involved in reversal
learning, findings are often equivocal. Some studies show that NAc lesions impair reversal
learning performance (Dalton et al., 2014; Stern and Passingham, 1995), whereas others
report no effects (Castañé et al., 2010; Schoenbaum and Setlow, 2003). This discrepancy
might be due to the known anatomical and functional heterogeneity of the NAc, including the
NAcC and th NAcS (Zahm, 1999), and a third region not examined in this thesis, the rostral
pole. The NAcC and NAcS have been described as having distinct yet often complementary
roles in reinforcement learning (Floresco et al., 2006). Supporting this functional dichotomy,
inactivation of the NAcS impaired performance in a PRL task in rats, involving spurious
negative feedback, whereas inactivation of the NAcC had no effect on reversal performance
but instead increased latencies to respond to the stimuli (Dalton et al., 2014).
Despite studies implicating the NAc, DA afferents to this region, and D2R in reversal
learning (Boulougouris et al., 2009; Radke et al., 2018), the role of D2R within subregions
of the NAc remains unclear. In Chapter 3 and previous research (Sala-Bayo et al., 2020),
pharmacological antagonism revealed that both NAcC and NAcS are involved in early
stages of reversal learning but via different receptors: D1R in the NAcS and D2R in the
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NAcC. However, DA depletion from the NAc reportedly impair reversal learning (Haluk
and Floresco, 2009; Taghzouti et al., 1985). Microinfusions of a D2R agonist into the NAc
also impaired reversal learning, and infusions of a D1R, but not D2R, antagonist in the NAc
disrupted set-shifting due to increased perseveration (Haluk and Floresco, 2009). Thus, the
role of D1R and D2R in the NAc – core or shell – in cognitive flexibility is ambiguous
potentially due to brain regions’ heterogeneity and feedback processing.
In addition, D2R are expressed both post-synaptically (i.e. in striatopallidal neurons),
and pre-synaptically (i.e. in mesoaccumbal neurons). The latter act as auto-receptors that
mediate auto-inhibition and suppression of DA release in conditions of high extracellular
DA levels (De Mei et al., 2009). The varied synaptic location of D2R in the striatum poses
challenges for the interpretation of the behavioural effects of D2R agents.
4.2 Aims, approaches, and hypotheses
In the present study, I aimed to: (1) investigate the role of D2R in approach/avoidance
behaviour as learning from positive and negative feedback sensitivity during reversal learning;
(2) dissociate the role of D2R in the NAcC and NAcS in regulating learning from positive or
negative feedback during reversal learning; (3) distinguish whether the effects of the D2R
agonist quinpirole on behaviour are mediated by pre- or post-synaptic D2R.
To address the first aim, I administered quinpirole systemically and tested visual reversal
learning performance on the recently developed VPVD task in rats (see Chapter 2) (Alsiö
et al., 2019). This task allowed us to discern whether animals learn from positive or negative
feedback by coupling the correct or incorrect stimulus with a third, neutral stimulus that is
rewarded 50% of the times. This variant of the task probes if animals learn by “approaching
positive” or “avoiding negative” outcomes. Based on the Frank model above, I predicted an
impairment in reversal learning caused by impaired sensitivity to negative feedback.
For the second aim, I locally infused the D2R agonist quinpirole into the NAcS and
NAcC and tested visual reversal learning performance on the VPVD task, where I expected
to observe the same impairment as in the systemic approach, with a potential opponent role
of the two subregions.
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Finally, to address the third aim, I administered systemic quinpirole to evaluate dose-
dependent responses and dissociate pre- and post-synaptic D2R mediated responses. Changes
in locomotor activity in a dose-response manner have been suggested to relate to pre-synaptic
D2R being more sensitive to DA agonists than post-synaptic D2R (Eilam and Szechtman,
1989). I therefore hypothesised that high doses, presumably acting via post- (and pre-
) synaptic D2R would impair reversal learning performance by impairing learning from
negative feedback (Frank et al., 2004). In contrast, lower doses of quinpirole would act
via pre- (not post-) synaptic D2R, and consequently not have the same impact on negative
feedback as higher doses of quinpirole.
For experiments employing intracerebral drug infusions, I investigated the effects of an
A2AR antagonist, which acts predominately on post-synaptic receptors. As described in
Chapter 1, A2AR are Gs-coupled receptors and co-localise in the striatum with post-synaptic
D2R in striatopallidal neurons, but not pre-synaptic D2R. Activation of A2AR stimulate the
production of cAMP in neurons whereas activation of D2R inhibit the production of cAMP
via Gi protein coupling (Fig. 1.7 in Chapter 1). Hence, I hypothesised that the effects of
A2AR antagonism would resemble those of higher doses of quinpirole, which activate both
pre- and post-synaptic D2R.
4.3 Material and methods
All experiments were performed at the Department of Psychology, at the University of
Cambridge, UK.
4.3.1 Subjects
See Chapter 2, section 2.1, for details on housing and ethical permissions. Subjects were 133
male Lister-Hooded rats (Charles River, UK) housed in groups of four under temperature-
and humidity-controlled conditions and a 12:12h dark cycle (lights on at 0700). Animals
were ∼300 g at the beginning of behavioural procedures, and ∼400 g when they underwent
surgery. Following surgical implantation of guide cannula, animals were single-housed.
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4.3.2 Apparatus
The behavioural apparatus consisted of 28 touchscreen operant chambers (modified from
Med Associates). See Chapter 2, section 2.2.1, for further details on the apparatus.
4.3.3 Drugs
For the systemic study, (-)-quinpirole hydrochloride (Sigma-Aldrich, UK), a D2R agonist,
was dissolved in filtered saline to achieve doses of 0, 0.01, 0.025, 0.1, 0.25 and 0.5 mg/kg.
Drugs were administered via the intraperitoneal (i.p.) route 60 min before testing. No adverse
reactions to the repeated injections were observed.
For local infusions, the A2AR antagonist ZM-241385 (Tocris, Bioscience, UK) was
dissolved in Kleptose hydroxypropyl beta-cyclodextrin (HPB) parenteral grade (Roquette
UK Ltd, UK) 10% weight/volume in filtered saline and sonicated for 30 min at 30°C, which
served as a vehicle. The drug was infused into the NAcC at the dose of 4 and 20 ng/µl.
(-)-Quinpirole hydrochloride was dissolved in the same vehicle described above and infused
into the NAcC at the doses of 0, 0.6, 6 and 20 µg/µ l (id. 0, 0.3, 3 and 10 µg/side). Quinpirole
was infused into the NAcS at 0, 0.6 and 6 µg/µl (id. 0, 0.3, 3 µg/side). As in the systemic
approach, aliquots were frozen at -80°C in the quantities required for each testing day.
4.3.4 Behaviour
Training
Rats were initially trained following the standard training procedure for visual reversal
learning. See Chapter 2, section 2.3.1, for details on behavioural training, including pre-
training, visual discrimination training, and reversal learning training.
VPVD task
See Chapter 2, section 2.3.1 for details on the VPVD task and dose randomisation. In the
systemic experiment, the reversal phase continued for an extra 4 days, up to 14 days in total,
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to allow for asymptotic performance levels. See Fig. 2.1 in Chapter 2 for the timeline and
overview of the present experimental design, as well as Table 2.1 in Chapter 2 for a summary
on the VPVD task.
4.3.5 Surgeries
Bilateral 22-gauge guide cannulas (Plastics One, Sevenoaks, UK) were implanted in the NAcS
(n = 29) and in the NAcC (n = 60) following standard stereotaxic techniques. See Chapter
2, section 2.4.1, for details on stereotaxic surgeries and cannula implantation. Coordinates
were taken from Paxinos and Watson (1998), for the NAcS: anteroposterior (AP) +1.6,
dorsoventral (DV) -1.9, mediolateral (ML) ±0.75; and for the NAcC: AP +1.2, DV -1.9, ML
±1.9. All AP and ML measurements were from Bregma, whereas DV were from dura. Four
metal screws and dental cement secured the guide cannulas to the skull. Obturators were
introduced in the guide cannulas and protected with a dust cap.
4.3.6 Drug microinfusions
Rats implanted with guide cannulas received local microinfusions. See Chapter 2, section
2.5, for details on drug microinfusions. Injectors for microinfusions extended 5 mm below
the guide cannula in both the NAcS and the NAcC, reaching a final DV of -6.9 mm from
dura. Doses were pseudo-randomised depending on baseline performance on the day prior to
testing and administered following a between-subject design.
4.3.7 Histologies for cannula tip placement
See Chapter 2, section 2.6, for details of the histological procedures.
4.3.8 Data analysis
The main dependent variables were percentage of correct responses (% Correct) on standard
trials (A- < B+) and percentage of optimal responses (% Optimal) on probe trials (A- <
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C50/50; B+ > C50/50). Errors from standard trials were also calculated by dividing trials into
separate phases depending on levels of performance in running blocks of 30 trials (Alsiö
et al., 2015). Trials were divided into “Early” or perseverative phase if animals achieved
less than 11 correct trials, or “Late” if they achieved more than 19 correct trials in a block
of 30 trials. Trials in between both criteria were classified as “Mid” or the random phase.
Latencies to collect the reward and to respond to the stimuli were averaged across sessions.
For the systemic drug data, I additionally examined the total number of trials. Latencies were
also analysed by splitting them into each type of trial: correct (i.e. choosing B+ over A-),
incorrect (i.e. choosing A- over B+), optimal (i.e. choosing B+ over C50/50), suboptimal (i.e.
choosing A- over C50/50) or probe (i.e. choosing C50/50 over A- or B+). In relation to reward
collection latencies, only rewarded trials were analysed.
See Chapter 2, section 2.7, for further details on statistical hypothesis testing. To
ensure normality, responses were arcsine-transformed; errors for each per phase square-root
transformed, and latencies log10-transformed. Choice data were then subjected to Linear
Mixed-Effects Model analysis using the lmer package in R. The model contained two fixed
factors (dose, session) and one factor (subject) modelled as a random slope to account for
individual differences between rats across phase (i.e. individual learning curves). Analysis of
latencies involved two fixed factors (dose, latency) and subjects as random variability. When
latencies were collapsed over sessions, data were subjected to a one-way ANOVA with one
within-subject factor (dose). Errors per phase analysis included two fix factors (dose, phase)
and the subject factor to account for individual differences. When significant dose × session




The ventral-most locations of injectors are shown in Fig. 4.2B. Rats were excluded from
the study if the injectors cannulas were positioned outside the target areas (n = 3 NAcC;
n = 2 NAcS). Targeted coordinates and final group sizes are shown in Fig. 4.1A. Each rat
underwent a single dose treatment, as experiment was based on a between-subject design.
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Fig. 4.1 A) Coordinates and group sizes for the injector placements in shell and core of the
nucleus accumbens (NAcS; NAcC). Anteroposterior (AP) and mediolateral (ML) coordinates
were measured from Bregma and dorsoventral (DV) from dura. B) Ventral-most injector tip
placements in the NAcS and the NAcC. C) Example of bilateral injector tip placement in the
NAcS and NAcC.
4.4.2 Behavioural results
Systemically administered quinpirole dose-dependently impairs reversal learning by block-
ing learning from negative feedback
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Systemic administration of quinpirole impaired overall reversal learning performance
by hindering learning from negative-probe trials, which led to reduced avoidance of the
non-rewarded stimulus (Fig. 4.2).
Fig. 4.2 The DA D2R agonist quinpirole impaired visual reversal learning in the VPVD task
by impairing learning from negative feedback. A) Standard reversal learning trials (A- <
B+). Quinpirole at high doses (0.25 and 0.5 mg/kg) impaired performance by decreasing the
percentage of correct responses. B) Errors on standard trials per phase: early (< 11 correct
responses in blocks of 30 trials), mid, late (> 19 correct responses in blocks of 30 trials).
Data were collapsed throughout sessions. Quinpirole did not affect the number of errors
per phases. C) Positive-probe trials (B+ > C50/50). Quinpirole did not alter the percentage
of optimal responses. D) Negative-probe trials (A- < C50/50). Quinpirole dose-dependently
decreased percentage of optimal choices, indicating an impairment in learning from negative
feedback. Data are shown as mean ± SEM. * p < 0.05 vs vehicle-treated group.
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On standard trials (Fig. 4.2A), linear mixed-effects model showed a main effect of dose
(F5, 41 = 9.903, p < 0.001) and a significant session × dose interaction (F65, 533 = 1.571, p
= 0.004). Post-hoc analysis revealed a significant difference with dose 0.25 mg/kg from
session 7 onwards in comparison to the vehicle-treated group (all days p = 0.002 - 0.041); and
dose 0.5 mg/kg from session 6 onwards (all days p = < 0.001 – 0.038), indicating impaired
performance from mid to late stages.
When errors were analysed splitting trials into early (< 11 correct in 30 trials), mid, and
late (> 19 correct in 30 trials) phases (Fig. 4.2B), a significant effect of phase was revealed
(F2, 82 = 30.23, p < 0.001), but there was no effect of dose (F5, 41 = 1.948, p = 0.107) or phase
× dose interaction (F10, 82 = 0.564, p = 0.836). Hence, changes in phases did not depend on
treatment.
Within negative trials (Fig. 4.2D), there was a main effect of dose (F5, 41 = 11.90, p <
0.001) and a significant session × dose interaction (F65, 533 = 2.212, p < 0.001). Post-hoc
comparisons revealed a significant effect with the high doses: 0.1 mg/kg during session 9
and 12 (p = 0.042, p = 0.041), 0.25 mg/kg from session 6 onwards (all p = < 0.001 - 0.028),
and dose 0.5 mg/kg from session 7 to 9 and from session 12 to 14 (all p = < 0.001 - 0.032).
On positive trials (Fig. 4.2C), no effect of dose (F5, 41 = 1.792, p = 0.136) or session × dose
interaction (F65, 533 = 1.293, p = 0.070) were observed. Probe trials therefore showed that
animals were impaired in reversal learning selectively due to processing negative feedback
from mid to late stages.
The total number of trials achieved per session were also averaged and analysed (Table
4.1A). One-way ANOVA revealed an effect of dose (F5, 41 = 4.592; p = 0.002). Post-hoc
analysis showed that only the highest dose decreased the number of trials completed per
session in comparison with the vehicle control group (0.5 mg/kg; p = 0.001).
Quinpirole treatment dose-dependently increased the latency to collect the reward (F5, 41
= 13.79, p < 0.001; Table 4.1A), but had no effect on the latency to respond to the screen
(F5, 41 = 0.188, p = 0.766; Table 4.1A). Post-hoc analysis showed that the doses of 0.025, 0.1,
0.25 and 0.5 mg/kg increased overall latencies to respond to the stimuli (p = 0.044, < 0.001,
< 0.001, < 0.001, respectively).
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Table 4.1 Following systemic administration of quinpirole, latencies to respond to the visual
stimuli and to collect the sucrose pellet from the magazine. A) Latencies and trials per session
collapsed throughout sessions. Latencies to collect the reward following administration of
quinpirole at doses 0.025, 0.1, 0.25 and 0.5 mg/kg were higher than those from the vehicle-
treated group were. Trials per session decreased with quinpirole at dose 0.5 mg/kg. B)
Latencies to respond to the stimuli were split depending on the type of trial. Latencies on
negative-probe trials in which animals made an error were longer than the other latencies.
C) Latencies to collect the reward were segregated according to type of trials. Quinpirole
did not affect latencies to collect the reward. Data are presented as mean ± SEM, collapsed
across sessions. * p < 0.05, *** p < 0.001 vs vehicle-treated group; ** p < 0.01 vs other trials
latencies.
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Fig. 4.3 Improved visual reversal learning by intra-NAcS infusions of the D2R agonist
quinpirole manifests from accentuated learning from positive feedback. A) Standard reversal
learning trials (A- < B+). Quinpirole at 0.3 and 3 µg/side improved performance. B) Errors
on standard trials split by reversal-learning phase: early (< 11 correct responses in sets of
30 trials), mid and late (> 19 correct responses in sets of 30 trials). Quinpirole at 0.3 and
3 µg/side decreased the number of errors during the mid-phase of reversal learning. Trials
were collapsed throughout sessions. C) Positive-probe trials (B+ > C50/50). Quinpirole at
0.3 and 3 µg/side increased optimal responses, indicating an improvement in learning from
positive feedback. D) Negative-probe trials (A- < C50/50). Neither quinpirole nor ZM-241385
affected percentage of optimal choices, indicating intact learning from negative feedback.
Data are shown as mean ± SEM. # p ∼0.05, * p < 0.05 vs vehicle-treated group.
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Latencies were next analysed depending on the trial type i.e. on standard trials choosing
B+ over A-, or vice versa; and on probe trials choosing B+ over C50/50, A- over C50/50, or
C50/50 over B+ or A- (Table 4.1B). On latencies to respond, I found a main effect of type of
trial (F4, 65 = 8.026, p < 0.001), but no significant dose × type of trial interaction (F20, 164 =
0.695, p = 0.827). Post-hoc analysis revealed that the difference was driven by those trials in
which animals chose the incorrect stimulus (A-) over the neutral stimulus (C50/50), so when
animals made an error in negative-probe trials (A- over C50/50 vs B+ over A-, p = 0.001; vs
A- over B+, p = 0.001; vs B+ over C50/50, p < 0.001; vs C50/50 over either A- or B+, p <
0.001). On latencies to collect the reward depending on each type of trial, I found no effect
of dose (F5, 41 = 0.517, p = 0.762) or dose × type of trial interaction (F10, 82 = 1.533, p =
0.142) (Table 4.1C).
Intra-NAcS infusions of quinpirole but not ZM-241385 improves reversal learning
Following infusions into the NAcS (Fig. 4.3), the D2R agonist quinpirole improved
reversal-learning performance by increasing learning from positive feedback. The A2AR
antagonist ZM-241385 had no effect.
On standard trials (A- < B+), I found a significant dose × session interaction (F3, 237.71
= 9.002, p < 0.001) (Fig. 4.3A). Post-hoc analysis revealed that the 0.3 µg/side dose of
quinpirole increased the percentage of correct responses from session 5 until session 9. The
dose of 3 µg/side had the same effect from sessions 5 to 7. In contrast, ZM-241385 did
not differ from the vehicle control group in any session of the VPVD task, thus it did not
replicate quinpirole results.
Quinpirole selectively improved performance from positive feedback while leaving intact
learning from negative feedback. On the positive-valence probe trials (B+ > C50/50), the
Linear Mixed-Effects Model revealed an effect of dose (F3, 247.31 = 5.319, p = 0.001) and dose
× session interaction (F3, 232.04 = 5.398, p = 0.001). Post-hoc comparisons showed that this
effect was specific for quinpirole 0.3 µg/side from session 5 onwards, and 3 µg/side between
sessions 5 and 6, respectively (Fig. 4.3C). No changes were detected on the negative-valence
probe trials (A- < C50/50) (dose: F3, 248.08 = 1.471, p = 0.223; dose × session: F3, 247.53 =
1.535, p = 0.206) (Fig. 4.3D).
On errors during standard trials when trials were split into early, mid and late phases (Fig.
4.3B), I found a significant dose × phase interaction (F6, 75 = 2.674, p = 0.021). Further
analysis showed a significant main effect of dose in the mid phase (F3, 25 = 4.273, p = 0.015).
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Post-hoc analysis revealed this effect was driven by the two doses of quinpirole in comparison
to the vehicle group: 0.3 µg/side (p = 0.025) and 3 µg/side (p = 0.025).
High doses of quinpirole, though not ZM-241385, selectively increased latencies to
collect the reward, while did not alter time to respond to the stimuli. Analysis of latency to
collect the reward showed an overall increase regardless of the type of trials (main effect of
dose: F3, 75 = 12.304, p < 0.001; dose × type of trial interaction: F6, 75 = 0.075, p = 0.998).
Post-hoc contrasts determined that this effect was apparent for the 0.3 and 3 µg/side doses
of quinpirole (both p < 0.001). Similarly, in relation to latencies to respond, I observed a
main effect of dose (F3, 125 = 10.855, p = < 0.001), but not a significant dose × type of trials
interaction (Ftextsubscript12, 125 = 0.250, p = 0.995). The main effect of dose was driven
by the effect of quinpirole at doses 0.3 and 3 µg/side (p = 0.007; p < 0.001) (Table 4.2).
Table 4.2 Following microinfusions of drugs, latencies to respond at the screen and to collect
the sucrose pellet from the magazine on rewarded trials. Data are shown as mean ± SEM,
collapsed across sessions. # p ∼0.05, * p < 0.05 vs vehicle-treated group. Quinpirole (Q),
ZM-241385 (Z).
Intra-NAcC infusions of quinpirole or an ZM-241385 affect reversal learning
Quinpirole at low doses and ZM-241385 both improved reversal-learning performance in
the mid-stages by improving learning from negative feedback. In contrast, the highest dose
of quinpirole (10µg/side) impaired performance in reversal learning by decreasing learning
from negative feedback during the late stages (Fig. 4.4).
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Fig. 4.4 Low doses of the D2R agonist quinpirole in the NAcC improves visual reversal
learning in the VPVD task whereas a higher dose of quinpirole impairs reversal learning. A)
Standard reversal learning trials (A- < B+). Quinpirole at 0.3 and 3 µg/side and ZM-241385
at 20 ng/µl improved, whereas quinpirole at 10 µg/side impaired performance. B) Errors on
standard trials split by reversal-learning phase: early (< 11 correct responses in sets of 30
trials), mid and late (> 19 correct responses in sets of 30 trials). Quinpirole at 0.3 µg/side
decreased the number of errors on standard trials during the mid phase of reversal learning.
Trials were collapsed throughout sessions. C) Positive-probe trials (B+ > C50/50). Drugs did
not affect optimal responses. D) Negative-probe trials (A- < C50/50). Quinpirole at 0.3 and 3
µg/side increased optimal responses, indicating an improvement in learning from negative
feedback. Quinpirole at 10 µg/side decreased optimal responses at later sessions, indicating
an impairment in learning from negative feedback. Data are shown as mean ± SEM. # p
∼0.05, * p < 0.05, *** p < 0.001 vs vehicle-treated group.
72 Systemic and intra-accumbal D2R agonism in the VPVD task
On standard trials (A- < B+) (Fig. 4.4A), I found a main effect of dose (F5, 54 = 3.188, p =
0.014) and a dose × session interaction (F45, 485 = 2.043, p < 0.001). Post-hoc analysis with
Dunnett’s correction showed that the dose of quinpirole 0.3 µg/side increased percentage of
correct responses in comparison to vehicle in sessions 4 (p = 0.016) and 5 (0.009). This same
effect was observed with the dose of 3 µg/side of quinpirole (p = 008; p = 0.006), and with
ZM-241385 in session 5 (p = 0.038). The dose of 10 µg/side decreased the percentage of
correct responses in session 10 (p = 0.006), with a trend decease during session 9 (p = 0.060).
Thus, quinpirole and ZM-241385 improved reversal learning, potentially during mid-stage
sessions.
When the number of errors during standard trials was analysed by splitting the trials
into early (< 11 correct/30 trials), mid or late (> 19 correct/30 trials) phases (Fig. 4.4B), a
significant dose × phase interaction was found (F10, 108 = 2.563, p = 0.022). Further analysis
revealed a change in errors in the mid phase of reversals learning (main effect of dose: F5, 54
= 4.858, p = 0.001), which post-hoc analysis suggested was driven by the quinpirole dose of
0.3 µg/side (p = 0.001), confirming the quinpirole-induced improvement was specific to the
mid phase.
Analysis of the choice performance on probe trials showed that quinpirole- and ZM-
241385-affected reversal learning was the result of selectively altering behaviour on negative-
probe trials (Fig. 4.4D). I observed a significant dose × session interaction (F45, 485 = 2.108, p
< 0.001). Post-hoc analysis showed that the effect on negative trials was driven by an increase
of optimal choices in session 4 following administration of quinpirole at 0.3 µg/side (p =
0.007) and 3 µg/side (p = 0.005), and in session 7 following administration of ZM-241385
at dose 4 ng/µl (p = 0.005). There was also a decrease in optimal choices after quinpirole
at dose 3 µg/side during session 8 (p = 0.04) and at 10 µg/side from session 9 onwards (p
= 0.011; p = 0.031). In the last session, the 3 µg/side dose of quinpirole appeared to also
decrease the percentage of optimal responses but this did not reach statistical significance (p
= 0.083). No effect was observed on positive-probe trials (dose × session: F45, 485 = 1.129, p
= 0.267), although there was a trend for a main effect of dose (F5, 54 = 2.142, p = 0.074) (Fig.
4.4C). All tested drugs and doses left optimal choice in positive-probe trials intact, but high
doses of quinpirole impaired choice on negative-probe trials during mid to late stages.
Latencies to collect the reward or to respond to the stimuli were analysed with reference
to the type of trial they were measured from: A- < B+, B+ > C50/50 and A- < C50/50, and
for responding latencies when they made an incorrect response too, i.e. choosing A- over
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C50/50 or C50/50 over B+. Although I did not observe a significant dose × type of latency for
latencies to collect the reward (F10, 534 = 0.048, p = 0.998) or to respond (F20, 534 = 0.308, p =
0.988), there was a main effect of dose with respect to latencies to collect the reward (F10, 534
= 3.869, p = 0.016). Post-hoc analysis showed that quinpirole at doses 3 (p = 0.043) and 10
µg/side (p = 0.022) increased the time to collect the reward from the magazine (Table 4.2).
Thus, quinpirole doses that affected performance by altering performance on responding to
negative feedback also increased selectively the time to collect the reward, while did not
affect animals’ speed to respond to the stimuli.
Overall, these experiments showed dissociable roles of D2R modulating reversal learning
performance when being quinpirole-activated across all brain regions by systemic injections
or locally into the NAcC and NAcS. Systemic quinpirole impaired reversal-learning perfor-
mance by decreasing avoidance of the negative stimulus, whilst local infusions into the NAc
generally accelerated learning by promoting approach to the positive stimulus (modulated by
the NAcS), or increasing avoidance of the negative stimulus (modulated by the NAcC). In
addition, an impairment in reversals was observed with the highest dose of quinpirole into
the NAcC.
4.5 Discussion
The present study demonstrated the theoretical advantages of using the recently developed
VPVD task, specifically in dissociating how learning from positive and negative feedback
influences visual reversal learning. I found strong supporting evidence for the hypothesis
that D2R activation impairs reversal learning by blocking learning from losses when targeted
systemically. In contrast, I found dissociable effects when quinpirole was administered
locally into the NAcS and NAcC, mainly leading to an improvement in reversal learning by
increasing approach responses to rewarded stimuli (NAcS) or increasing avoidance responses
to negative feedback (NAcC). With respect to the NAcC, I also found blunted learning from
negative feedback following administration of high doses of quinpirole.
Systemic D2R agonism with quinpirole impairs visual reversal learning by blunting learn-
ing from negative feedback
Systemic administration of quinpirole severely disrupted reversal learning at the highest
administered doses, while left learning from positive feedback intact. This impairing effect
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is in agreement with my hypothesis and previous studies where D2R agonism impaired
reversal learning in rats (Boulougouris et al., 2009), non-human primates (Smith et al., 1999),
and humans (Mehta et al., 2001). The present results extend such findings by revealing
a dose-dependent and highly selective effect of quinpirole on negative-probe trials in the
VPVD task, indicating a selective deficit on learning from negative feedback. Rats treated
with high doses of quinpirole showed poorer performance on standard trials than rats treated
with lower doses or vehicle, and remained at random levels on negative trials, even after two
weeks of training.
To further explore these findings, Alsiö and colleagues (Alsiö et al., 2019) investigated the
effects of quinpirole on performance of the PRL task. The results of this experiment concurred
with the findings from the novel VPVD task by revealing a dose-dependent decrease in the
number of reversals per session. Importantly, the PRL study was complemented by a
computational model of the behavioural results based on Rescorla-Wagner reinforcement
learning (Rescorla and Wagner, 1972) and hierarchical Bayesian analysis (Daw, 2009). The
model showed that the highest dose of quinpirole (0.25 mg/kg) selectively decreased the
learning rate from losses (i.e. α loss parameter), representing learning from negative feedback,
whilst left learning from positive feedback intact (i.e. αwin parameter) ((Alsiö et al., 2019);
Fig. 4.5). The computational analysis also revealed enhanced inverse temperature (i.e. β
parameter), the proportion of how much subjects “exploit” or “explore” the stimuli depending
on expected reward properties (Alsiö et al., 2019). Higher β parameters indicate an increase
in reinforcement sensitivity and that animals are driven by exploiting the choice they expect
is going to be rewarded. In a reversal situation, anticipated reinforcement is placed on the
stimulus that was previously rewarded (now unrewarded), so in the absence of exploration
of the previous unrewarded (now rewarded) stimulus, animals would perform suboptimally.
According to this logic, therefore, high dose quinpirole may have impaired reversal learning
by attenuating learning from losses and/or by increasing exploitation of the non-rewarded
stimulus.
A wide range of doses was used to determine if quinpirole-induced effects were mediated
by pre- or post-synaptic D2R. As hypothesised, high doses of quinpirole impaired rever-
sal performance, suggesting the drug is modulating behaviour acting via post- (and pre-)
synaptic D2R (Frank et al., 2004). It is worth noting that whereas the higher doses affected
performance on reversal (> 0.1 mg/kg), the dose of 0.5 mg/kg not only modified percentage
of correct and optimal choices, but also the number of trials completed per session. The
observed impairment in flexible behaviour was similar to the effects of 0.25 mg/kg quinpirole,
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Fig. 4.5 Computational model parameters estimated by hierarchical Bayesian analysis of
trial-by-trial choice data from the PRL task. D2R agonist quinpirole impaired learning rate
after losses and increased the increase temperature or likelihood to explore over exploit a
stimulus. A) Learning rate from rewards (αwin). B) Inverse temperature or exploit/explore
ratio (β ). C) Learning rate from lack of reward (α loss). D) Stickiness parameter or likelihood
to repeat the choice from the previous trial regardless of its rewarding properties (τ). From
Alsiö et al. (2019).
but we cannot exclude the possibility that rats were slower to learn with 0.5 mg/kg quinpirole
due to a reduced opportunity to sample the reward contingencies of the stimuli (Table 4.1A).
Dissociable effects of subregion specific infusions of quinpirole on reversal learning
Contrary to the effects of systemically administered quinpirole on reversal learning, the
administration of quinpirole to restricted subregions of the NAc generally improved reversal-
performance. When infused into the NAcS, quinpirole at doses 0.3 and 3 µg/side improved
performance, mainly by increasing optimal choices on positive-probe trials, indicating an
enhanced sensitivity to positive feedback. The A2AR antagonist, ZM-241385, infused into
this same region had no significant effect on reversal learning compared with the vehicle-
treated group. Conversely, when infused into the NAcC, quinpirole at doses 0.3 and 3
µg/side improved performance during the mid-stages of reversal by improving performance
on negative-probe trials, which was also observed following the administration of the A2AR
antagonist. In addition, the highest dose of quinpirole into the NAcC impaired performance
during late sessions by blunting learning from negative feedback.
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In relation to the NAcC, I obtained a complex set of findings, which was partly at odds
with my hypotheses. The lower doses of quinpirole improved reversal-learning performance
on standard trials, as did the A2AR antagonist, ZM-241385, by selectively improving
optimal choices on negative-probe trials. However, at the highest dose of 10 µg/side,
quinpirole impaired reversal-learning performance and decreased optimal responses on
negative-probe trials, indicative of blunted learning from negative feedback. The impairing
effects of 10 µg/side quinpirole is broadly consistent with my hypothesis and similar effects
of systemically administered quinpirole. This deficit perhaps accords with quinpirole acting
at post-synaptic D2R but surprisingly was not matched by ZM-241385 (Fig. 4.6 for visual
interpretation), which instead resembled the enhancing effect of lower dose quinpirole.
Unfortunately, it is not possible to definitively demonstrate whether the behavioural effects
were the result of activating pre-synaptic D2R (or D2R on interneurons), or the implication
of a different mechanism, including the involvement of other brain regions such as the dorsal
striatum. Nonetheless, while lower doses of quinpirole lost their enhancing effect on negative-
probe trials and performance returned to vehicle level in sessions 5 and 6, in later sessions,
the dose of 3 µg/side decreased performance even below the control group, suggesting that
such dose is intermediate both in terms of dose range and effects. This suggests the presence
of a potential adaptive mechanism to high or repeated doses of quinpirole, possibly as the
result of sensitisation to the drug or internalisation of D2R. Thus, the effect of the highest
dose of quinpirole could be regulating behaviour via diminishing the role of post-synaptic
D2R. It would be of interest to repeat these experiments including the dose of 10 µg/side
into the NAcS to determine if the impairment is exclusively modulated by the NAcC in the
ventral striatum or if the NAcS also plays a role in the deficit.
In contrast, lower doses of quinpirole improved performance by activating post-synaptic
D2R, as suggested by the replication of these effects with ZM-241385 (Fig. 4.6C). This
result did not match my hypothesis of an impairment driven by post-synaptic receptors.
The discrepancy between my results (i.e. improvement when overactivating D2R) and
what Frank’s model of the basal ganglia would have predicted (i.e. impairment when
overactivating D2R) could be relate to a less dichotomous dissociation of the direct and
indirect pathways expressing D1R and D2R in the ventral striatum in comparison to the dorsal
striatum (Kupchik et al., 2015). Hence Frank’s model potentially being more accurate for the
dorsal striatum. Indeed, up to one-third of neurons in NAc have been suggested to express
both D1R and D2R together on the same MSN (Cole et al., 2018; Humphries and Prescott,
2010); Fig. 1.4 Chapter 1). Also, both pathways extend inhibitory projections towards the
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other pathway that are sufficient to produce lateral inhibition (Salery et al., 2020), which
may alter neuronal activity. Hence, the observed modulation could result from combined
D1R- and D2R-expressing MSNs activity in the NAcC (Fig. 4.6D). In addition, the A2AR
antagonist ZM-241385 was used as a probe to dissociate pre- versus post-synaptic effects of
quinpirole (Fig. 4.6B). While I expected ZM-241385 to replicate quinpirole results if this
was modulating behaviour via post-synaptic D2R, hence when high doses of quinpirole were
infused. However, ZM-241385 matched the effect of lower doses of quinpirole. While other
receptors or brain regions could be involved, as discussed, it is important to bear in mind when
interpreting the results that doses of quinpirole and antagonising A2AR constitute indirect
approaches to assess receptor specificity, and we cannot exclude the involvement of other
mechanisms, especially when the ZM-241285 did not differ from the vehicle control group.
Clear definitive evidence could be sought by producing pathway-specific D2R knockdowns
and comparing the results with drug infusions, or selectively manipulating these pathways
with an inhibitory opsin or the expression of Gi-coupled DREADDs (Deisseroth, 2011;
Nichols and Roth, 2009). Chapter 6 describes an attempt to use optogenetic approaches to
investigate another reversal paradigm.
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Fig. 4.6 Representation of the potential effects of D2R agonism and A2AR antagonism in
NAcC MSNs. A) Baseline signalling by D1R- and D2R-expressing MSNs. DA is released
by pre-synaptic neurons that express D2S, the short isoform of D2R, as auto-receptors. DA
can then join D1R and D2R (mainly the long isoform, D2L) in post-synaptic neurons and
activate their signalling cascade. A2AR are co-expressed with D2R in post-synaptic neurons.
B) Interpretation of A2AR antagonism by ZM-241385. The antagonist may join A2AR
and block their downstream signalling, resulting in lower cell activation, and decreased
pathway signalling, which improved reversal learning performance by enhancing learning
from negative feedback. C) Interpretation of D2R agonism by mid doses of quinpirole. As
the effects matched those induced by the post-synaptic D2R-probe agent, ZM-241385, mid
doses of quinpirole into the NAcC might be acting via post- (as well as pre-) synaptic D2R.
Agonising these receptors leads to increased inhibition of cell activation, hence reduced
signalling via efferent D2R-expressing MSNs. This improved reversal learning performance
by enhancing learning from negative feedback. D) Interpretation of D2R agonism by high
doses of quinpirole. Increased post-synaptic D2R agonism might lead to further regulatory
mechanisms, including lateral inhibition of D1R-expressing neurons. In combination with
reduced DA release, there might be a decline in D1R signalling, leading to an impairment in
reversal learning performance by blunting learning from negative feedback.
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By contrast with the above findings, intra-NAcS administration of quinpirole improved
reversal learning by enhancing learning from positive feedback. The lack of effect of
ZM-241385 into the NAcS suggests that quinpirole was affecting pre-synaptic D2R on
mesolimbic DA neurons projecting to the NAcS, rather than post-synaptic D2R on MSNs,
originally thought to be implicated in learning from negative feedback (Frank et al., 2004).
As opposed to post-synaptic receptors, pre-synaptic D2R provide feedback inhibition and
regulate DA neuron activity and release (Ford, 2014), hence the improvement could be related
to a reduction in DA release into the NAcS (Fig. 4.7 for visual interpretation). Quinpirole-
induced effects on DA release could be integrated by both the direct and indirect pathway,
which the present results suggest to enhance reversal-learning performance by increasing
positive approach behaviour. In support of both pathways being involved in controlling
flexible behaviour, I observed that D1R antagonism in the NAcS improved performance in
a serial reversal learning task by decreasing the number of errors to reach criterion in rats
(Chapter 3).
Fig. 4.7 Representation of the potential effect of D2R agonism in NAcS MSNs. Since the post-
synaptic D2R-probe agent, ZM-241385, did not replicate the effects of quinpirole, quinpirole
must be acting via pre-synaptic D2R. Agonising these receptors inhibits DA release from
pre-synaptic neurons, resulting in lower DA levels in the synaptic cleft. A decrease in DA
availability, leads to decreased D1R and D2R activity, blocking their respective cell activation
and inhibition of the activation. In both cases, this results in enhanced pathway signalling and
improvement in reversal learning performance by promoting learning from positive feedback.
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Finding an improvement following local quinpirole administration was at odds with my
reasoning based on the systemic effects presented in this chapter and previous research. For
example, it has been reported that administration of L-DOPA, which increases DA concen-
tration in the synaptic cleft, disrupts reversal learning performance by altering NAc activity
in patients with Parkinson’s disease (Cools et al., 2007). However, other studies are in line
with the observed improvement. In patients with OCD, low levels of DA D2R binding have
also been related to poor levels in reversal-learning performance (Denys et al., 2004). Drug
abuse disorder patients, who often suffer from cognitive inflexibility (Ersche et al., 2011),
show decreased responsiveness to DA (Volkow et al., 2009), suggesting that a boost in DA is
necessary to reach normal levels of performance. In rats, pharmacological inactivation of the
NAcS impaired performance in a probabilistic reversal learning task (Dalton et al., 2014), as
did lesions of the projections innervating this region (Groman et al., 2019), which indicates
that the NAc is necessary for optimal reversal learning. Moreover, DA acting in the NAc
enhanced conditioned reinforcement (the process by which a stimulus previously associated
with reward comes to reinforce instrumental behaviour (Mackintosh, 1974)). Thus, intra-
NAc administration of amphetamine, which increases extracellular DA levels, selectively
potentiated instrumental responses for a conditioned reinforcer (Taylor and Robbins, 1984),
and this effect was blocked by depletion of NAc DA using 6-hydroxydopamine (6-OHDA)
(Taylor and Robbins, 1986).
The enhancement in reversal learning following administration of the A2AR antagonist
is in line with the enhancement of cognitive flexibility, in both attentional set-shifting and
reversal learning, after knocking down A2AR in the NAc (Zhou et al., 2019). Notably, in the
present task, whereas quinpirole slowed reward collection latencies, the A2AR antagonist
induced the same beneficial effect without slowing motor activity or developing sensitization
in later stages of the testing period. The therapeutic implication of this novel finding is
discussed in Chapter 7.
The NAcC and NAcS are broadly hypothesised on the basis of several lines of evidence
to play opponent roles in modulating behaviour (Dalley and Robbins, 2017). Taken together,
the present results from local infusions of quinpirole suggest that these two regions improve
reversal learning but via two different mechanisms: enhanced learning from negative feedback
via post-synaptic receptors in the NAcC, and enhanced positive feedback via pre-synaptic
D2R, potentially resulting from reduced DA release in the NAcS. This suggests that the DA
system in the ventral striatum is working in complementary ways in the NAcS versus the
NAcC, as we also found for ventral versus dorsal striatum (Sala-Bayo et al., 2020). The
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impairment observed following D2R agonism in the NAcC at higher doses of quinpirole
indicates the presence of a complex and dynamic mechanism depending on the level of
D2R occupancy, potentially related to the inverted U-shaped function of DA suggested by
Yerkes-Dodson principle (Yerkes and Dodson, 1908). Intra-striatal quinpirole has also been
shown to improve reversal learning in marmosets with deficits at higher doses (Horst et al.,
2019), as well as PET imaging in humans revealed a correlation between striatal DA release
and reversal learning performance (Clatworthy et al., 2009).
In addition, while the systemic study was followed by local infusions with the aim of
studying the role of striatopallidal or mesoaccumbal MSNs, we cannot exclude the potential
interference of D2R in other loci, such as on cortical projections to the striatum or striatal
interneurons. Around 95% of neurons within the NAc are MSNs, 5% are interneurons (Castro
and Bruchas, 2019), from which 80% express D2R. Selective optogenetics activation of these
interneurons enhances phasic DA release in the NAc (Cachope et al., 2012). Furthermore,
activation of D2R by tonic DA release selectively inhibits inputs from the PFC, suppressing
PFC-dependent set-shifting responses and response inhibition (Goto and Grace, 2005), which
may affect performance on the VPVD task. While Frank’s model of basal ganglia function
(Frank et al., 2004) did not predict the behavioural results from targeting the ventral striatum,
it did predict the systemic results. Thus, the systemic quinpirole effect might result from
the interaction of different brain regions, rather than having a localised focus, or from the
interaction of these regions with a main modulatory structure, such as the dorsal striatum –
where direct and indirect pathways expressing D1R and D2R, respectively, are more clearly
dissociated –, and this might be working in communication with the ventral striatum to
regulate reversal learning.
Interpretation of quinpirole-induced effects on reward collection latencies
Expanding on the local latencies discussed in the previous section, relatively high doses
of systemic quinpirole slowed overall latencies to collect earned food pellets. While latencies
to respond were not affected, from the dose of 0.025 mg/kg upwards latencies to collect
the reward were prolonged relative to the vehicle control group. Altered latencies to collect
the reward while responding times are unaffected indicate possible changes in Pavlovian
approach motivation. Increased latencies to collect the pellet could indicate decreased
motivation for the reward. However, if this were the case, we would expect to find an effect
on positive-probe trials, which are the trials measuring approach to rewarded stimulus. The
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lack of effects on such trials is at odds with altered motivation and indicates that these effects
on performance may be due to cognitive mechanisms.
In contrast, the speed to respond to the stimuli was not affected overall by quinpirole,
when collapsed throughout all sessions on trials, which suggests that the drug did not affect
the control of choice speed. However, when analysed depending on the type of trial, I
observed an increased time to respond regardless of dose on negative-probe trials when
animals made an error. In these trials, animals had to dissociate between the negative (A-)
and the probe (C50/50) stimulus, and it was in those same trials that higher doses of quinpirole
impaired performance leading to a reduction on optimal choices. This indicates that animals
required more time to make a decision, suggesting that the stimuli processing on those trials
was cognitively challenging, but further research would be needed to confirm this hypothesis,
as collection latencies were also affected in the same direction.
While these results extend our understanding of the role of D2R and the NAcC and
NAcS in reversal learning, a more selective approach is needed to dissociate the involvement
of pre- and post-synaptic D2R. Chapter 5 aims to provide evidence for this dissociation
by using a systemic A2AR antagonist. In addition, a direct link between modulation of
behaviour, changes in DA dynamics, and learning from positive and negative feedback is
yet to be established. Chapter 6 seeks to establish this link by artificially stimulating striatal
inputs with in-vivo optogenetics during specific times in reversal learning when feedback is
processed to guide behaviour.
4.6 Conclusions
This study demonstrated dissociable effects and mechanisms of systemic and striatal D2R
activation with quinpirole, and striatal A2AR antagonism with ZM-241385 into the NAcC
and NAcS in a visual reversal-learning task in rats. Using the recently developed VPVD
task, I observed that high doses of quinpirole impair reversal-learning performance by
blocking learning from negative feedback, as predicted by Frank’s model of the basal ganglia
(Frank et al., 2004). In contrast, I found that whereas low doses of quinpirole into the
NAcC improved performance in reversal learning by enhancing learning from negative
feedback, quinpirole into the NAcS improved performance by selectively enhancing learning
from positive feedback. Administration of KW-241385 suggested that these effects were
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modulated by pre-synaptic D2R in the NAcS, potentially leading to reduced DA release,
but by post-synaptic D2R in the NAcC. In addition, higher doses of quinpirole into the
NAcC impaired reversal learning by blunting learning from negative feedback, as observed
following systemic administration of quinpirole.

Chapter 5
Effects of adenosine 2A and dopamine
D2 receptor agents on spatial
probabilistic reversal learning
5.1 Introduction
Convergent evidence implicates striatal DA as an important neuromodulator of reversal
learning (Clarke et al., 2008; McAlonan and Brown, 2003). Electrophysiological experiments
in animals have shown that DA signalling corresponds with RPE coding whereby unexpected
rewards produce a phasic activation of DA neuronal activity, while unexpected omission of
rewards results in a dip in DA activity (Schultz et al., 1997).
In humans, D2R have been widely implicated in reversal learning (Clatworthy et al.,
2009; den Ouden et al., 2013; Mehta et al., 2001). Imaging experiments revealed that D2R
radioligand binding correlates with learning from negative feedback (Cox et al., 2015). In
vervet monkeys and rats, systemic blockade or agonism of D2R impairs reversal learning
(Boulougouris et al., 2009; Lee et al., 2007), highlighting an inverted U-shaped function of
striatal DA involvement (Horst et al., 2019), while D2R knockout mice show deficiencies in
initial visual discrimination and in reversal learning (Kruzich and Grandy, 2004).
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Understanding and dissecting the role of DA signalling is challenging due to the expres-
sion of D2R in both pre- and post-synaptic striatal MSNs (De Mei et al., 2009; Delle Donne
et al., 1996). Both have been shown to regulate DA-evoked release, but only pre-synaptic
D2R, also called autoreceptors, regulate DA re-uptake and release (Anzalone et al., 2012).
Our work with systemic quinpirole in the VPVD task learning from positive or negative
feedback suggested that the D2R agonist quinpirole modulated behaviour via post-synaptic
D2R (Alsiö et al., 2019), but it is difficult to conclude if the results were modulated by pre-
or post-synaptic D2R.
Apart from being expressed in pre- and post-synaptic striatal neurons, D2Rs are also
expressed in striatal interneurons (Delle Donne et al., 1996), which play an important role
in associative and motor learning processes (Surmeier et al., 2007; Wang et al., 2006).
However, a key anatomical difference between interneurons, mesolimbic/nigrostriatal and
striatopallidal neurons is that only the latter selectively express A2AR. A2AR are expressed
as D2R heterodimers in higher density in striatopallidal neurons than any other cells in
the central nervous system (Gerfen, 2004; Schiffmann et al., 2007). Thus, A2AR appear
to be specific marker of striatopallidal neurons. A2AR are Gs-coupled receptors and their
antagonism has been suggested to enhance the efficacy of DA bound to striatal D2R.
Although selective serotonin reuptake inhibitors (SSRI) are the choice of preference for
OCD patients, some subjects show treatment resistance; highlighting that novel neurological
disorder (like OCD) treatments are an unmet need that remain challenging (Pallanti et al.,
2004). In OCD-like behavior in rodents induced by repetitive administration of quinpirole,
blocking A2AR with the antagonist Istradefylline® rescued impaired behaviours that were
either responsive or not to the current SSRI treatment, and it improved cognitive flexibility
(Asaoka et al., 2019). In this line, epidemiological studies report that caffeine, a non-selective
adenosine receptor antagonist, has pro-cognitive and anti-depressant properties, thus has
been suggested as self-medication for depressed patients (Leibenluft et al., 1993). Caffeine’s
action at A2AR has been proposed as an alternative preventive or therapeutic strategy for
parkinsonian symptoms (Prediger, 2010). In addition, selective A2AR antagonists are being
tested in clinical trials for disorders related to dopaminergic dysfunction such as Parkinson’s
disease, and positive results suggest they can be used as auxiliary therapies (Hung and
Schwarzschild, 2014).
Thus, targeting A2AR in a reversal learning context might contribute to dissociating
the receptors by which quinpirole induces its effect on cognitive flexibility, and provide
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preclinical evidence for a potential clinical treatment for neuropsychiatric disorders associated
with DA dysfunction and/or cognitive inflexibility.
5.2 Aims, approaches, and hypotheses
The overarching aim of the experiments described in this chapter was to investigate if the
effects of DA agents on cognitive flexibility. Specifically, I sought to research whether
the impairments observed in Chapter 4 following systemic quinpirole administration were
modulated by striatal post-synaptic D2R, rather than pre-synaptic or interneuron D2Rs.
A2ARs form heteromers with D2R in striatopallidal neurons, have been reported to influence
DA function, and stimulate the formation of cAMP, whereas D2Rs decrease this cellular
cascade. Thus, it was hypothesised that antagonising A2AR would induce a similar effect
to agonising D2R (i.e. inhibiting cAMP formation vs activating the inhibition of cAMP
formation, respectively), if D2R agonism was acting via post-synaptic receptors.
This hypothesis was tested by systemically administering the D2R agonist, quinpirole,
and the A2AR antagonist, KW-6002 (Istradefylline® being the clinical name), while rats
performed in a spatial PRL task. It was predicted that both quinpirole and KW-6002 would
impair reversal-learning performance. In addition, it was hypothesised that, the D2R agonist,
raclopride, and KW-6002 would counteract each other so their combined effect would not
differ from vehicle control.
5.3 Material and methods
All experiments were performed at the CNS Department, in Boehringer Ingelheim GmbH,
Germany.
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Fig. 5.1 Figure caption on following page
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Fig. 5.1 Overview of the drugs used and experimental design. A) Experimental timeline of
the behavioural procedure, including training stages to respond to the operant boxes, training
in the PRL task, and testing. During testing, for each LSQ, animals underwent a baseline
session with administration of vehicle, followed the next day by a session on drug. The
day after, animals ran the task off-drug as a washout day (WO). The sequence of ‘On-WO’
continued until the LSQ was completed i.e. n sessions of ‘On’ and n-1 sessions of ‘WO’,
where n is the total number of doses included in the LSQ. After this, animals rested for at
least one day, as an ‘Off’ day, before starting the following LSQ, if needed. Time indicated
above each cell indicates expected time required to complete the stage. B) Drugs used,
including doses, route (i.p.: intraperitoneal; p.o.: per os, oral), volume, time of administration
before testing in the operant boxes, and vehicle. Note that the dose of raclopride 0.3 mg/kg
was exclusively used when administered in combination with another drug within the LSQ,
not when originally tested separately. C) Cohorts size and doses per cohort. Doses were
administered following a LSQ design, where each doses was tested during one behavioural
session. When the cohort experienced more than one LSQ, the LSQ containing only one
drug was tested before that combining multiple drugs. Where n = 15, one rat was excluded
due to seizures. Doses are presented as mg/kg.
5.3.1 Subjects
See Chapter 2, section 2.1, for details on housing and ethical approval. A total of 65 male
Lister-Hooded rats (Charles River GmbH & Co, Germany) was housed in groups of four
under humidity- and temperature-controlled conditions and a 12:12-h light-dark cycle (lights
off at 0730 h).
5.3.2 Drugs
The D2R antagonist s(-)raclopride(+)-tartrate salt (Sigma-Aldrich, Dorset, UK) and the
D2R agonist (-)-quinpirole hydrochloride (Sigma-Aldrich, Dorset, UK) were dissolved in
physiological saline (0.9%). Aliquots were stored at -20°C for a maximum of 1 week in the
quantities required for each testing day. The A2A-R antagonist KW-6002 (Istradefylline®,
Tocris Bioscience, Germany) was suspended in 1% methylcellulose 400 cP. Doses were
prepared daily before testing (Fig. 5.1B). In this chapter, I used KW-6002 instead of
ZM-241385 because administration was systemic as opposed to intracerebral (Chapter 4).
Systemic ZM-241385 induces peripheral effects before crossing the blood brain barrier
(Coney and Marshall, 1998).
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5.3.3 Behavioural procedures
Apparatus
The behavioural apparatus consisted of eight lever-pressing operant chambers (Med Asso-
ciates, Georgia, VT, USA). See Chapter 2, section 2.2.2, for further details on the apparatus.
Training
Rats were initially trained following the standard training procedure for spatial reversal
learning. See Chapter 2, section 2.3.2, for details on behavioural training.
PRL task
See Chapter 2, section 2.3.2, for details on the PRL task.
5.3.4 Drug administration and behavioural testing
Fig. 5.1A shows the experimental timeline of the behavioural procedures. After reaching
criterion for testing, rats underwent a baseline session following the administration of
vehicle (habituation). On the following day, testing started. For all experiments, drugs were
administered according to a within-subject LSQ design, fully randomised based on baseline
performance. Drug administration was conducted every 48 h to allow for drug wash-out. In
between on-drug sessions, an off-drug session was run to maintain performance stability.
Raclopride was administered i.p. at doses of 0, 0.01, 0.03, 0.1 and 0.3 mg/kg, 20 min prior to
testing. Quinpirole was administered i.p. at 0, 0.025, 0.1 and 0.25 mg/kg, 30 min before the
behavioural task. KW-6002 was administered orally, via gavage, at 0.3, 1, 3 and 10 mg/kg, in
a volume of 5 ml/kg, 30 min before the task. Both i.p. drugs were administered in a volume
of 1 ml/kg, whereas the oral drug was administered in a volume of 5 ml/kg (Fig. 5.1B).
Suspensions (i.e. KW-6002 doses) were continually stirring prior to administration to avoid
the compound settling to the bottom of the vial. In case of combined administration, animals
were injected first with the compound of longer waiting time and returned to the cage until
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the second administration was needed. Combinations consisted of quinpirole with raclopride,
and raclopride with KW-6002 (Fig. 5.1C).
5.3.5 Behavioural data analysis
Behavioural performance was quantified with the dependent variable of the number of
reversals either per session or per trial. Trials per session, omissions and latencies to collect
the reward were also analysed. I additionally investigated the effect of previous feedback
on subsequent decisions, namely the probability of repeat choices after reward (“win–stay”)
or shifting responses after losses (“lose–shift”). I also looked in detail at responding during
the reversal stage. I divided the type of trials following the first reversal into perseverative,
correct or incorrect trials, as previously reported (Dhawan et al., 2019; Jones and Mishkin,
1972). Following each reversal, trials prior to the first correct response (i.e. trials touching the
previous optimal lever, now suboptimal) were classified as perseverative. Responses on the
optimal lever were registered as correct, including the first correct response and disregarding
the last eight consecutive correct responses that would lead to a new reversal. Responses on
the suboptimal lever, subsequent to the first correct trial were classified as incorrect. Trials
were corrected by the number of reversals achieved. Trials from the beginning of the task
until the first reversal were analysed as discrimination trials and classified as correct if these
were directed to the optimal lever (and up to the first of the eight consecutive trials that led to
reversal), or incorrect if responses were done to the suboptimal lever.
Statistical tests were performed using RStudio, version 1.2.1335 (RStudio, Inc). Data
were subjected to Linear Mixed-Effects Model analysis with the lmer package in R. The
model contained one within-subject factor (dose) and one factor (subject) modelled as
an intercept to account for individual differences between rats. For trial type, the model
contained two within-subject factors (dose; type of trials) and one factor (subject) as the
intercept. Normality was checked with both Q-Q plots and the Shapiro test. To analyse win-
stay/lose-shift probabilities, a general model with the glmer package in R was used. Latencies
were log transformed while the number of reversals was square root transformed to ensure
normality. Homogeneity of variance was verified using Levene’s test. For repeated-measures
analyses, sphericity was checked with Mauchly’s test, and the degrees of freedom were
corrected using the Greenhouse-Geisser whenever the sphericity assumption was violated.
When significant interactions or main effects were found, analysis was followed by post-hoc
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pairwise comparisons corrected by a Tukey’s test if all the conditions were compared, or by
a Dunnett’s test if compared against the control group.
5.4 Results
5.4.1 Initial discrimination
Fig. 5.2 shows that high doses of both D2R agonist quinpirole and antagonist raclopride
impaired performance during initial discrimination. This within session effect manifested
as an increased number of trials to reach the criterion, with increased correct and incorrect
responses.
When each drug was administered separately, mixed effects model analysis showed a
significant effect of quinpirole dose on the number of trials to reach criterion (F3, 45 = 25.168,
p < 0.001), and when raclopride and KW-6002 were administered in the same LSQ (F3, 46.548
= 3.372, p = 0.017) leading to a decrease in the number of reversals achieved. Post-hoc
multiple comparisons revealed an impairment caused by the high doses of quinpirole: 0.1
mg/kg (p < 0.001) and 0.25 mg/kg (p < 0.001), but not by the low doses (ns, Fig. 5.2A). For
raclopride, only the dose of 0.3 mg/kg impaired performance in comparison with the vehicle
control group (p = 0.028; Fig. 5.2C). No significant effects were observed with KW-6002 (p
= 0.966; Fig. 5.2E).
With respect to trial type, there was a significant main effect of dose after administration
of quinpirole (F2.097, 31.45 = 18.78, p < 0.001). Post-hoc comparisons showed that this effect
was driven by all three doses, but in different directions. While the lower dose induced a
decrease in the number of trials, and the higher doses induced an raised the number (0.1 and
0.25 mg/kg; p < 0.001 for both). I also found a main effect of type of trials with raclopride
(F1, 14 = 19.16, p < 0.001) and with KW-6002 (F1, 15 = 17.61, p < 0.001). Whereas post-hoc
analysis revealed a difference between correct and incorrect trials with the dose of 0.01 mg/kg
(p = 0.047), this dissociation was not found with any dose of KW-6002 (ns; Fig. 5.2F).
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Fig. 5.2 Administration of a higher dose of quinpirole impairs performance to reach criterion
to the first reversal. The highest dose of raclopride induces the same effect, except when
combined with quinpirole in the same LSQ. For each drug separately: A) Trials completed and
B) type of trials following administration of D2R agonist quinpirole; C) Trials completed and
D) type of trials following administration of D2R antagonist raclopride; E) Trials completed
and F) type of trials following administration of A2AR antagonist KW-6002. For combined
drugs: G) Trials completed and H) type of trials following co-administration of quinpirole and
raclopride; I) Trials completed and J) type of trials following co-administration of KW-6002
and raclopride. Type of trials include correct trials excluding the eight consecutive trials
leading to reversal (bottom; green), and incorrect trials (top; orange). Black line representing
significance indicates an overall impairment, including correct and incorrect trials. Data are
shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001 vs vehicle
treatment.
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When drugs were co-administered, the impairment induced by raclopride on discrimina-
tion trials was reversed by KW-6002, returning performance to vehicle control levels (dose:
F3, 45 = 25.168, p < 0.001; pairwise comparison of combined drugs vs vehicle: p = 1.000)
(Fig. 5.2I). Similarly, the impairment induced by quinpirole was reversed with raclopride
(dose: F3, 56 = 5.210, p = 0.003; pairwise comparison of combined drugs vs vehicle: p =
0.215) (Fig. 5.2G).
In relation to trial type, a significant main effect of dose was found following co-
administration of quinpirole and raclopride (F1.827, 25.58 = 8.926, p = 0.002) and of KW-6002
and raclopride (F2.304, 34.56 = 3.215, p = 0.046). Post-hoc comparisons revealed these effects
were driven by quinpirole (p < 0.001), and raclopride did not fully reverse the impairment (p
= 0.002; in comparison to vehicle control), but attenuated quinpirole effects (quinpirole vs
quinpirole + raclopride: p = 0.045). Following co-administration of raclopride and KW-6002,
an overall increase in correct and incorrect trials was observed when raclopride was adminis-
tered alone (p = 0.035), which was reversed when combined with KW-6002 (p = 0.097) (Fig.
5.2J).
5.4.2 Reversal learning
Effects of D2R agonism with quinpirole on reversal learning
D2R agonism with quinpirole impaired reversal learning performance at the highest doses
tested (0.1 and 0.25 mg/kg), with rats completing fewer reversals than controls per session
(Fig. 5.3).
The impairment in performance was observed as a decrease in the number of completed
reversals (Fig. 5.3A; F3, 45 = 39.195, p < 0.001), trials per session (Table 5.1; dose: F3, 45.001
= 42.767, p < 0.001) and the ratio of reversals per trials (F3, 45 = 27.203, p < 0.001). Further
analysis revealed that this effect was specific to the 0.1 and 0.25 mg/kg dose levels (all p <
0.001).
Analysis of win-stay and lose-shift probabilities indicated that quinpirole affected both
types of feedback (dose for win-stay: F3, 45 = 41.408, p < 0.001; for lose-shift: F3, 45.002
= 3.722, p = 0.018). Post-hoc pairwise comparisons revealed that whereas the dose of 0.1
mg/kg dose decreased win-stay (p < 0.001) and increased lose-shift probabilities (p = 0.029),
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the dose of 0.25 mg/kg decreased win-stay (p < 0.001), but left lose-shift probability intact (p
= 0.978) in comparison to vehicle control. The dose of 0.025 mg/kg did not affect sensitivity
to either positive or negative feedback (ns, Fig. 5.3C, D).
Fig. 5.3 Administration of the three drugs separately impaired reversal-learning performance
with relatively high doses. A), E) and I) Number of reversals achieved. B), F), J) Type
of trials completed. Perseverative (grey, bottom) trials as touching the new suboptimal
(previously optimal) lever following reversal, until touching the new optimal (previously
suboptimal) lever; correct trials (green, middle) as touches to the optimal lever until the
final error i.e. excluding the eight consecutive responses that lead to reversal; incorrect trials
(orange; top) as touches to the suboptimal lever. The colour of the line indicating significance
represents what type of trial was significant (i.e. perseverative, correct or incorrect). The line
is presented as black if there was an overall significance (i.e. including all type of trials). C),
G), K) Win-stay probability. D), H), L) Lose-shift probability. Results are shown as mean ±
SEM. # p ∼0.05, * p < 0.05, ** p < 0.01, *** p < 0.001 vs vehicle treatment.
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Table 5.1 Effect of each drug on latencies to collect the reward, latencies to respond and
omissions. High doses of quinpirole and raclopride increase latencies to respond and
omissions. The joint administration of raclopride and KW-6002 counteracts these effects.
The combination of quinpirole with raclopride reverses the increase in omissions, but not in
latencies. Data are mean ± SEM. *** p < 0.001 vs vehicle treatment.
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With respect to trial type (Fig. 5.3B), a significant dose × type of trials interaction was
found (F1.888, 23.60 = 7.998, p = 0.003). Post-hoc pairwise comparisons revealed that this
change was driven by the highest dose of quinpirole (0.25 mg/kg) during incorrect trials in
each reversal in comparison to vehicle control (p = 0.009). A strong trend with the dose of
0.1 mg/kg was also observed in all type of trials (perseverative: p = 0.050; correct = 0.063;
incorrect: 0.060).
Quinpirole also significantly increased the latency to respond (F3, 45 = 51.934, p < 0.001)
and omissions (F3, 45 = 7.500, p < 0.001) (Table 5.1). Further analysis revealed that this effect
were selective for the two highest doses, 0.1 and 0.25 mg/kg (all p < 0.001). No changes
were observed in these variables after administering quinpirole at 0.025 mg/kg or in latencies
to collect the reward with any of the administered doses (ns, Table 5.1).
Effects of A2AR antagonism with KW-6002 on reversal learning
Administration of the A2AR antagonist KW-6002 significantly impaired reversal learning
when administered at 3 mg/kg.
With respect to the number of reversals achieved in each session, linear mixed-effects
model showed a main effect of dose (F4, 74 = 2.704, p = 0.037). Further analysis revealed
that this was due to an impairment caused by administration of KW- 6002 at dose 3 mg/kg (p
= 0.011; Fig. 5.3E). The same effect was observed on reversals per trials (F4, 70 = 3.191, p =
0.018). Post-hoc comparisons showed that this effect was specific to the dose of 3 mg/kg (p
= 0.010).
When analysing trial type during each reversal (perseveration, correct, incorrect re-
sponses), a main effect of dose was found (F2.913, 43.70 = 3.004, p = 0.042), which according
to post-hoc comparisons was driven by the dose of 3 mg/kg (p = 0.003; Fig. 5.3F).
In terms of win-stay probability, there was a close to trend main effect of dose (F4, 70 =
1.990, p = 0.101), and planned pairwise comparisons revealed this was driven by the dose of
3 mg/kg (p = 0.041). No main effect of dose was detected on completed trials per session,
latency to collect the reward, latency to respond, lose-shift probability or omissions (ns;
Table 5.1).
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Effects of D2R antagonism with raclopride on reversal learning
D2R antagonism with raclopride impaired reversal learning only at the high doses tested. For
the raclopride study, the doses of 0, 0.01, 0.03 and 0.1 mg/kg were originally used. These
doses proved to have no effect in any of the main analysed variables (Fig. 5.3I-L). A main
effect of dose in latency to respond was found (F3, 44.020 = 3.644, p = 0.020), but post-hoc
pairwise comparisons did not reveal the effect of any dose in comparison to vehicle control,
suggesting it was an overall impairment (Table 5.1).
In light of these results, a higher dose of raclopride was tested when combined with the
other drugs. The highest dose, 0.3 mg/kg, induced a decrease in reversals per session (dose:
F4, 46.379 = 8.703, p < 0.001; Fig. 5.3A, E) and per trials (dose: F4, 46.141 = 4.835, p = 0.002).
On type of trials, there was no specific effect of low-dose raclopride or when combined in
the same LSQ as quinpirole, but had an overall effect when combined with KW-6002 (see
section 5.4.2).
A main effect of dose for omissions was also observed (F4, 46.785 = 9.377, p < 0.001; Table
5.1), latency to respond (F4, 45.257 = 31.228, p < 0.001; Table 1), and win-stay and lose-shift
probabilities (F4, 44.597 = 11.518, p < 0.001; F4, 45.520 = 3.181, p = 0.022, respectively; Fig.
5.3G, H). Post-hoc analysis revealed that the main effect of Dose was due to the high dose of
raclopride: 0.3 mg/kg (all p < 0.001, except for lose-shift probability: p = 0.011) in all of the
significant variables. No effects were observed in latencies to collect the reward (ns; Table
5.1).
Effects of combining D2R antagonism with D2R agonism or A2AR antagonism
After combining the effective dose of the D2R antagonist raclopride (0.3 mg/kg) with the
effective dose of the D2R agonist quinpirole (0.1 mg/kg) or of the A2AR antagonist KW-6002
(3 mg/kg), there was a partial recovery of the impairment in reversal learning caused by each
drug separately.
The dose of quinpirole 0.1 mg/kg was chosen over 0.25 mg/kg as it induced a similar
impairment, but with a reduced impact on latencies or trials, and it tended to affect all type
of trials, not only the incorrect (as observed with 0.25 mg/kg). In addition, from previous
experiments in our laboratory (Alsiö et al., unpublished), I observed that counteracting the
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effects of quinpirole is challenging, so a weaker dose would enable detecting rather small
changes than a larger dose. The dose of 3 mg/kg for KW-6002 was used, as it was the only
dose found to cause an effect in reversal-learning performance.
With respect to the number of reversals per session, both raclopride and KW-6002
impaired reversal learning (dose: F3, 45.250 = 11.817, p < 0.001) (Fig. 5.4). In contrast, when
administered together, there was no significant difference compared with the control group
(p = 0.185; Figure 5.4E). The same conclusion was reached when analysing reversals per
trials (dose: F3, 45.120 = 6.285, p = 0.001; combine drugs vs vehicle: p = 0.101), and trials per
session (dose: F3, 45.120 = 6.285, p = 0.001; combined drugs vs vehicles: p = 0.211; Table
5.1). Trials per session was originally decreased only by raclopride (p < 0.001), not KW-6002
(p = 1.000) (Table 5.1). Administering both drugs together also reversed the impairment
observed with raclopride alone in omissions and latencies to respond (p = 1.000; p = 0.796; p
= 0.723, respectively; Table 5.1). Whereas the reduction in lose-shift probability induced
by the D2R antagonist (F3, 44.749 = 4.072, p = 0.012; raclopride vs vehicle: p = 0.017) was
prevented by A2AR antagonist (p = 0.165; Figure 5.4H), the decrease in win-stay remained
significant (F3, 44.415 = 14.431, p < 0.001; raclopride vs vehicle: p < 0.001; combined drugs
vs vehicle: p = 0.001) (Fig. 5.4G, H).
In contrast, when quinpirole and raclopride were co-administered, the effects of each
drug were not neutralised by the other drug in any of the analysed dependent variables, hence
animals showed impaired performance as when quinpirole or raclopride were administered
separately (Fig. 5.4A-D; Table 5.1). This was except for omissions, which did not differ from
vehicle control (ns; Table 5.1). In this LSQ, there was no effect in lose-shift probabilities (ns;
Fig. 5.4D).
In summary, the results from this chapter indicate that systemic quinpirole impairs
cognitive flexibility via striatal post-synaptic D2R, as suggested by the replication of its
effects by the A2AR antagonist, KW-6002. KW-6002 not only replicated the cognitive
effects of quinpirole, but also counteracted the impairment observed after antagonising D2R
with raclopride.
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Fig. 5.4 Raclopride and KW-6002, not quinpirole, counteracted their effects when adminis-
tered together. When drugs are co-administered, doses are represented as the first letters of
the drug and followed by the dose in mg/kg i.e. Q: quinpirole, R: raclopride, KW: KW-6002.
A), E) Number of reversals achieved. B), F) Type of trials completed. Perseverative (grey,
bottom) trials as touching the new suboptimal (previously optimal) lever following reversal,
until touching the new optimal (previously suboptimal) lever; correct trials (green, middle)
as touches to the optimal lever until the final error i.e. excluding the eight consecutive
responses that lead to reversal; incorrect trials (orange; top) as touches to the suboptimal
lever. The line for significance is presented as black since there was an overall significance
(i.e. including all type of trials); Square bracket line represents significance from main
effect of dose, not interaction, and overall impairment. C), G) Win-stay probability. D), H)
Lose-shift probability. Results are shown as mean ± SEM. * p < 0.05, *** p < 0.001 vs
vehicle treatment.
5.5 Discussion
This chapter demonstrated that stimulation or inhibition of D2R via administration of the D2R
agonist quinpirole or the D2R antagonist raclopride impaired spatial probabilistic reversal
learning performance by increasing the number of trials needed to achieve a reversal. The
A2AR antagonist KW-6002 had similar impairing effects, which were blocked by raclopride.
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Impairing effects of D2R agonism and antagonism on reversal learning
Quinpirole and raclopride severely impaired probabilistic reversal learning and its pre-
ceding spatial discrimination. These results are supported by earlier observations in our
laboratory and in previous literature in which D2R agonism and blockade impaired perfor-
mance in rats (Boulougouris et al., 2009), non-human primates (Smith et al., 1999) and
humans (Mehta et al., 2001). These findings on one hand provide a validation of the task for
the future optogenetics experiments (see Chapter 6); and on the other hand extend previous
findings by showing that the detrimental effects of DA imbalance (e.g. induced by raclopride)
in a probabilistic version of reversal learning are counteracted by A2AR antagonism.
Following previous experiments in the VPVD task (Chapter 4) (Alsiö et al., 2019), I
reasoned that the impairing effects of quinpirole were mediated by post-synaptic D2R. This
assertion is partly supported by the observation that only the higher doses of quinpirole,
which putatively act at both pre-synaptic and post-synaptic striatal D2R, rather than lower
doses which potentially act pre-synaptically (Eilam and Szechtman, 1989), impaired reversal
learning. To test this hypothesis, I combined the administration of D2R agents with the A2AR
antagonist KW-6002, clinically known as Istradefylline®. A2AR are structurally coupled
with D2R in striatopallidal neurons i.e. exclusively to post-, not pre-, synaptic striatal D2R
(Moreno et al., 2018). Since A2AR are Gs-coupled receptors and their antagonism enhances
the efficacy of striatal D2R, it is reasonable to assume that the antagonism would replicate
the effects of quinpirole if the latter was acting via post-synaptic D2R, but would not if it
were via the pre-synaptic D2R. Similarly, it would counteract the effects of raclopride if this
assumption was correct.
KW-6002 reproduced the effects of quinpirole in reversal learning performance and
attenuated those caused by raclopride. When administered with raclopride, KW-6002 partially
recovered the impairment induced by raclopride – or raclopride of those caused by KW-
6002 – in terms of number of reversals achieved. However, it did not affect the decrease in
win-stay probability. In addition, the lowest dose of quinpirole – thought to act selectively
via pre-synaptic D2R – improved performance in the discrimination phase by decreasing
the number of correct and incorrect trials, in opposition to the impairment observed with
higher doses. Thus, it can be concluded that the observed deficit in probabilistic reversal
learning induced by quinpirole is probably modulated by post-synaptic D2R. However, a
more complex system or interaction cannot be excluded, and this interpretation should be
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made with caution since both raclopride and quinpirole interact with not only D2R, but also
D3R.
D2R agonism with quinpirole decreased win-stay probability
Modulation of D2R expressing striatopallidal neurons during reversal was also supported
by my studies with systemic quinpirole by the deficit in learning from negative feedback
in the VPVD task (Chapter 4). Seminal work from Frank and colleagues (Frank et al.,
2004) suggests that the indirect pathway of the striatum mainly contributes to learning
from negative feedback i.e. it reinforces “NoGo” behaviours in the presence of negative
outcomes. According to the RPE theory, the ’dip’ produced during negative outcomes allows
the disinhibition of the indirect pathway and acts as a teaching signal. Thus, increased tonic
DA activity produced by quinpirole would be expected to prevent learning from such a
dip and therefore learning from negative feedback. This is also supported by the decrease
in lose-shift probability in rats (Alsiö et al., 2019) and the relationship between D2R and
learning from negative outcomes in humans (Cox et al., 2015). Nonetheless, although I
observed a comparable impairment in the general performance, in this case, it was driven
by a decrease in win-stay probability, not lose-shift. This drug-induced decrease in win-
stay indicates that even after receiving a reward, animals treated with quinpirole shifted to
the other lever in the following trial more often than when receiving the saline treatment.
Although this finding was unexpected, other studies are in agreement with this finding. For
instance, D2R binding in the striatum of vervet monkeys correlates with sensitivity to positive
feedback in reversal learning, measured as win-stay probability (Groman et al., 2014, 2011).
Systemic administration of quinpirole also reduced win-stay probabilities in rats. A decrease
in reversals has not only been related to a reduction in the learning rate from losses, but also
to decreased learning from wins (Alsiö et al., 2019). In addition, Verharen and colleagues
recently reported decreased win-stay probability in a spatial deterministic reversal task
following cocaine and amphetamine pre-treatment (Verharen et al., 2018). These behavioural
findings suggest that the observed decline in reversal learning in the present study was due to
insensitivity of learning from positive feedback, which contributes to optimal performance
in the task. Nevertheless, it is important to note that win-stay and lose-shift probabilities
are indirect measures of learning from positive or negative feedback, and so both modes of
feedbacks should be integrated to produce either win-stay or lose-shift behaviours.
When quinpirole and raclopride were included in the same LSQ, neither affected win-
stay or lose-shift probability when administered separately nor combined. Quinpirole is
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well known for having long-term effects. I provided a washout day in between sessions to
prevent carry-on effects, but this may not have been long enough to prevent residual drug
effects on future performance. Since raclopride interacts with the same receptors, they could
have neutralised each other regarding their effect on win-stay probability. However, this
neutralisation was not observed on reversals. Each drug individually had a strong impairing
effect, potentially making it less likely to be reversed. Another speculative possibility would
be that quinpirole and raclopride were primarily acting in different brain subregions that
co-operate or compete for the modulation of flexible behaviour. Further research would be
needed to confirm this hypothesis.
Importance of DA levels for reversal-learning performance
Administration of quinpirole and raclopride, D2R agonist and antagonist, respectively,
lead in both cases to an impairment in reversal learning. This is consistent with opposite
effects observed on reversal learning after the up- or down-regulation of striatal DA activity.
Thus, systemic amphetamine administration, which raises synaptic DA, induced perseverative
behaviour following visual object reversal in marmosets (Ridley et al., 1980), whereas
selective depletion of caudate DA disrupted reversal in marmosets (Clarke et al., 2011) and
rats (O’Neill and Brown, 2007).
The relationship between DA function and behaviour or cognitive output often takes
the shape of an inverted-U-shaped function (Yerkes and Dodson, 1908). Recently, Horst
and colleagues (Horst et al., 2019) reported that quinpirole acting in D2R has a tri-phasic
behavioural effect, in which low and high doses of quinpirole into the caudate in marmosets
impaired behavioural flexibility, whereas intermediate doses led to an improvement in reversal
performance. Their study showed causal evidence of an inverted U-shaped DA function in
cognitive flexibility in a reversal-learning task. Although this inverted U-shape of DA has
received criticism in experimental psychology for its capacity to account for various data
sets, it conforms to the results found here on reversal performance following administration
of D2R agonism and antagonism: quinpirole and raclopride might adjust the optimal level of
striatal DA neurotransmission for performance to detrimental levels.
In this study, quinpirole-induced impairment in reversals were accompanied by an in-
crease in perseverative, correct and incorrect trials per reversal at the dose of 0.1 mg/kg, or
incorrect responses at the dose of 0.25 mg/kg in comparison to saline treatment. The potential
increase in perseverative errors is in line with a decreased learning rate from losses (i.e. α loss
104 A2AR and D2R modulation of PRL
parameter) or increased “inverse temperature” (i.e. β parameter) observed in our previous
research (Alsiö et al., 2019). Reduced α loss indicates that animals learn less from negative
feedback on quinpirole compared with vehicle control. Since following reversal trials on the
previously rewarded lever are now more likely to be unrewarded, pressing that lever would
provide negative feedback. Hence, animals with blunted learning from losses would tend
to perseverate. In addition, elevated β indicates higher reinforcement sensitivity i.e. less
exploration, suggesting that rats on quinpirole were guided by the expected outcome of their
responses. In this case, rats would exploit the lever that was optimal (now suboptimal) more
instead of exploring the previous suboptimal lever (now optimal). This could similarly apply
to the increase in incorrect trials. In summary, the observed impairment could be explained
by either or both decreased α loss or increased β parameters. However, for the dose of 0.1
mg/kg a trend to increase the number of correct trials was also observed, which highlights the
importance of animals staying on one lever to complete the eight consecutive responses for
reversal. For this task, the number of correct trials does not necessarily reflect the quality of
performance in reversal learning. Their consecutiveness becomes more relevant, as reversals
would only be achieved after eight correct trials in a row. The lack or weaker increase in
perseverative errors following raclopride or KW-6002 during reversals indicates that animals
could initially inhibit the previously learned choice, but were challenged in maintaining this
new choice pattern after initial selection.
The effects of D2R manipulation on discrimination are controversial. During the initial
trials up to the first reversal, here named as discrimination trials, there was a selective
impairment with the higher doses of quinpirole, and of raclopride when administered in
the LSQ with KW-6002, and not with quinpirole. The increase in trials, including both
correct and incorrect trials, indicates that animals were impaired at discriminating between
the optimal and suboptimal lever, or at remembering this condition from the previous session,
making them struggle to find a pattern or stick to one lever to successfully perform in the task.
While Lee and colleagues found that administration of quinpirole to monkeys impaired both
acquisition and reversal-learning in a three-choice task (Lee et al., 2007), Boulougouris and
colleagues observed no differences on acquisition of a spatial reversal learning discrimination
after quinpirole treatment (Boulougouris et al., 2009). These discrepancies could be explained
by the difference in tasks e.g. two vs three-choice discrimination or visual vs spatial or by
the definition of discrimination. In our study, this discrimination cannot be accounted as
acquisition since animals have experienced these conditions and reversals several times prior
to the session under quinpirole treatment.
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Localisation of the effects in the striatum
Although this study was based on systemic administration of drugs, the observed effects
are potentially driven by altered functioning of the striatum, which has been widely implicated
in reversal learning performance via D2R. The question remains as to which subregion is
involved. D2R availability in the dorsal subregions of the striatum of vervet monkeys has
been associated with performance in reversal learning (Groman et al., 2011). Within the
dorsal striatum, the DMS has been associated with goal-directed actions and is active in the
early-mid phases of reversal learning. Instead, the DLS has been associated with habitual
behaviours and becomes engaged at later stages (Brigman et al., 2013). In the ventral striatum,
increased DA activity or infusion of quinpirole impaired reversal learning in rats (Haluk
and Floresco, 2009). Inactivation of the NAcS, but not the NAcC, impaired probabilistic
reversal learning performance (Dalton et al., 2014). According to our previous research (see
Chapter 3) (Sala-Bayo et al., 2020), whereas D2R antagonism improved early stages of serial
reversal learning when administered into the NAcC (not NAcS), it impaired performance
in mid stages when infused in the DMS and induced an overall impairment when infused
into the DLS. Verharen and colleagues (Verharen et al., 2019) observed that D2R agonism
in the NAc, not DMS or DLS, impaired performance in rats in a similar PRL task to the
one used in our study. Therefore, the observed effects of quinpirole in the present Chapter
may have been mediated within the ventral striatum, with a larger influence of the NAcS;
and the effects of raclopride in the NAcC, but most likely the DLS than the DMS from the
dorsal striatum. Although speculative, this heterogeneity could account for some of the
inconsistencies observed in our results, e.g. quinpirole and raclopride inducing a reduction in
win-stay probability when administered in different LSQs, but not when both drugs were
administered in the same LSQ.
Higher doses of quinpirole and raclopride affect choice performance, but not food collection
latencies
Higher doses of quinpirole (≥ 0.1 mg/kg) and of raclopride (0.3 mg/kg) slowed animals’
lever pressing (Table 5.1) and their co-administration failed to overcome this effect. Never-
theless, these doses failed to prolong the latency for reward (food) collection. This suggests
that the induced impairment did not depend on decreased motivation or reward sensitivity.
In addition, lower but not higher doses are speculated to reduce motivation by acting at
pre-synaptic D2Rs to inhibit activity in midbrain DA neurons (Alsiö et al., 2019). This
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again supports that the conclusion that post-synaptic D2R mediated the impairing effects of
quinpirole and raclopride in the present study.
On top of counteracting the raclopride-induced decline in performance, antagonism of
A2AR did not alter latencies or trials completed per session. As also shown by previous
research, A2AR antagonism is a promising tool to treat neuropsychiatric disorders such as
depression, OCD, or Parkinson’s disease (Asaoka et al., 2019; Hung and Schwarzschild,
2014; Leibenluft et al., 1993). Potential therapeutic benefits of clinically targeting A2AR are
discussed in Chapter 7.
5.6 Conclusions
In the present Chapter, the PRL task was validated at Boehringer Ingelheim and demonstrated
that both D2R agonism with quinpirole and D2R antagonism with raclopride impair reversal-
learning performance in a spatial probabilistic reversal-learning task. This was also found
following A2AR antagonism with KW-6002 (Istradefylline®), which additionally blocked
the effects of raclopride, suggesting that D2R modulate reversal learning via striatopallidal
neurons i.e. via post-synaptic D2R, not pre-synaptic D2R. Whereas raclopride and quinpirole
also affected the initial discrimination, trials completed throughout the task and latencies
to respond to the stimuli, these were not affected by KW-6002. The lack of effects beyond
those in cognitive flexibility suggest that A2AR could be a therapeutic target for treating
neuropsychiatric disorders relates to impaired cognitive flexibility due to DA deficiency.
Hence, the present study expands our understanding of the neural mechanism underlying
reversal learning and contributes to the design of clinical approaches for patients with
neurological or neuropsychiatric disorders related to DA dysfunction.
Chapter 6
Mesoaccumbal, but not nigrostriatal,
projections mediate reversal learning by
regulating behaviour after reward
omission: an in-vivo optogenetics
approach
6.1 Introduction
In the brain, the pattern of DA cell activity is thought to form the basis of RPEs, which act
as a teaching signal to update the value associated with stimuli and/or actions (see Chapter
1; (O’Doherty, 2011; Rescorla and Wagner, 1972). DA fibres that originate in the VTA and
SNc provide dense, topographic innervation to the striatum (Björklund and Dunnett, 2007;
Dahlström and Fuxe, 1964; Groenewegen et al., 1999). The VTA projects preferentially to
the NAc (mesolimbic system), whereas the SN projects preferentially to the dorsal striatum
(nigrostriatal pathway). The direction and magnitude of the DA neuron response within
the midbrain regions depends on the degree to which the reward is expected. When an
experienced reward is better than predicted (positive RPE), a burst in DA neuronal activity
and DA release occurs, thereby signalling a discrepancy between prediction and experience.
Conversely, if the reward is worse than predicted (negative RPE), a dip in DA neuronal firing
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is observed (Daw, 2009; O’Doherty et al., 2017; Schultz et al., 1997). An overdose of DA in
the synaptic cleft might prevent the dip originated during negative RPEs, observed during
reversal stages, and could prevent learning from worse outcomes than expected (Frank et al.,
2004; Klanker et al., 2017). However, the circuit level mechanism underlying negative RPEs
is poorly understood.
Within the ventral striatum, the NAcS is involved in suppressing actions to non-rewarded
stimuli and plays a key role in behavioural flexibility and response to changes in the incentive
value of stimuli (Aquili et al., 2014; Floresco et al., 2006). Indeed, inactivation of the NAcS
in rats impaired flexibility on a spatial PRL task (Dalton et al., 2014) and activating D2R
improves reversal learning (Chapter 4), while inactivation of the NAcC did not affect reversal
learning performance in rats in a spatial PRL task (Dalton et al., 2014). This manipulation
did, however, slow approach responses to the levers. Antagonising D2R in this subregion
improved early stages of reversal learning in a deterministic visual discrimination task in rats
(Dalton et al., 2014; Sala-Bayo et al., 2020). Verharen and colleagues found that increased
dopaminergic activity in the VTA-NAc pathway impeded learning from reward losses or
punishment, highlighting a causal link between negative RPEs and reinforcement learning
(Verharen et al., 2018).
The DMS modulates reversal learning and complex processes associated with shifting
between different strategies (Castañé et al., 2010; Ragozzino et al., 2002). It is critical for
both learning and expressing goal-directed actions (Ostlund and Balleine, 2008) by mediating
the association of a response and outcome representation (Balleine and O’Doherty, 2010).
The DLS has been strongly related to habit learning and the formation of stimulus-response,
as well as stimulus-reward associations (Aosaki et al., 1994; Yin and Knowlton, 2006).
Although previous studies using single-unit electrophysiology, Ca2+ imaging, and fast-
scan voltammetry established a correlative association between phasic changes of DA neu-
ronal activity, RPEs signalling, and value-based learning, little causal evidence exists. Previ-
ous pharmacological and genetic studies aiming to shed light on this topic lacked the required
accuracy in terms of cellular and temporal resolution (Iordanova et al., 2006; Takahashi
et al., 2009). Indeed, genetically-engineered manipulations (e.g. gene knockdown) generally
produce long-term compensatory effects that hinder the evaluation of selective processes
(Parker et al., 2010). Moreover, chemogenetic approaches with transfected receptors (e.g.
DREADDs) do not provide sufficient temporal resolution (Boekhoudt et al., 2018; Verharen
et al., 2018). By contrast, in-vivo optogenetics is temporary and spatially highly resolved, and
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recently has been used to investigate the causal link between RPEs and associative learning
(Chang et al., 2015; Steinberg et al., 2013). Steinberg and colleagues established for the
first time a causal role for temporally precise DA VTA signalling in cue-reward learning in
associative blocking (i.e. impaired association between CS and US due to the presence of a
second CS) and extinction procedures. Chang and colleagues showed that brief pauses can
replace negative RPEs in a Pavlovian over-expectation task. However, the use of optogenetics
to investigate the mechanisms of RPEs is still nascent and much further research is needed,
especially in the context of cognitive inflexibility. For example, it could be used to determine
whether brief pauses or increases in firing can account for how RPEs drive behaviour in
a reversal-learning task. However, it is unclear how changes in DA neuronal firing affect
not only overall reversal learning, but also its constituent subprocesses of learning, such as
making a decision, inhibiting prepotent tendencies or learning from the presence or omission
of reward. In addition, the mechanism whereby VTA DA neurons interact with diverse brain
regions and support RPEs has not been clearly specified.
Learning and translating A-O representations into action needed for reversal-learning
performance is amenable to analysis by computational modelling. Indeed, reinforcement
learning has been suggested as a tractable computational process underlying trial-and-error
learning (Rescorla and Wagner, 1972). One of the most prominent models to analyse
sequential learning data is the Q-learning model (Daw, 2009). The use of such models
has allowed unravelling information about how organisms solve and learn cognitive tasks,
which was not accessible with traditional behavioural analysis (Alsiö et al., 2019; Verharen
et al., 2020, 2019). This includes understanding at what rate animals learn from rewarded
or unrewarded trials, the likelihood of exploiting or exploring the stimuli depending on the
learned rewarding properties, and the tendency of animals sticking to one of the stimuli,
choosing the same stimulus as in the previous trial regardless of its rewarding properties.
6.2 Aims, approaches, and hypotheses
The overarching aim of this study was to provide a demonstration of the causal link between
midbrain neuronal firing dynamics and reversal learning performance. Specifically, I sought
to obtain novel evidence to dissociate the effect of positive and negative RPEs during specific
behavioural events on reversal-learning performance.
110 In-vivo optogenetic stimulation during reversal learning
It was hypothesised that increased VTA-NAcS neuron activation timed to coincide with
omission of reward (i.e. negative RPE) would interfere with reversal learning inducing
an impairment in performance by blocking the natural dip of DA release that encodes
the teaching signal. That is, the impairment would arise from an insensitivity to negative
feedback, which the computational model would reflect as a decrease in the learning rate
from losses. In contrast, it was reasoned that the neuronal activation aligned with reward
during reversals (i.e. positive RPE) either would improve performance by enhancing the
natural burst of neurochemical release or would remain unaltered due to ceiling effects.
It was further reasoned that increased SN-DMS neuron activation could similarly induce
an impairment in performance when activation was aligned with the unexpected omission
of reward. Alternatively, it is conceivable that the DMS may not be involved in the PRL
task since its key role is to regulate goal-directed actions (Balleine et al., 2007), which
hypothetically would be required during earlier stages of training rather than following
extensive training (i.e. as probed during the testing stages).
To investigate this hypothesis, an in-vivo optogenetics approach was used to test whether
activation of the VTA to NAcS or the medial SNc to DMS pathways regulate reversal-
learning performance. Specifically, the impact of this intervention was determined after (1)
the presentation or (2) omission of reward, after spurious (3) presentation or (4) omission of
reward, and (5) prior to the choice response in a spatial PRL task (Fig. 6.1A).
Using computational modelling, I further investigated whether animals learn by positive
or negative feedback, or whether other strategies are adopted (e.g. exploration versus
exploitation or sticking to the previous response regardless of reward outcome). Since it
was assumed that stimulating midbrain DA neurons projecting to the striatum would blunt
dips of DA and impair learning from negative feedback, I hypothesised that the learning rate
from reward omissions would decrease relative to controls when the optogenetic stimulation
coincided with the lack of reward.
6.3 Material and methods
All experiments were performed at the CNS Department, in Boehringer Ingelheim GmbH,
Germany.
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6.3.1 Subjects
A total of 76 male Lister-Hooded rats (Charles River GmbH & Co, Germany) was housed
in groups of four under humidity- and temperature-controlled conditions and a 12:12-h
light-dark cycle (lights off at 0730 h). After surgery, animals were housed in pairs.
6.3.2 Behavioural procedures
Apparatus
Rats were trained in eight lever-pressing operant chambers (Med Associates, Georgia, VT,
USA), as described in Chapter 2 (section 2.3.2). Briefly, the chambers were enclosed within
sound-attenuating boxes with a fan for ventilation. Each chamber had two retractable levers,
with a light above each lever, flanking the food magazine. Rewards (45 mg sucrose pellets)
were delivered to the magazine by a pellet dispenser. Access to the chambers were through a
hinged sidewall, and optogenetics cables were connected from the rats to the ceiling of the
boxes through a ceiling centred hole.
Training
See Chapter 2 (section 2.3.2) for details in training. Briefly, animals were habituated to
make a lever press response to obtain food reward across four different stages of increasing
difficulty. During these stages, animals were presented to the probabilistic nature of the task
(80%/20%) and were forced to sample both levers to avoid developing a side bias.
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Fig. 6.1 Figure caption on following page
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Fig. 6.1 In-vivo optogenetic stimulation of the mesoaccumbal and nigrostriatal pathways
during a spatial PRL task. A) Flowchart overview of the PRL task. In orange, time-points
when the neuronal pathways were optogenetically stimulated after an omission (loss) of
reward (AL), after a win (AW), after a spurious loss (ASL) or spurious win (ASW), and up
until making a choice (UUC). B) Schematics showing viral vector infusion in the VTA/SN,
and fibre optic implantation in the NAcS or DMS for optogenetics stimulation. C) (Left)
Coronal section of the VTA stained for TH and showing viral-transfected neurons. Scale
bar: 1 mm. (Right top) Detailed expression of virus positive neurons, (Right middle) TH
positive neurons (i.e. TH+), and (right bottom) both channels merged. Scale bar: 50 µm. D)
Fibre optic tip placements in the NAcS and DMS. Anteroposterior (AP) coordinates from
Bregma. E) Representative histology images showing coronal sections of the striatum and
representative fibre optical tip location in the NAcS (Left) and DMS (Right). Expression of
viral vector (Bottom left), TH (Bottom right) and both channels merged (Top). Scale bars: 1
mm. F) Percentage co-expression of TH, GAD67 or VGLUT2 in neural fibres expressing the
viral vector containing ChR2 (or its inert ‘empty’ version containing mCherry) in the NAcS
or DMS. Data are shown as mean ± SEM.
PRL task
Behavioural training in the PRL task is described in detail in Chapter 2 (section 2.3.2). Briefly,
animals underwent daily sessions consisting of 200 trials or 60 min, whichever came first,
including ITI 10 sec, TO 5 sec and LH 10 sec. At the start of each session, one of the two
levers was randomly selected to be optimal or suboptimal. A response to the optimal lever
delivered a single reward pellet on 80% of the trials, whereas a response to the suboptimal
lever gave reward on only 20% of the trials. A failure to press a lever within the limited
hold period was noted as an omission. After eight consecutive correct trials (i.e. pressing
the optimal lever regardless of this being reinforced or not), the contingency was reversed.
Animals were trained to attain at least three reversals over three consecutive sessions before
the start of testing.
6.3.3 Stereotaxic surgery
Rats were anaesthetised using isoflurane in oxygen. Anaesthesia was induced with 5% isoflu-
rane and maintained at 2.5%. Animals were ear fixed on a stereotactic frame (KOPF Model
1900, Bilaney Consultants, Germany). An incision was made along the midline of the skin
overlying the dorsal skull. The skull surface was cleaned and OptiBond®. All-in-One bone
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glue (Kerr, USA) was applied and hardened with UV light for 60 s. Animals were infused
bilaterally a total volume of 2400 nL of viral vector per site at a flow rate of 200 nL/min.
Control animals received pAAV8-hSyn-mCherry (8.38 × 1012 particles/ml; Boehringer
Ingelheim GmbH, Germany) and opsin-expressing pAAV8-hSyn-mChR2-mCherry (7.3 ×
1012 particles/ml; Boehringer Ingelheim GmbH, Germany). Animals were divided into
VTA-NAcS (n = 30) or SNc-DMS (n = 46) groups. For the first group, the virus was infused
into the VTA at AP -5.4 and -6.2, ML ± 0.6, DV -8.4 and -7.8 (600 nL per infusion), and
optical fibres (Doric Lenses, Canada) were implanted in the NAcS at AP +1.5, ML ± 0.8,
DV –7.0. For the second group, the virus was infused into the SN at AP -5.4, ML ± 0.6; DV
-8.1 and -8.0 (600 nL/infusion), and optical fibers (Doric Lenses, Canada) were implanted
in the DMS at AP +1.2, ML ± 2.0, DV –5.3. All coordinates were in mm from bregma
and skull. The infuser was left in place for 5 min after each infusion to allow for diffusion.
Implants were secured with dental cement, four screws into the skull and Charisma (Kulzer,
Germany) hardened with UV light for 20 s to increase the gripping surface for the cement.
All surgeries took place before starting behavioural training to allow at least four weeks for
viral transfection before testing. After surgery, rats received saline (2 ml once, subcutaneous)
and were single housed for the first 3 days of recovery. Training started after allowing at
least seven days of recovery.
6.3.4 Behavioural testing
Rats received at least two habituation training sessions with the cables attached prior to testing.
A baseline session occurred on the day before testing with the cables attached but without
optical stimulation. For each session, the optimal lever was the same as the optimal lever at
the end of the previous session. All rats underwent five different optogenetics stimulation
conditions (Fig. 6.1B) that were maintained throughout each session and compared against a
“light off” (Off) session. These were: (1) “after loss” (AL) when pressing the suboptimal
lever, (2) “after win” (AW), when pressing the optimal lever, (3) “after spurious loss” (ASL)
when pressing the optimal lever but not receiving the expected reward (20% of the times), (4)
“after spurious win” (ASW) when pressing the suboptimal lever but receiving an unexpected
reward (20%), and (5) “up until choice” (UUC) from the start of the trial until the choice of
a lever. For testing, all conditions were pseudo-randomised according to baseline levels of
performance using a LSQ design ((LSQ1) Off – AL - AW; (LSQ2) Off – ASL – ASW) or
cross-over design ((LSQ3) Off – UUC, called here LSQ for simplification in below figures
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and text/purposes). Testing took place every second day. During days between each test
sessions, animals ran with cables attached but with the laser light off to habituate animals to
the test apparatus and avoid possible carry-over effects of the light.
6.3.5 Optical stimulation
Mono fibre-optic patch-cord cables (Doric Lenses, Canada) were metal shielded and termi-
nated with an optical fibre of 200 µm of diameter and with a numerical aperture of 0.37 NA.
One end of each cable was connected to a PlexBright dual LED commutator via magnetic
Blue (λ = 470 nm, max current 200 mA) PlexBright compact LED modules (Plexon, Camp-
den Instruments, UK). A computer running Med PC IV (Med Associates) software, which
also recorded responses at both levers and magazine, controlled the optical stimulation. A
second computer controlled the behavioural task via transistor-transistor logic (TTL) signals.
Patch-cord cables were covered with 16 cm plastic tubes to prevent animals bending and
interfering with the cables. Cables were secured to the rats’ implants with a fitted zirconia
sleeve (Doric Lenses, Canada) for 1.25 mm diameter ferrule. Intracranial stimulation was
achieved with 20 repetitions of 5-ms light pulses (thus 20 Hz), with 2 mW at the tip of
each optical fibre, which was checked before and after each photostimulation session. Fig.
6.2 shows the timeline of the experimental design for the optical stimulation. Data from
sessions where light output was compromised because of broken or disconnected optical
cables were discarded. This criterion led to the exclusion of rats from both groups, leading to
the following final numbers per experiment: DMS (LSQ1) n = 18, (LSQ2) n = 15, (LSQ3)
n = 26; and NAcS (LSQ1) n = 15, (LSQ2) n = 13, (LSQ3) n = 13. The optogenetics light
condition was a between-subject factor and the same animals could be tested in multiple
LSQs.
6.3.6 Histological assessment of fibre-optic probe placement and viral
vector expression
Following completion of the behavioural procedures, animals were anaesthetised with a
lethal dose of pentobarbital (Narcoren, Boehringer Ingelheim GmbH, Germany) and perfused
transcardially with 0.01 M phosphate-buffers saline (PBS) followed by 4% paraformaldehyde
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Fig. 6.2 Experimental timeline of the behavioural procedure and optical stimulation. Fol-
lowing pre-training stages to respond to the levers, animals train in the PRL task. In later
sessions of this stage, animals are connected to the patch-cord cables without light. Once
performance was stable (i.e. ≥ 3 reversals in 3 sessions in a row), testing started. Testing
consisted on two LSQs and a crossover design, labelled here as LSQ3. Each LSQ started
with a baseline session consisting on a PRL session with the cables connected to the rats,
without light. The different conditions (e.g. Off-AL-AW) were then tested. Light (λ = 470
nm) was selectively turned on after each trial that presented the tested condition e.g. after
not receiving a reward (AL). Intracranial stimulation was induced with 20 repetitions of
5-ms pulses, with 2 mV at the tip of the optical fibres. Testing conditions within each LSQ
(or crossover design) were pseudo-randomised. Final group sizes: DMS (LSQ1) n = 18,
(LSQ2) n = 15, (LSQ3) n = 26; and NAcS (LSQ1) n = 15, (LSQ2) n = 13, (LSQ3) n = 13.
Abbreviations: after loss (AL), after win (AW), after a spurious loss (ASL), after a spurious
win (ASW), up until making a choice (UUC), session (sess).
(PFA) administered with a pump flow rate of 8 ml/min. Brains were removed and post-fixed
in PFA for 24 h and dehydrated for cryoprotection in 30% sucrose in 0.01 M PBS.
Brains were sectioned coronally at 60 µm using a cryostat (Leica, Germany), collected
in PBS containing 25% polyethylene glycol and 25% glycerol, and stored at + 4°C. Free-
floating sections were washed in PBS and subsequently blocked and permeabilised in PBS
containing 3% normal goat serum (NGS) and 0.3% Triton for 1 h. Sections were incubated
overnight with primary antibodies in PBS containing 3% NGS and 0.3% Triton. Since the
infused viral vector inherently expressed fluorescence, no antibodies were required. For a
first set of slices, TH was detected with the primary antibody anti-TH in rabbit (1:600, EMD
Millipore - Merck, USA). After washing in PBS, sections were incubated with secondary
antibodies for 2 h (anti-rabbit in goat Alexa-Fluor 488 nm, 1:500, Invitrogen Thermo Fisher
Scientific, USA). For a second set of slices, double staining was achieved with the primary
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antibodies anti-GAD67 in mouse (1:1000, Invitrogen Thermo Fisher Scientific, USA) and
anti-VGLUT2 in rabbit (1:600, Invitrogen Thermo Fisher Scientific, USA). As secondary
antibodies, goat anti-mouse (Alexa-Fluor 647 nm, 1:500, Invitrogen Thermo Fisher Scientific,
USA) and goat anti-rabbit (Alexa-Fluor 488 nm, 1:500, Invitrogen Thermo Fisher Scientific,
USA) were used. After washing in PBS, sections were mounted in distilled water and covered
with mounting medium (DAPI, EMD Millipore, USA) and a coverslip. Immunofluorescence
sections were checked and digitised using a PerkinElmer Opera Phenix High-Contrast




To model the computational processes underlying reversal learning performance, several
reinforced learning algorithms introduced previously were used (Zhukovsky et al., 2019),
including three variants of the Q-learning model (Daw, 2009) defined below, and three
parameters: α , β , and κ . The learning rate α determines the degree to which animals
learn in response to feedback. In model 3, the learning rate was split into αReward or αR,
and αNoReward or αNoR. The learning rate αR determines how quickly the model adjusts
the expected Q-value of a response following the receipt of a reward (positive feedback),
while the learning rate αNoR determines how quickly the expected Q-values were adjusted
following a non-rewarded response. These expected Q-values were converted into action
probabilities using the softmax rule with the inverse temperature parameter β and the choice
autocorrelation or “stickiness” parameter κ . In this implementation of the model, high β
values result in random exploration of all options, and down weight the contributions of
the expected Q-values to the probability of choosing a given action. Low β values result in
greater exploitation of the chosen action. In the present reversal task, with 80/20 probabilistic
outcomes, a high β value would result in fewer rewards. Finally, the choice autocorrelation
parameter κ is a measure of “stickiness”, or how likely an animal will perform the same
response again regardless of reward outcome. Values of κ close to 1 reflect an agent “sticking”
to the previous response while κ values close to -1 reflect choice alternation. In the 80/20
probabilistic reversal task, a moderately high “stickiness” is advantageous as it leads agents
to ignore the spurious losses or reward omissions. Model parameters were fitted to each
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animal’s individual data and compared using analysis of variance (ANOVA).
Model-free Q-learning: model 1
Simple Q-learning is equivalent to Rescorla-Wagner learning (Rescorla and Wagner,
1972) whereby an agent assigns an expected Q-value to each choice available; presently a
left or right response (L or R) at each trial t. The expected Q-value is updated on each trial
according to the following:
Qt+1(ct) = Qt(ct)+α(r−Qt(ct)) (6.1)
where 0 ≤ α ≤ 1 is a learning parameter, Qt(ct) is the value of the choice ct at trial t
and r takes the value of 1 if the choice was rewarded and a value of 0 if not. A large α
implies faster updating of the expected Q-values of a response after a trial is completed. The
probability of making the choice ct at trial t was calculated using the softmax rule:
P(ct = L|Qt(L),Qt(R)) =
exp(Qt(L)/β )
exp(Qt(L)/β )+ exp(Qt(R)/β )
(6.2)
whereby larger β values lead to more exploration of the responses with lower Q-values.
On the other hand, smaller β values result in exploitation of the response with higher Q-
values.
Model-free Q-learning: model 2
Model 2 differed from Model 1 only in including the “stickiness” parameter (κ) in the
observational part of the model in addition to β :
P(ct = L|Qt(L),Qt(R),Lt−1,Rt−1) =
exp(Qt(L)/β +κLt−1)
exp(Qt(L)/β +κ ∗Lt−1)+ exp(Qt(R)/β +κ ∗Rt−1)
(6.3)
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Whereby a larger κ results in greater probability of the choice ct at trial t being the same
as the choice ct at trial t −1. The same approach was applied to the right sided choice.
Model-free Q-learning: model 3
Model 2 was extended to include a separate α for learning from rewards and losses,
αR and αNoR, depending on whether the animal received a reward on trial t. The decision
probability was updated in the same way as in Model 2.
Model fitting and comparison
More details on the model fitting and comparison can be found in (Zhukovsky et al., 2019)
and (Daw, 2009). Briefly, the parameters were fitted to maximize the probability of data D
(the product of the individual probabilities of making a choice ct at trial t) by finding the
maximum of the probability density function arg(max)
θ
P(D|M,θ).
P(DataD|Model M, parametersθ) = P(D|M, θ) = ΠP(ct |Qt(L), Qt(R)) (6.4)
Model space was treated as discrete, using the following range of parameters: αR and
αNoR [0.001 0.005 0.01 0.015 0.02 0.04 0.06 0.08 0.1 0.15 0.2 0.25 0.3 0.4 0.5 0.6 0.7 0.8
0.85 0.9 0.95 0.99]; 0.005 ≤ β ≤ 5 with a step size of 0.1 and -1 ≤ κ ≤ 1 with a step size of
0.05. The parameter range was chosen based on the a priori expectations regarding α and κ ,
as well as empirical information about best-fit β parameters. More refined ranges were also
tested, without a clear advantage on results accuracy. Model selection was conducted using
the Bayesian Information Criterion (BIC) that incorporates the likelihood of data given the
model with the best fit parameters (P(D|M, θ̂M)) and a penalty term n2 logm:
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where n = number of free parameters and m = number of observations. We also report
a biased measure of model fit, pseudo r2. Scripts implementing the models were written in
Matlab R2016a and can be found in the following link: https://github.com/peterzhukovsky/
reversal_learning).
Model validation using simulations
To further assess the validity of the winning model, a set of simulations was used. Specifically,
groups of rats (n = 40 rats/group) were simulated with parameter values randomly taken from
the distribution of the estimated parameters from each opsin group and light condition in the
actual experiment. Then, each simulated rat completed the PRL task in a virtual environment,
updating the Q values and the probabilities of choosing left or right depending on the four
individual parameters of that particular rat (i.e. αR, αNoR, β and κ for model 3) and a
trial-by-trial accumulation of information, including reward probabilities (i.e. 80%/20%) and
reversals after eight consecutive responses to the optimal lever.
6.3.8 Behavioural data analysis
Behavioural performance was quantified with the dependent variable of the number of
reversals either per session or per trial. Trials per session, omissions, and latencies to collect
the reward were also analysed. We additionally investigated the effect of previous feedback
on subsequent decisions, namely repeat choices after reward (“win–stay” probability) and
shifting responses after losses (“lose–shift” probability).
Statistical tests were performed using RStudio, version 1.2.1335 (RStudio, Inc). Data
were subjected to Linear Mixed-Effects Model analysis with the lmer package in R. The
model contained a two fixed factors (group, light) and one factor (subject) modelled as an
intercept to account for individual differences between rats. Normality was checked with
both Q-Q plots and the Shapiro test. To analyse probabilities (e.g. win-stay/lose-shift),
I used a general model with the glmer package in R. Latencies were log transformed to
ensure normality. Throughout the experiment, there were no significant differences between
reversals per session and reversals per trial. However, reversals per trial (or x100 trials)
followed a normal distribution after being squared root transformed, whereas reversals per
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session was not following a normal distribution regardless of the modification. Furthermore,
for purposes of visual presentation, the findings are presented as reversals/100 trials.
Homogeneity of variance was verified using Levene’s test. For repeated-measures
analyses, sphericity was checked with Mauchly’s test, and the degrees of freedom were
corrected using the Greenhouse-Geisser whenever the sphericity assumption was violated.
When significant interactions were found, analysis was followed by post-hoc pairwise
comparisons corrected by a Tukey’s test if all the conditions were compared, or by Dunnett’s
test if compared against the control group.
Group sizes were based on the minimum number of animals required to obtain statistically
reliable results. These were informed by power analyses with significance = 0.05 and power
= 0.8, using expected effect sizes based on our own preliminary data or other laboratories’
studies, which resulted in required group sizes of 10 subjects (Cohen, 1988). As the success
of obtaining results depended on To account for the risks of transfection, targeting of optic
fibres, implants durability and animal behaviour, nine extra rats were included in each group,
leading to an initial group size of n = 19. Power calculation with the final group sizes was
conducted using the pwr package in R based on previous work by Cohen (1988).
6.4 Results
6.4.1 Power calculation
After excluding animals due to poor performance, lost implants or misplaced viral expression
or optical fibres, final group sizes ranged from 7 to 14 for all the conditions. For the NAcS,
group sizes varied between 7 and 8 rats per group. For the DMS, group sizes varied between
7 and 14. From a power analysis, power was calculated to vary from 0.60 (n = 7) to 0.93 (n =
14).
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6.4.2 Viral expression and fibre optic placement
Figure 6.1C, E, F show that the administration of the opsin-expressing virus into the VTA or
SNc resulted in high expression of ChR2. Although the infusion coordinates were different
for each region, both regions showed high viral expression.
To identity the neurochemical phenotype of neurons infected, the expression of virus
and neuronal markers in the neuronal fibres was measured in the DMS and the NAcS. In
the DMS, 73.51 ± 2.26% of transfected neurons were TH positive, 8.99 ± 0.69% were
VGLUT2 positive, and 6.17 ± 0.83% were GAD67 positive. In the NAcS, 55.28 ± 3.74% of
transfected neurons were TH positive, 15.24 ± 1.56% were VGLUT2 positive, and 4.77 ±
1.13% were GAD67 positive (Fig. 6.1F).
Fig. 6.1D shows fibre optical tip placements in the DMS or the NAcS for those animals
that completed the study. Rats with misplaced fibre optic cannula or inappropriate expression
were excluded (n = 1 in the NAcS; n = 2 in the DMS).
6.4.3 Behavioural data
Fig. 6.3A indicates that optical stimulation of the VTA-NAcS pathway during reward
omission impaired reversal-learning performance by reducing the number of reversals in
each session. Activation of this pathway during other trial types did not cause a change in
performance (Fig. 6.3B-I). In addition, no significant effects were observed on performance
when the DMS was stimulated.
Activation of the VTA-NAcS pathway decreases reversal after reward omission
Fig. 6.3 shows that stimulating the VTS-NAcS pathway impaired performance by reducing
the number of reversals attained. For the first set of light conditions (Fig. 6.3A-C), i.e. light
on AL or AW, a significant group × condition interaction (group: opsin vs control; condition:
Off vs AL or AW) for the number of reversals relative to the trials per session was present
(F2, 26 = 5.985, p = 0.007). There was also a trend in significance for the group × condition
interaction in the lose-shift probability, (F2, 26 = 2.500 p = 0.100) win-stay probability (F2, 26
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Fig. 6.3 In-vivo optogenetic stimulation of the mesoaccumbal pathway impairs reversal
learning when selectively activated after a lack of reward. A), D), G) Reversals achieved
during each session over 100 trials; B), E), H) win-stay probabilities; and C), F), I) lose-shift
probabilities for the different three LSQs to test all light conditions. Light conditions: light
off (Off), after lack of reward (AL), after a win (AW), after spurious lack of reward (ASL),
after a spurious win (ASW) and up until making a choice (UUC). Data are shown as mean ±
SEM. * p < 0.05 vs light off; § p < 0.05 vs light off after a trend in group × light condition.
= 2.119, p = 0.131) and in latencies to collect the reward (group × condition: F2, 26 = 2.896,
p = 0.073).
Post-hoc analysis revealed that optogenetics stimulation of the mesolimbic pathway
selectively impaired performance by decreasing the number of reversals when the light
was on after a lack of reward (p = 0.007, Fig. 6.3A). This was matched by an increase in
the latency to collect the reward with the light on after lack of reward (p = 0.012, Table
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1). Further analysis showed a decrease in win-stay probability when the light was on after
reward omission (p = 0.039, Fig. 6.3B). There was also an increase in lose-shift probability
specifically when optogenetics stimulation was matched with a win (p = 0.034, Fig. 6.3C).
There was no difference in terms of trials per session (group ×condition: F2, 26 = 0.402, p
= 0.673), omissions (group × condition: F2, 39 = 0.009, p = 0.991) or latencies to respond
(group × condition: F2, 26 = 0.245, p = 0.785).
We observed no behavioural effects with optogenetic activation following the other two
sets of light conditions: Off vs ASL or ASW, or Off vs UUC, in any of the behavioural
parameters analysed (Fig. 6.3; Table 6.1).
Table 6.1 Lack of effect of SN-DMS stimulation on latencies to collect food reward, latencies
to respond, and omissions. Data are shown as means ± SEM.
No effect of SNc-DMS stimulation on reversal learning performance
Activation of the nigrostriatal pathway had no effects on reversal learning performance (Fig.
6.4). However, in relation to the number of reversals achieved, there was a strong trend for a
main effect of condition following stimulation of the nigrostriatal pathway up until making
choice (condition: F2, 24 = 4.244, p = 0.050). We also detected an overall decrease in the
win-stay probability (condition: F2, 24 = 5.054, p = 0.034).
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Fig. 6.4 In-vivo optogenetic stimulation of the nigrostriatal pathway (substantia nigra –
dorsomedial striatum; SN-DMS) does not affect reversal learning. A), D), G) Reversals
achieved during each session over 100 trials; B), E), H) win-stay probabilities; and C), F),
I) lose-shift probabilities for the different three LSQs to test all light conditions. Light
conditions: light off (Off), after lack of reward (AL), after a win (AW), after spurious lack of
reward (ASL), after a spurious win (ASW) and up until making a choice (UUC). Data are
shown as mean ± SEM.
For the other conditions, there was no main effect of condition (Off-AL-AW: condition:
F2, 32 = 0.214, p = 0.310; Off-ASL-ASW: condition: F2, 18 = 1.618, p = 0.227). Nor were
there significant effects of group nor a group × condition interaction in any of the tested
conditions: Off-AL-AW, Off-ASL-ASW or Off-UUC (all main effect of group and group ×
condition interaction: p > 0.05).
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Optogenetic stimulation of the SN-DMS pathway also did not affect latencies to respond
to the stimuli, latencies to collect the reward, or omissions (Table 1).
6.4.4 Computational model parameters and simulated data
To sample latent variables influencing behaviour in the probabilistic spatial serial reversal-
learning task, three different reinforced learning algorithms were used. Model 3 and model 2
provided a better fit than model 1 (average model 3: pseudo r2 = 0.16, and BIC = 119.62;
and model 2: pseudo r2 = 0.15, BIC = 119.67, compared to model 1: pseudo r2 = 0.12, and
BIC = 120.71). Thus, model 3 was chosen as the best-fitting model. A fourth model was
additionally tested, which included a separate learning rate (i.e. α parameter) for each lever.
The aim was to investigate if learning was updated not only by the explored stimulus, but
also by the non-explored option. However, this model failed to improve fit and hence was
not included in the analysis.
Model 3 included four free parameters, αR, αNoR, β , and κ , which were fitted to the
data from each session of each animal, allowing for within-subject comparisons of model
performance of sessions with optogenetic stimulation against the “Off” sessions. Fig. 6.5
reports individual modelled parameters for control and ChR2-expressing rats in control light
conditions and optogenetic mesoaccumbal stimulation after lack or delivery of reward. We
observed a significant group × condition interaction for αNoR (F2, 24 = 10.56, p < 0.001).
Post-hoc comparisons showed this effect was marked by an impairment in αNoR with light
on after a win in the opsin group (p = 0.005). There was also a strong trend for a group ×
condition interaction for κ (F2, 24 = 3.360, p = 0.051). Post-hoc comparisons revealed the
trend was due to decreased stickiness when light was on after lack of reward (i.e. AL) (p =
0.052). Whereas correlation between αNoR and reversals following light on after reward (i.e.
AW) was acceptable (r = 0.56), correlation between κ and reversals following light on AL
was relatively strong (r = -0.65), indicating linear dependence between the computational
parameters and reversal performance i.e. highlighting the correlation between the two
variables.
To interrogate the validity of the winning model, the choice behaviour of agents on the
PRL task was simulated based on the extracted parameters in model 3. Fig. 6.5 shows that
the simulations matched the raw data for the main result: an impairment in reversals when
the mesoaccumbal pathway was stimulated with optogenetics after the lack of reward, which
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Fig. 6.5 Optogenetic stimulation of the mesoaccumbal pathway after reward omission impairs
reversal learning in the PRL task. (Left panel) A) Learning rate from rewards (αR) remained
unaltered. B) Learning rate from lack of rewards (αNoR) increased when the pathway was
stimulated after a win. C) Exploration/Exploitation (β ) parameter remained unaltered. D)
Stickiness (κ) parameter decreased when the pathway was stimulated after a loss. (Right
panel) E) Reversals, F) win-stay, and G) lose-shift probabilities analysis of data from simu-
lated rats revealed that the behaviour of the actual rats was mostly recovered and strengthened
by the winning model. Model parameters data are shown as mean ± 95% highest posterior
density intervals. Simulated data (n = 40/group) are shown as mean ± SEM. ** p < 0.01 vs
light off; * p < 0.05 vs light off; # p = 0.051 vs light off.
was related to a decrease in win-stay probability. The simulated data showed a significant
group × condition interaction for reversals (F2, 156 = 14.950, p < 0.001), win-stay (F2, 156
= 17.520, p < 0.001), and lose-shift probabilities (F2, 156 = 52.570, p < 0.001). Post-hoc
analysis revealed a significant effect in the opsin group of light on AL in comparison to Off
in the three variables: reversals (p = 0.004), win-stay (p < 0.001) and lose-shift probabilities
(p < 0.001). No effects were found with optogenetic stimulation after a win.
In summary, activation of the VTA-NAcS aligned with reward omission impaired reversal
learning performance. This was related to the tendency of animals to switch between levers
regardless of their rewarding properties, as indicated by a decrease in the κ parameter. The
κ parameter refers to the likelihood for the animals to stick to the lever to which they
responded to during the previous trial. In contrast, stimulation of the SN-DMS pathway had
no significant effect on any of the modelled parameters.
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6.5 Discussion
In this chapter, in-vivo optogenetics was used to stimulate the mesoaccumbal (i.e. VTA-
NAcS) or nigrostriatal (i.e. SN-DMS) pathways during a spatial PRL task. It was demon-
strated that trial specific interventions neutralised the brain’s response to negative RPEs when
stimulation was timed with a lack of reward, or hyper-stimulated positive RPEs when timed
with delivery of reward. Dissociable roles were observed for both pathways in cognitive
flexibility. Whereas hyper-activation of the VTA-NAcS pathway following reward omission
impaired reversal-learning performance by reducing the number of reversals achieved, no
significant changes were observed after stimulation of the SN-DMS pathway. These results
are consistent with the hypothesis that stimulating the mesoaccumbens pathway would impair
reversal learning during reward omission.
The novelty of the present study stems from the selective stimulation of neuronal pro-
jections during specific time points in the probabilistic reversal-learning task to decipher
the causal effects between neuronal activation, positive and negative feedback, and reversal-
learning performance. These findings indicate that hyper-activation of the VTA-NAcS path-
way aligned with reward omission impaired reversal learning, suggesting that the VTA-NAcS
pathway mediates the causal link between DA neuronal signalling and reversal performance
in the present spatial PRL task. This is in line with the NAcS suppressing actions to non-
rewarded actions and its involvement in modulating probabilistic rather than deterministic
reversal learning (Dalton et al., 2014).
Although the DMS is implicated in goal-directed behaviours and reversal learning (Cas-
tañé et al., 2010; Ragozzino, 2007; Sala-Bayo et al., 2020), stimulation of the SN-DMS had
no effect on performance. This might be due to the rats in the present study being highly
trained. In initial stages of reinforcement-based tasks, the DMS plays a key role to identify
and apply a successful strategy. As the subjects become more familiar with the task, the
involvement of the DMS diminishes, with other regions such as the DLS now serving to
dominate behavioural control (Balleine and O’Doherty, 2010). Although reversals happened
within each session and animals had to change their behaviour, they were familiar with this
switch, thus potentially not requiring the participation of the DMS. In a stimulus-action task,
whereas activation of VTA-NAcS projections induced cue approach behaviour and led to the
cue becoming reinforcing on its own, activation of SNc-DMS projections induced aimless
movement and did not lead to the cue becoming reinforcing (Cox and Witten, 2019). This
6.5 Discussion 129
supports the idea that RPEs are more strongly embedded in the mesoaccumbens than the
nigrostriatal pathway. Recent studies suggest that rather than being a uniform signal, DA
release dynamics vary throughout different striatal subregions. Indeed, whereas phasic DA
release patterns in the ventromedial striatum rapidly adapt during reversal learning (Klanker
et al., 2015), DA release dynamics do not change significantly following a reversal in the
dorsal striatum (Klanker et al., 2017). Instead, in this structure, small changes in DA release
are observed after the onset of a visual cue, followed by pronounced DA release during
lever extension or lever pressing regardless of trials being rewarded or unrewarded. This
suggests that the dorsal striatum is involved in the initiation and execution of a learned
operant response instead of encoding RPEs. It is also important to note that the DMS is a vast
structure compared to the area that in-vivo optogenetics can activate, so another subregion
within the DMS not affected by the light (e.g. posterior DMS) cannot be discounted from
playing a role in modulating reversal learning Yin et al. (2005). Nonetheless, there was
no difference in performance between posterior and anterior DMS regulating serial visual
reversal-learning in rats following local infusions of D1R and D2R antagonists (Sala-Bayo
et al., 2020).
After blocking the decrease in DA release that normally occurs following omission of
expected reward by artificially activating the neurons targeting the NAcS, an impairment
in reversal performance was found. Unexpected reward omission is considered to reduce
neuronal spiking and neurotransmitter release. Previous research suggests that the observed
effect could result from the combination of altered DA activity in striatal D1R and D2R.
The research of Frank and colleagues (Frank et al., 2004) predicts that blocking the dip
of DA into the striatum would prevent the disinhibition of the indirect D2R-expressing
pathway. This would block its role controlling behaviour in a "No-Go" pathway. Hence,
the hyper-dopaminergic state would hinder the suppression of actions towards the non-
rewarded stimulus, and therefore impairing reversal-learning performance – as observed
when stimulating VTA fibres after reward omission–. Although the lack of behavioural
effects on lose-shift after hyper-activating the pathway after lack of reward runs contrary
to the original reasoning, hyper-activation of VTA-NAc neurons with chemogenetics also
reduced win-stay probability, with no effect on lose-shift, and decreased sensitivity to
negative feedback (Verharen et al., 2018). A potential explanation could be the increased
DA release acting via striatal D1R, which would activate the direct pathway controlling
Go behaviour. Supporting this, administration of a D1R antagonist in the NAcS improves
early reversal-learning performance, as described in Chapter 4. Whereas the improvement in
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performance results from reduced activity in D1R, the observed impairment could arise from
enhanced activity in D1R. In addition, striatopallidal neurons extend dense axon collaterals
and target other MSNs within the same subregion in the striatum forming functional synapses
(Somogyi et al., 1981; Wilson and Groves, 1980)). These connections drive lateral inhibition
between the direct and the indirect pathways, so that activation of D1R- or D2R-expressing
pathways could be shaping the output of the striatum by influencing on the other pathway
i.e. D2R- or D1R-expressing pathways, respectively (Burke et al., 2017). As discussed
in Chapters 1 and 3, D1R and D2R expression in the direct and indirect pathways in the
NAcS is less segregated, hence allowing for a larger influence or competition D1R-D2R to
modulate behaviour (Kupchik et al., 2015; Soares-Cunha et al., 2016). Overall, this suggests
that balanced DA neurotransmission with the direct and indirect pathways is necessary for
effective learning and may be regulated by a shared cellular downstream.
Our results are also in line with the observed reduced ability in rats to use loss and
punishment signals to adapt behaviour following chemogenetic-induced hyper-activation of
the mesoaccumbens pathway (Verharen et al., 2018). The impairment could be explained by
increased baseline levels of DA, which would occlude reaching the signalling threshold that
incorporates negative RPEs after an unexpected negative outcome.
Contrary to expectations, the impairment in reversal learning was related to a decrease
in win-stay, not lose-shift probability. As discussed above, this could be due to the NAcS
regulating reversal-learning performance via D1R following DA release. The computational
model revealed no change in the learning rate AL following stimulation of VTA-NAcS
neurons, but a tendency to a decreased stickiness or κ parameter, matching the impairment
in reversal learning performance. Decreased stickiness in this task becomes detrimental for
reversal performance, since animals would struggle to reach the eight consecutive responses
to the optimal lever to achieve a reversal. Together with previous studies, our results suggest
that dopaminergic projections from the VTA to the NAcS controls the likelihood of animals
to repeat the previously approached stimulus while performing in a reversal-learning task.
It was also reasoned and observed that hyper-activation in the NAcS after lack of reward
would impair performance. However, an improvement was expected after optogenetically
activating the pathway after spurious losses, considered a real negative RPE i.e. after the lack
of reward following a response to the optimal lever, which would have made animals shift
less to spurious negative feedback. However, these trials only appear 20% of the times on the
optimal lever, representing a minority in comparison to non-spurious-feedback trials. Their
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low number throughout the task may be insignificant to modify overall performance when
timed with optogenetics light. Less surprising was the lack of effect AW or ASW, since the
stimulated pathway that was already being activated by the animal’s experience. In this case,
it could have been expected that the hyper-activation would increase the burst of neuronal
spiking and facilitate reaching the threshold to act as a teaching signal in positive RPEs, or
increase the rewarding properties of the reward, in both or either case leading to improved
performance. Since no effect was observed, it is reasonable to assume that this is not the
mechanism underlying positive RPEs processing, or that the system reached ceiling levels.
To discount the latter possibility, it would be of interest to test these conditions using an
inhibitory opsin.
We did not observe any effect on the “up until choice” condition either i.e. when the
pathways were stimulated from the beginning of the trial until animals responded to the
levers. I speculated that stimulation of mesoaccumbal cells during specific time points could
strengthen reward expectancy signals, which would hinder switching to a correct response
after an error. However, our results are in line with previous observations in rats experiencing
local optogenetics inhibition of the NAcS: no effect during action selection, only if the light
was present during reward feedback (Aquili et al., 2014).
It could be argued that lack of significant results could originate from low statistical
power. However, while group sizes were not as powerful as planned, their power ranged
from 0.60 to 0.93. These values stay between, or beyond, the acceptable power range of
0.60-0.80 (Cohen, 1988). Thus, the probability of presenting a type II error is rather low,
especially considering that the pathway with lower power, the VTA-NAcS pathway, induced
behavioural effects when being stimulated by in-vivo optogenetics.
The computational model also revealed a reduction in learning rate from non-rewarded
trials (i.e. αNoR), surprisingly when the mesoaccumbal pathway was activated AW i.e. after
the delivery of reward. This could explain the trend for reduced lose-shift probability during
this same condition. Notably, the simulated data shown in Fig. 6.5 provided two additional
insights into our behavioural data. First, it confirmed the trend in win-stay during the AL
condition (i.e. after reward omission), and it revealed a significant decline in lose-shift
probability, which was in line with our original hypothesis and what the behavioural data
suggested. Second, they contradicted the trend in win-stay during the AW condition, sug-
gesting it was an artefact and hyper-activation after positive RPEs does not alter flexible
performance, or alternatively the model is not accurately capturing latent processes. Further
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research (e.g. replicating this experiment with a larger n), would be needed to corroborate
this conclusion. Nonetheless, win-stay and lose-shift probabilities have been broadly used to
measure learning from positive and negative feedback, respectively; but they are indirect mea-
sures, and both depend on the integration of positive and negative RPEs. The computational
model in this study, as in previous studies (Verharen et al., 2019, 2018), shows that win-stay
and lose-shift probabilities are not a straightforward measure of learning from positive and
negative feedback, and are instead more strongly linked to the stickiness parameter. A more
direct approach, like the VPVD task (Alsiö et al., 2019), could reveal new insights for our
understanding of positive and negative feedback encoding, as shown in Chapter 3.
In the present study, a role for non-DA VTA neurons cannot be excluded. Although
the virus was mainly expressed in TH+ neurons, it was not restricted to TH+ neurons and
was therefore also present in non-TH+, including GAD67+ and VGLUT2+ neurons. The
observed outcomes could therefore result from the combined activity of DA, GABA and
glutamate. A broad and convincing body of work has related DA to reinforcement learning,
but a recent study reported that glutamate release from VTA neurons projecting to the NAc is
sufficient to promote reinforcement independent of concurrent DA co-release, suggesting a
DA-independent mechanism (Zell et al., 2020). Expression of VGLUT2 in VTA, but not SN
neurons, is consistent with optogenetic stimulation in the ventral striatum eliciting excitatory
responses, whereas activation in the dorsal striatum produces very weak or no responses
(Mingote et al., 2015). In addition, DA terminals co-release glutamate preferentially in the
ventromedial, not the dorsal striatum (Mingote et al., 2019; Stuber et al., 2010; Tecuapetla
et al., 2010). Since the NAcS receives more glutamatergic projections than the DMS and
showed larger co-expression of VGLUT2 and ChR2 positive neurons, it is plausible that the
observed effects after manipulating this region were due to glutamate modulation, not DA –
which is consistent with a lack of effects when targeting the DMS. However, VTA-VGLUT2
fibres predominantly innervating the medial shell contribute to aversive learning (Qi et al.,
2016), which would most likely have contributed to an improved rather than impaired
performance in this study, due to an increased ability to use negative feedback to adapt
behaviour. In addition, intracranial self-stimulation of VTA-NAc glutamatergic terminals
reinforces operant behaviour, suggesting an improvement in reversals that was not observed
in our results. That said, our results are in line with the improved performance in behavioural
flexibility after inhibiting NAcS DA neurons (Aquili et al., 2014) and enhanced response
switching induced by systemic amphetamine (Evenden and Robbins, 1985). Therefore,
further research should be conducted to establish if – or up to what point – the decrease
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in reversal learning performance after activating the mesoaccumbal pathway is DA- or
glutamate-dependent.
A smaller proportion of neurons co-expressed the virus and GAD67. Stimulation of
VTA-GABA projections to the NAc have been shown to enhance stimulus-outcome learning,
likely by inhibiting cholinergic neurons in the striatum (Brown et al., 2012). However,
increased stimulus salience would result in improved performance, unlike the deficit in
reversal learning observed in the present study, as it could not explain the lack of decreased
reward consumption if this was delivered. Hence, combined with the finding that GABA
neurons were the minority of neurons expressing the virus, it is unlikely the observed deficit
in reversal learning was the result of increased GABA signalling in the NAcS.
These results open an interesting and little explored dimension to understand the mecha-
nisms underlying reinforcement learning and cognitive flexibility. Most studies have focused
on studying the role of DA encoding RPEs by using genetically modified animals, e.g.
TH::Cre rodents for DA studies, but an increasing body of findings is proving this strategy
insufficient, since TH-expressing neurons co-release DA with other neurotransmitters, such
as glutamate or GABA. Therefore, a more sophisticated approach should be considered.
For example, it would be informative to measure the different neurotransmitters released
simultaneously with neuronal activation, or use conditional knockouts combined with a
virus-based CRISPR/Cas9 approach to disrupt the release of certain neurotransmitters e.g.
DA, while controlling for developmental adaptations (Zell et al., 2020).
Another factor to bear in mind is the potential reinforcing effect of light applied via
optogenetics, which could be rewarding in itself. However, in similar optogenetics conditions,
Steinberg and colleagues questioned the same limitation and assessed the rewarding properties
of light-induced neuronal activation (Steinberg et al., 2013). They proposed that if the
light itself were rewarding, then animals would need to learn two parallel associations:
optogenetics light and natural reward (i.e. sucrose pellet in this thesis). If this was the case,
two separate independent prediction errors should be computed, which could explain the
phenomenon of blocking (i.e. impaired association between CS and US due to the presence
of a second CS). They found that that their two cues interacted and competed for associative
strength when being blocked, hence it was unlikely that the light was forming a parallel
association. In addition, when paired with reward (e.g. in rewarded trials “after win”), the
light could increase the salient value of the natural reward, or of the stimulus associated with
such reward, leading to increased preference or dissociation from the non-rewarded stimulus.
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However, performance in reversal learning did not improve when either the mesolimbic or
nigrostriatal pathways were stimulated timed with reward delivery; neither Steinberg and
colleagues found increased value or preference for paired rewards (Steinberg et al., 2013).
This suggests that optical stimulation was not sufficient to compete with or enhance the
properties of the natural reward.
Overall, the present research expands and supports the role of midbrain-striatal circuit
encoding RPEs as teaching signals to allow learning. For the first time, it demonstrates
the link between hyperactivity within the VTA-NAcS pathway and performance in reversal
learning when negative outcomes are encoded. Our work adds to a scarce but increasing
body of literature establishing and characterising the causal link between DA signalling
during RPEs and reward learning (Aquili, 2014; Chang et al., 2015; Steinberg et al., 2013),
and highlights a novel mechanism (i.e. increased response switching) for impaired reversal
learning after feedback-specific aberrant DA signals. Further understanding the processing
of learning from negative feedback is relevant for patients with major depressive disorder
or OCD, who show an accentuated bias towards negative feedback (Clark et al., 2009;
Elliott et al., 1997; Hales et al., 2014), and in the latter reduced response perseverance (i.e.
stickiness) (Kanen et al., 2019).
6.5.1 Conclusions
The present study investigated the causal link between positive and negative feedback, DA
signalling in mesoaccumbal projections, and cognitive flexibility. Using a spatial probabilistic
reversal-learning task and in-vivo optogenetic stimulation, dissociable roles of the mesolimbic
and nigrostriatal pathways in reversal learning were demonstrated.
We provided evidence that only the VTA-NAcS pathway computes negative feedback with
stimulation reducing repetition of the just-performed response (i.e. reduced ’stickiness’). In
contrast, no significant changes were detected following stimulation of the SN-DMS pathway.
These findings demonstrate with an unprecedented timeframe, a causal link between activity
in the VTA-NAcS pathway and reversal learning performance when negative outcomes
are processed. They add to a scarce but increasing body of literature establishing and
characterising the causal link between DA signalling during RPEs and reward learning
(Aquili, 2014; Chang et al., 2015; Steinberg et al., 2013), and highlight a novel mechanism
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for impaired reversal learning after feedback-specific aberrant DA signals (i.e. increased
response switching).
This work enhances our understanding of the psychological and neural mechanisms
of cognitive inflexibility and may have relevance for the aetiology and treatment of brain





This thesis spans a range of investigations into the neural substrates of behavioural flexibility
and their relevance in shaping learning from positive and negative feedback. Behavioural
flexibility refers to the ability to adapt behaviour to changes in the environment. Although
it is a crucial ability for wellbeing and success in daily life, it is impaired in a wide range
of neurological and neuropsychiatric disorders. Optimal flexibility depends in part on DA
neurotransmission in the cortico-striatal loop circuits, but the precise mechanism and brain
loci underlying the modulatory effects of DA on behavioural flexibility are unclear.
In this thesis, cognitive flexibility was inferred in experimental rats by evaluating their
behavioural performance on a set of both spatial and visual reversal-learning tasks involving a
simple discrimination between rewarded and non-rewarded stimuli. During reversal, subjects
must adapt and respond to the formerly non-rewarded stimulus whilst ignoring the initially
rewarded stimulus. Successful performance on these tasks requires behavioural shifts,
which encompass distinct psychological processes, including: (1) responding to positive and
negative feedback, which shape the learning process, (2) flexibly disengaging from previous
strategies by inhibiting previous behaviour, and being goal-directed to find a new strategy
and gain rewards. This is then followed by forming habits that allow for fast and automatic
responses lessening the cognitive demand, and (3) creating new reward-related associations,
via Pavlovian or instrumental conditioning.
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The research described in this thesis aimed to make headway in providing refined informa-
tion of the neural, psychological and computational processes underlying cognitive flexibility
to understand how flexible decision-making is modulated and to inform the aetiology of
neuropsychiatric and neurological disorders that are associated with cognitive inflexibility.
7.2 The neural substrates of reversal learning: hypothesis
testing
The overarching hypothesis of this thesis was that DA modulates reversal learning perfor-
mance by signalling positive and negative RPEs, presumably within the direct (rewarded) and
indirect (non-rewarded) striatal output pathways, respectively, and that these error signals are
dissociably regulated by distinct striatal subregions and DA receptor subtypes.
I started by examining which stages of reversal learning learning (i.e. early, mid or late
(Jocham et al., 2009)) are regulated by striatal dopaminergic receptors. In previous studies,
presumed increases in DA transmission in the ventral striatum in pathological conditions have
been associated with disrupted reversal learning (Cools et al., 2007; Dagher and Robbins,
2009). It was hypothesised that reduced DA activity in the NAc would improve performance
in reversal learning tasks, and investigated which DA receptor would mediate such effect:
D1R or D2R. In Chapter 3, a D1R antagonist, SCH23390, and a D2R antagonist, raclopride,
were infused into the NAcS while animals performed a serial visual reversal-learning task.
As predicted, D1R and D2R antagonism improved reversal learning. This was selective for
D1R during the early phase, when animals tended to persevere in the formerly rewarded
stimulus, which is now non-rewarded. Such receptor and phase specificity refines previous
reports demonstrating that changes in NAc DA signalling alter behavioural flexibility (Haluk
and Floresco, 2009; Verharen et al., 2019, 2018), and that different striatal subregions
play a complementary role in modulating reversal learning (Sala-Bayo et al., 2020). Such
mechanisms could be influenced by learning form positive or negative feedback, which are
differently presented throughout the task i.e. during initial reversal animals would perseverate
on the previous CS+, now CS-, hence receiving more negative feedback, which would switch
to positive feedback as animals learn the task and respond to the current CS+. In addition, the
present research was performed using touchscreen paradigms, which hold high translational
value (Oomen et al., 2013).
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Following Frank’s model of the basal ganglia, I hypothesised that hyperactivation of D2R
would block the signalling induced by dips of DA neuronal activity that are produced after
negative RPEs i.e. after receiving less reward than expected. This hypothesis was tested
by systemically administering the D2R agonist, quinpirole, while rats performed the visual
VPVD task (Chapter 4), or the spatial PRL task (Chapter 5). In both cases, an impairment
in reversal learning performance was found in terms of a decrease in the percentage of correct
choices (Chapter 4) or in the number of reversals achieved (Chapter 5). As expected, in
Chapter 4, this deficit was caused by blunted sensitivity to negative feedback. This extends
previous work where D2R agonism impaired reversal learning across species, including rats
(Boulougouris et al., 2009), monkeys (Smith et al., 1999) and humans (Mehta et al., 2001),
and with the modulation of reinforcement learning by regulation of learning from negative
events (Cox et al., 2015; Frank et al., 2004). Whereas this first hypothesis was based on the
role of D2R in striatopallidal neurons, behaviour could also be modulated by pre-synaptically
located D2R. In Chapters 4 and 5, I used a wide range of doses of the D2/3R agonist
quinpirole: low doses were expected to act primarily on pre-synaptic receptors, whereas
higher doses were expected to also activate post-synaptic D2R due to their different effect
on locomotion in rats (Eilam and Szechtman, 1989). In Chapter 5, I also tested the effects
of A2AR antagonist KW-6004, as a probe for post-synaptic behavioural effects. I found
that quinpirole-induced impairment was dose-dependent, and KW-6004 replicated the deficit
in performance, which, in addition, was counteracted by the D2R antagonist, raclopride.
These results suggest that the effect of systemic quinpirole in reversal learning was mediated
by post-synaptic D2R, which is consistent with our hypothesis and with previous research
examining the role of the striatal indirect pathway in feedback modulation (Frank et al.,
2004).
I then examined which brain regions were involved in regulating the observed effects in
behaviour. Phasic DA release into the ventromedial striatum has been reported to predict
individual differences during reversal learning performance in a manner that resembles the
changes in DA signal used to correct inaccurate reward predictions (i.e. RPEs) (Klanker
et al., 2015; Schultz et al., 1997). Thus, it was hypothesised that D2R in the NAc would
play a key role in modulating reversal learning, which could account for the results observed
with systemic manipulations. In addition, the two main subregions in the NAc, i.e. the
NAcC and NAcS, which are broadly described to display complementary roles in behaviour
(Floresco et al., 2006), were predicted to mediate dissociable contributions to reversal
learning. Hence, in Chapter 4, I investigated the effect of D2R agonism in the NAcC and
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NAcS. Additionally, I used an A2AR antagonist, ZM-241385, to probe if behaviour was
modulated by pre- or post-synaptic D2R. The highest dose of quinpirole into the NAcC
(10 µg/side) induced the impairment predicted by our systemic study. While I expected to
obtain a similar result with lower doses, I instead found an improvement in reversal learning
performance. This enhancement was related to increased learning from positive feedback
when quinpirole was infused into the NAcS and from negative feedback when the same
compound was infused into the NAcC (at doses 0.3 and 3 µg/side in both regions). In
addition, whereas the A2AR antagonist replicated the effects of quinpirole in the NAcC,
indicating that the change in behaviour was modulated by post-synaptic D2R, the A2AR
antagonist had no significant effects when infused into the NAcS. This suggests that the
dopaminergic modulation of reversal learning within striatal subterritories is much more
complex than Frank’s model of the basal ganglia would suggest. Although increases of DA in
the NAc following L-DOPA administration in Parkinson’s patients disrupt reversal learning
(Cools et al., 2007), low levels of DA D2R binding in OCD patients (Denys et al., 2004), and
low DA responsiveness in substance use disorder patients (Ersche et al., 2011), also predict
impairments in reversal learning. This suggests that increased DA signalling in both cases
would improve performance, as indicated by our local, but not systemic, NAc infusion results
in Chapter 4.
I next interrogated the hypothesised causal link between dips of DA induced during
negative RPEs and changes in reversal learning performance. I hypothesised that hyper-
activation of mesostriatal neurons timed to coincide with reward omission (i.e. negative RPE)
would interfere with learning by preventing the natural dip that acts as a teaching signal and
would therefore impair reversal learning. To test this hypothesis, in Chapter 6, I used in-vivo
optogenetics to examine whether reversal behaviour would be affected by activation of the
VTA-NAcS or the SNc-DMS – counteracting the signalling dip from a negative RPE – either
upon presentation (or absence) of a reward, or in the period just before making a choice.
While increased signalling in the pathway from the VTA to the NAcS timed with omission
of reward impaired performance in the spatial PRL task, no effect was observed in other
conditions or when targeting the pathway from the SN to the DMS. This is consistent
with our hypothesis and previous literature reporting DA changes in the NAc following
reversal (Klanker et al., 2015), as well as the encoding of negative RPEs within the striatum
via the striatopallidal pathway (Cox et al., 2015; Frank et al., 2004). While I expected
to observe blunted learning from negative feedback caused by a decrease in lose-shift
probability, win-stay was reduced. Surprisingly, this same effect was found when systemic
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quinpirole was injected during the PRL task, whilst the VPVD task clearly showed the
impairment was related to blunted learning from negative feedback, not positive feedback.
Computational modelling in Chapter 6 showed that win-stay and lose-shift probabilities do
not necessarily correspond with learning from rewards or lack thereof, respectively, indicating
that a reframing of the meaning of win-stay and lose-shift probabilities is necessary, as well
as more accurate tasks for assessing feedback sensitivity. The VPVD task perhaps makes
some headway in assessing such sensitivity.
Overall, several hypotheses relating to impaired cognitive flexibility and the underlying
neural underpinnings have been tested, with some providing unexpected findings. While it
was found that hyperdopaminergic states in the ventral striatum affect learning from positive
and negative feedback, Frank’s model of the basal ganglia could not explain the behavioural
results, suggesting that this model better reflects the systemic mechanisms of reversal learning
modulation, or that its locus resides in another brain region e.g. the dorsal striatum, or both.
These studies span our understanding of the neural mechanisms underlying cognitive
inflexibility and refine our understanding of the brain regions and receptors recruited at
different stages of learning.
7.3 Cortico-striatal circuits in reinforcement learning: from
Pavlovian to instrumental
Dissociating which brain subregions and receptors are involved and how they interact to
regulate behaviour is critical to understand reversal learning and its underlying mechanism.
Reversal learning is modulated by cortico-striatal circuits.
Previous work in our laboratory also showed that antagonising D2R in the DMS impaired
the mid phase of reversal learning, which is proposed to be the period when animals have
disengaged from the previous strategy and begin to adopt a new goal directed behaviour (Sala-
Bayo et al., 2020). The DMS (equivalent to the caudate nucleus in primates) belongs to the
so-called associative loop, which is connected to various associative cortical areas, parietal
cortex and the PL from the PFC. This loop is involved in orientation, attention, affordance
processing, response inhibition, and working memory, among other putative functions
(Hikosaka and Watanabe, 2000; Mannella et al., 2013). Due perhaps to a combination of
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these functions, the DMS is involved in learning and storing A-O associations and goal-
directed behaviours (Yin and Knowlton, 2006; Yin et al., 2005), as our results suggested.
Following these observations, in Chapter 6 I investigated if the effect was causally linked
to SNc-encoded RPEs while rats performed in a spatial PRL task. However, I did not find
a change in behaviour when hyper-activating nigrostriatal neurons targeting the DMS, in
any of the conditions investigated. This suggests that, although the DMS is involved in
cognitive flexibility by mediating goal-directed behaviours and A-O associations, the role
of nigrostriatal neurons in reinforcement of instrumental responses is limited or can be
compensated by other pathways. Indeed, Keiflin and colleagues found that neurons from
the SNc to the DMS are important for instrumental conditioning but their involvement is
less than mesoaccumbal projections, which also participate in outcome predictive learning
(Keiflin et al., 2019).
Of particular interest for this thesis is the limbic loop, whose role in reversal learning is
less clear. In rats, it is formed by the NAc in the ventral striatum, which is connected to the
agranular insular cortex, PL and IL (especially the NAcS). In Chapter 3, I observed that
D1R antagonism into the NAcS selectively improved reversal learning in the early phase.
The limbic loop integrates information about reward, context and motivational drive to guide
behaviour (Mogenson et al., 1980), and develop goal-directed behaviours. This is especially
important during early stages of learning (Dalley et al., 2004; Ragozzino, 2007). In this
context, the NAcS is involved in extinction of reversal when the associated behaviour is
gradually suppressed (Peters et al., 2008). This process seems to be controlled by small
dips in DA signalling during negative RPEs caused by responding to the former CS+, now
CS-. Therefore, antagonising D2R as in Chapter 3 could reduce DA neurotransmission
in striatopallidal neurons. NAcS activity would then better detect negative outcomes and
reduce the response to the previous rewarded stimulus while enabling a search for responses
receiving positive-feedback, ultimately improving performance.
I also observed that the NAcS-led improvement was specific to D1R, not D2R. The role of
D1R in the NAcS might also rely on the function of striatal loops, which transfer information
and contribute to “Pavlovian-Instrumental-Transfer” (i.e. PIT). Striatal projections are the
main input into midbrain DA cells (Lanciego et al., 2012). The descending striatonigral
pathway is organised in an inverse ventral/dorsal topography. Once in the midbrain, informa-
tion is processed and these cells send nigrostriatal or mesolimbic projections exhibiting an
inverse dorsoventral and mediolateral arrangement. Importantly, this creates a feedforward
organisation based on spiral inputs and outputs between the striatum and the midbrain so
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that information can be carried from one striatal region to the other – in particular from the
ventral to the dorsal as NAcS, NAcC, DMS, DLS -, and back to the cortex via the thalamus
(Haber, 2016).
In PIT, a conditioned stimulus that has been previously associated with reward through
Pavlovian conditioning alters motivational salience and influences instrumental responding,
a transition that is enhanced by training. The NAcS triggers Pavlovian conditioning and
hence PIT. The NAcS acts as the gateway to pass reward properties associations to the
DMS, and to the DLS, then contributing to the formation of goal-directed actions and habits
(Gruber and McDonald, 2012; Mannella et al., 2013). Thus, modulating activity of the NAcS
– probably the one of the initial regions in the striatum to process rewarding salience of
the stimuli and their associated outcomes –, could accelerate processing in early stage of
reversal learning as observed in Chapter 3, and reach dorsal structures more efficiently in
subsequent stages. In previous studies, I observed that the DMS is involved in the mid phase
of reversal learning, coming directly after the initial early phase (Sala-Bayo et al., 2020), and
the DLS is implicated throughout the task, including the late phase (Sala-Bayo et al., 2020),
while the NAcS and NAcC participated in early stages (Chapter 3; (Sala-Bayo et al., 2020)).
In agreement with the concept of the transfer of information from the NAc to the DMS,
in Chapter 4, I found that infusions of D2R agonist improved performance in the VPVD
reversal-learning task from session 4 out of 10, i.e. around the mid phase of the task. This
effect was selective for learning from positive feedback. Similarly, chemogenetics inhibition
of the mPFC-NAcS pathway improved flexibility during early reversal learning by reducing
perseverative responding (Milton et al., 2020). Thus, enhanced Pavlovian conditioning
processed in the NAc, and its transfer to the DMS could explain the observed improvement
in learning once animals disengaged from the previous strategy and are developing a new
approach by being goal directed (i.e. session 4 in the VPVD task), engaging the DMS, and
better approaching the CS+ (and avoiding the CS-). This is supported by the plateau in
performance reached at later stages, suggesting that animals’ level of reversal learning is not
necessarily better reaching higher levels of performance (i.e. closer to 100%), but that they
can solve the task faster.
While there are overlapping functions between the NAcC and the NAcS, dissociations
of their role also exist (Dalley and Robbins, 2017). The NAcC generates appropriate
approach behaviours towards task-related objects in a flexible manner (Day et al., 2006;
Nicola et al., 2004a; Parkinson et al., 2000), is involved in assigning behavioural salience to
stimuli (Berridge and Robinson, 1998) and mediates effortful responding (Salamone et al.,
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2009). In Chapter 4, I observed that relatively low doses of the D2R agonist quinpirole
improved reversal-learning performance by enhancing learning from negative feedback. The
A2AR antagonist ZM-241385 produced the same improvement, indicating that our findings
may have been dependent on post-synaptic D2R-expressing MSNs. However, this seems
counterintuitive considering the role of the NAcC in behaviour and the expected modulation
of D2R of reversal learning according to the basal ganglia model (Cox et al., 2015; Frank
et al., 2004). This effect might highlight that the role of these regions does not only rely on
their direct modulation of reversal learning, but on influencing other regions such as the dorsal
striatum or neurons such as striatonigral MSNs via parallel and integrated circuits to control
and adapt behaviour. Together with lateral inhibition (Salery et al., 2020) and co-expression
of receptors in striatal MSNs (Aizman et al., 2000), discussed in Chapters 3 and 4, spiral
mesostriatal loops highlight the integration of cognition and reinforced learning throughout
multiple brain regions and cross-talk interactions. Thus, our results could stem from a
competition with different striatal neurons over the control of animals’ cognitive and motor
resources (Lauwereyns et al., 2002; Nicola et al., 2004b), and the observed improvement
could be modulated by D2R-expressing MSNs acting on D1R-expressing neurons.
Conversely, in Chapter 4, the highest dose of quinpirole infused into the NAcC induced
an impairment in reversal learning by blocking learning from negative feedback. A decrease
in levels of performance was also observed with systemic quinpirole in Chapters 4 and 5
(although in Chapter 5 learning from negative feedback was not assessed). Similar to our
results, Verharen and colleagues found an impairment in reversal learning when a high dose
of quinpirole (5 µg/side) was infused into the ventral striatum while rats performed a spatial
PRL task (Verharen et al., 2019). Effects of quinpirole in this thesis were therefore dose-
dependent and suggest that when the system is saturated in the NAcC, direct and indirect
pathways regulate behaviour as proposed by Frank’s model of the basal ganglia (Frank
et al., 2004). This emphasises the plausibility of strong DA signals in the ventral striatum
being transmitted to the dorsal striatum, where regulation of reinforcement learning is better
constrained by D1R and D2R modulating learning from positive and negative feedback,
respectively. An example of transferring information from the ventral to the dorsal striatum
is observed following infusions of amphetamine into the NAcC (Wyvell and Berridge, 2000).
Increasing local DA levels with amphetamine potentiates PIT for food rewards, which, as
discussed, is a process based on transferring information from the NAc to the DMS and DLS
(Wyvell and Berridge, 2000).
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These findings demonstrate the role of different regions in the striatum having dissociable
roles and sensitivities to different receptors, which suggest a competing or complementary
role in modulating reversal learning.
7.4 Learning from positive and negative feedback and clin-
ical implications
Reversal learning tests require the subjects to discriminate between different options and
associate each option with specific rewarding properties, which shift after achieving dis-
crimination. Solving the task (i.e. disengaging from the previous rewarded stimulus and
responding to the originally unrewarded stimulus) is often studied as a single-faceted cog-
nitive process. However, subjects can develop new strategies by learning from positive or
negative feedback. That is, subjects can solve the task by either approaching the rewarded
stimulus or avoiding the negative. A key factor to expand our understanding of the neural
mechanism underlying cognitive flexibility is therefore to comprehend how brain regions
integrate and process sensitivity to positive and negative feedback.
In Chapter 4, I found that enhanced overall activity of D2R led to decreased sensitivity
to negative feedback in the VPVD task. Intra-NAcS D2R agonism improved reversal learning
performance by promoting learning from positive feedback. Similarly, in Chapter 6 I found
that manipulating input signalling from the VTA to the NAcS decreased win-stay probability.
Win-stay probability has traditionally been used to assess sensitivity to positive feedback, as
lose-shift is accepted to reflect sensitivity to negative feedback (Rygula et al., 2018), although
other studies have suggested it is not a reliable measure of feedback sensitivity (Alsiö et al.,
2019; Verharen et al., 2019, 2018). Ventral striatal regions have been especially involved in
learning the value of positive feedback linked to a particular stimulus (Rygula et al., 2018).
In rats, Dalton and colleagues observed that manipulating the NAcS reduced win-stay in
the PRL task (Dalton et al., 2014). However, their effect was induced by inactivating the
NAcS, which also impaired overall performance, as our pharmacological study in Chapter 4
would have predicted. In a subsequent study, inactivation of the mOFC, which projects to the
medial NAc (i.e. NAcS), reduced sensitivity to positive and negative feedback during the
initial phases of discrimination (Dalton et al., 2016).
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Conversely, when the D2R agonist was infused into the NAcC, it initially improved
performance by enhancing learning from negative feedback, while it switched to impairing
reversal learning by blocking sensitivity to negative feedback at the highest doses. The direc-
tion of the effect in the NAcC was dose-dependent. The effect induced by the highest dose
matched with the impairment I found in Chapter 4 when the D2R agonist was administered
systemically, modulating more brain regions involved in reversal learning. As discussed in
previous sections, this transition might reflect the integrative communication between brain
regions and neuronal types modulating behavioural flexibility, including the dorsal striatum.
In this line, inactivation of the lOFC (which projects to the DMS) impaired reversal stages in
the PRL task by making rats shift less when responding to the incorrect stimulus, suggesting
that the lOFC and its efferent projections may be particularly important in signalling negative
feedback and the violations of reward expectancies (Dalton et al., 2016).
Abnormal sensitivity to feedback has been observed in patients with depression (Elliott
et al., 1997; Gradin et al., 2011; Rygula et al., 2018). Depression has been broadly linked to
a cognitive bias towards negative feedback. A growing number of studies suggest that, apart
from hypersensitivity to negative feedback, depressive patients also show hyposensitivity to
positive feedback (McFarland and Klein, 2009; Robinson et al., 2012). Several attentional
and reversal learning tasks can be applied in humans to assess underlying mechanisms of
cognitive flexibility and reinforcement learning (Izquierdo, 2017; Rygula et al., 2018). The
PRL paradigm is also used in humans to investigate the neurochemical and neuroanatomical
correlations of feedback processing. Patients with depression show cognitive inflexibility
(Remijnse et al., 2013) and their negative bias is linked to aberrations within the reward
system (Keedwell et al., 2005; Tremblay et al., 2002). In Chapters 3, 4 and 6 I found that
the NAc in the ventral striatum played a critical role in modulating reversal learning and the
sensitivity to feedback. Indeed, ventral striatal activity in patients with major depressive is
altered, showing reduced activity in response to positive stimuli in comparison to healthy
volunteers (Epstein et al., 2006; Surguladze et al., 2005).
Parkinson’s disease patients tend to learn faster from negative feedback than positive
feedback (Frank et al., 2004). Critically, this abnormality depends on whether or not the
patient is under treatment with L-DOPA. By increasing DA levels in the brain, especially
the SN, L-DOPA shifts the learning bias towards positive feedback. This disparity in
performance between medicated and non-medicated Parkinson’s patients has resulted in
theoretical explanations that attribute these changes in the bias to adaptions in the striatal
dopamine system. As seen in Chapter 4, increases in D2R activity in the NAc influence
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positive and negative feedback, and in a dose-dependent manner can switch from inducing
an improvement to an impairment in feedback sensitivity.
Similarly, OCD patients show attentional bias towards threats, although there are contra-
dictory reports in this area. It has been observed that individuals with OCD take longer to
respond to words with negative valence, and OCD washers (i.e. patients that perform exces-
sive and repetitive washing) show greater conflict for words representing poor cleanliness,
their most negative trigger (Lavy et al., 1994). OCD patients also show reduced binding to
DA receptors in striatal regions (Denys et al., 2004). Although this is in contradiction with
our D2R antagonist results in the NAcS from Chapter 3, it highlights that D2R agonism, as
found in Chapter 4, or increased DA activity in the striatum could hypothetically improve
flexible performance in subjects with low DA activity baseline, which has been observed in
drug abusers (Ersche et al., 2011; Kanen et al., 2019).
Our experiments provide region, receptor and phase specificity to the modulation of
behavioural flexibility and learning from positive and negative feedback. They also emphasise
the importance of personalised medicine specific to the individual, as the same manipulation
might have opposite effects depending on the targeted area, and while patients cannot be
locally treated yet, treatment efficacy could be predicted depending on patients’ neuronal
impairment. Our results provide refined information on the neural circuit underlying cognitive
disorders, which contributes to the understanding of how different symptoms (i.e. sensitivity
bias) relate to distinct brain mechanisms.
7.5 Causal link between phasic DA and behavioural per-
formance
RPEs are a crucial parameter in associative learning models. The sign and magnitude in
midbrain DA neurons vary according to the degree to which the reward is expected (Cohen
et al., 2012; Hollerman and Schultz, 1998), which manifest bilaterally, in both VTA and
SN. Despite the prevalence and impact of the theory that RPE signalling by DA neurons
induces associative learning, only a few studies have supported a causal role between DA-
mediated RPE activity and learning about natural reward e.g. food. Indeed, this question
had not been explicitly tested in the context of reversal learning. In Chapter 6, I aimed
to address this by testing the causal link between overdoses of DA in the nigrostriatal or
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mesoaccumbal pathways during feedback processing and performance in the spatial PRL task
in rats. The impairment I found on reversal learning performance following hyper-activation
of mesoaccumbal, not nigrostriatal, neurons at the time of reward omission is the first direct
evidence of RPEs being causally related to reversal learning. This expands on the correlations
found between increases in DA neuron firing, especially within the VTA (Fields et al., 2007;
Swanson et al., 1997). In this line, microdialysis studies have shown that DA release is
strongly correlated with behavioural activity, particularly when the release occurs into the
NAcS (Freed and Yamamoto, 1985; Hamid et al., 2016). While this effect was predicted by
the model described by Frank and colleagues (Frank et al., 2004), which suggests that hyper-
physiological levels of DA during integration of negative outcomes blunt the natural dip in
release and disrupt learning, I did not observe a change in lose-shift probabilities, canonically
linked to sensitivity to negative feedback (Rygula et al., 2015). Instead, I found decreased
win-stay probability, commonly related to sensitivity to positive feedback. This indicates
that NAcS mediates learning from negative feedback by adjusting the approach behaviour
towards the newly rewarded stimulus, originally unrewarded. However, the learning rate
obtained from the computational model was not affected by the quinpirole treatment, but
instead animals showed decreased stickiness, which indicates that instead of affecting how
animals learned from reward or omissions of reward, optogenetic stimulation made animals
less likely to remain in the same stimulus from the previous trial in general. The NAcS and
its afferents from the VTA might be key in producing and modulating the teaching signal in
cognitive flexibility, although RPEs might not be directly modulating learning in the context
of reversal learning. This raises the question of what is the exact role of DA signalling RPEs
within these regions.
First, fluctuations of DA levels are widely accepted to have two separable modes: large
amplitude subsecond phasic release, and steady-state ‘background’ tonic release arising over
a timescale of minutes (Grace, 1991). Previous literature proposes that phasic transmission
may support reward learning information (including RPEs) (Klanker et al., 2015; Wanat
et al., 2009), whereas tonic changes may instead modulate overall motivation or arousal
(Schultz et al., 1997) or, more specifically, enable animals to exploit the reward-related
information that they have learnt (Beeler et al., 2010). Since drugs alter DA levels for
prolonged periods, whilst in-vivo optogenetics alter neuronal activity on the millisecond
timescale, it could be interpreted that pharmacological results represent changes in tonic
release, while optogenetics reflects changes in phasic release. This would be supported by the
drug-modulated behaviour I found in Chapter 4, which was related to increased percentages
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of optimal choices towards the positive stimulus when targeting the NAc or, in other words,
exploiting positive feedback. However, the computational model did not show any difference
in the β parameter or exploitation/exploration rate and I also observed changes in win-stay
probability following optogenetics stimulation. Nonetheless, I did not assess tonic or phasic
changes in DA in our studies, and direct evidence of covariance between tonic transmission
and motivational states is lacking. Others have also observed modulation of phasic firing
by changes in motivations, not only RPEs, in reinforcement learning (Phillips et al., 2003;
Wassum et al., 2012), suggesting the role of phasic and tonic DA signalling is not clear-cut.
Second, the current work was strongly based on and is supportive of the concept that mid-
brain DA cells signal RPEs that act as teaching signals in reinforcement learning (although
Chapter 6. DA transmission has a striking similarity to a reinforcement error signal repre-
senting the update between predicted and delivered reinforcer, and its timing is characteristic
and precise (∼100 ms of latency and ∼100 ms of duration), which suggests that the role of
DA in timing with the reinforcement is crucial (Redgrave and Gurney, 2006). Although a
large and compelling body of work supports the role of phasic DA as an error teaching signal,
recent studies have questioned this view (Hamid et al., 2016; Howe and Dombeck, 2016;
Wassum et al., 2012). DA signal persists after prolonged training and steadily increases (i.e.
ramps) over the duration of each trial in certain tasks (Hamid et al., 2016; Howe et al., 2013;
Kim et al., 2019). In light of these observations, it has been suggested that DA-RPE theory
by Schultz (Schultz et al., 1997) could represent a fraction of a larger set of functions for DA
that act as teaching signals. In other words, Schultz’s RPE theory for DA may only apply to
specific events.
Nevertheless, although compelling evidence indicates that DA neurons provide teaching
signals, the intricacies of such signalling are unclear and little proof exists to support a
causal link between both phenomena, especially in reversal learning. In this thesis, I used
behavioural procedures in which learning is considered to be driven by RPEs and targeted
neuronal pathways involved in reinforcement learning with high temporal precision. Hence,
the data presented in Chapter 6 are the first approach to investigate the causal relationship
between phasic DA signals timed with reward omission during reversal learning and reversal
performance, and emphasise the dissociable role between nigrostriatal and mesoaccumbal
projections.
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7.6 New therapeutic approaches
Cognitive inflexibility in neuropsychiatric and neurological disorders is often treatment-
resistant or even worsens with pharmacotherapy. To overcome this limitation, treatment
tools are expanding to non-dopaminergic strategies. Adenosine receptors antagonists are
being tested in clinical trials for disorders such as Parkinson’s disease, OCD and depression
(Asaoka et al., 2019; Hung and Schwarzschild, 2014; Leibenluft et al., 1993). For example,
caffeine, an A1AR and A2AR antagonist, has been suggested as alternative preventive and
complementary treatment in Parkinson’s patients, where it has been reported to improve both
cognitive and motor symptoms (Prediger, 2010).
A2AR co-localise with D2R on striatopallidal MSNs and converge onto the same signal
transduction downstream pathways in an antagonistic way. Selective A2AR antagonists
have shown positive results as treatment for pathologies related to dopaminergic dysfunction
(Hung and Schwarzschild, 2014; López-Cruz et al., 2018). In Chapter 5, antagonism of
A2AR not only counteracted the raclopride-induced decline in performance but also left
latencies or trials completed per session intact. Similarly, in Chapter 4, local infusion of
the A2AR antagonist KW-231485 into the NAcC and NAcS improved reversal-learning
performance without increasing latencies to collect the reward, as opposed to quinpirole in
these same regions, which made animals slower. These findings suggest that targeting A2AR
in D2R related disorders is an advantageous approach in clinics to incorporate the benefits
(e.g. recovery of cognitive flexibility) of altering DA activity without its disadvantages (e.g.
impaired motor control).
In individuals with neurological and neuropsychiatric disorders not only is cognitive
flexibility affected, but other symptoms are also present such as lack of motivation, decreased
psychomotor speed, and fatigue (Goldsmith et al., 2016; López-Cruz et al., 2018). Adenosine
receptor antagonists have proved to recover symptoms related to both dopaminergic and non-
dopaminergic dysfunction. However, high doses of methylxanthines (e.g. caffeine) are often
poorly tolerated (Frozi et al., 2018). I also observed in Chapter 5 that a relatively high dose of
systemic KW-6002, the A2AR antagonist, impaired reversal learning, but when administered
following a raclopride-induced imbalance of DA signalling, it recovered flexible performance.
This indicates and supports previous literature suggesting that adenosine receptor antagonists
might be particularly effective when the dopaminergic system is compromised.
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Determining when patients would benefit from a dopaminergic or an alternative strategy
is key to therapeutic success. Further research is necessary to understand the predominant
symptomatology, neural mechanisms, and potential drug effects on each patient. The present
thesis supports the therapeutic benefits of A2AR antagonism and expands our comprehension
of the circumstances whereby it might improve or impair symptoms, as well as providing




The VPVD task was originally suggested by Nilsson and colleagues (Nilsson et al., 2015)
and builds upon previous research aiming to dissociate between perseveration or inhibition of
responding to the no longer rewarded stimulus (A-), and learned non-reward or approaching
the previously rewarded stimulus (B+) (Alsiö et al., 2015; Clarke et al., 2007; Piantadosi
et al., 2018). As a task, it has its strengths and weaknesses, which are discussed below.
The main strength of this task is its ability to assess how learning from positive and
negative feedback impact reversal-learning performance. This is achieved by using probe
trials in which it is necessary to leverage a probabilistically reinforced “neutral” stimulus
against a deterministic positive or negative stimulus. Since tracking the preference of stimuli
happens across all the reversal phase, it allows us to investigate feedback sensitivity as a
learning curve. This is an advantage over previous tasks, like the PRL, in which feedback
sensitivity is extracted from trial-by-trial changes responding to immediate reward, or lack of
it, as win-stay or lose-shift probabilities. That is, the probability of animals to stay on the
same stimulus after receiving a reward or shift after a loss or lack of reward. In order to behave
in a win-stay or lose-shift manner, animals need to simultaneously integrate positive and
negative feedback, since deciding if it is more valuable to shift or to stay on the same stimulus
depends on an integrative processing of both the received feedback and the expected value of
the other stimulus. In addition, as seen in Chapter 6 and previous literature, computational
modelling has revealed that there is no correlation between win-stay/lose-shift probabilities
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and learning rates from rewarded or unrewarded trials, respectively (Alsiö et al., 2019;
Verharen et al., 2019). The VPVD task overcomes the limitation of these probabilities since
measurement of positive and negative feedback sensitivities do not require the simultaneous
assumption of the rewarding properties of the explored and non-explored options. In addition,
tracking stimulus preferences throughout the length of the learning curve allows for the
investigation of events characteristic of specific stages in the task e.g. perseveration towards
the previously rewarded stimulus, visible in early stages of reversal learning, or formation of
habits, detectable throughout the late stages.
Another benefit of the task is that the dissociation of the two type of sensitivities (i.e.
positive and negative) together with learning on standard trials can capture subtle changes
that would not be detected if only performance as a whole was investigated. I observed this
phenomenon with the mid dose of quinpirole (0.1 mg/kg), which affected learning from
negative feedback in later sessions in the reversal phase but was not sufficient to affect the
overall performance.
The VPVD task is not without limitations, however. Although trials in which the C50/50
stimulus is presented are considered probe trials to investigate how animals are learning
to discriminate A- and B+, it is plausible that animals are actually learning to solve three
different pairs, instead (i.e. A- vs B+, A- vs C50/50 and B+ vs C50/50. To minimise separate
learning, probe trials are presented less often than standard trials (i.e. A- vs C50/50 or B+ vs
C50/50 each appear only 1 in 8 trials). This ensures that the main learning is based on the
standard deterministic trials but cannot completely remove the possibility of separate learning.
In addition, reversal-learning performance might be highly influenced by other processes in
addition to cognitive flexibility, such as attention, locomotor activity, and motivation.
PRL task
Despite some evidence suggests that the PRL task does not provide accurate information on
the subjects’ sensitivity to positive or negative feedback, it has been broadly used due to its
advantages in animals and its translation to humans. In animals, the PRL paradigm allows for
testing effects of different probabilities of rewards (i.e. uncertainty) while assessing the effect
of experimental manipulations (e.g. drug, optogenetics, and chemogenetics) as between-
and within-subject factors – with the latter applicable only for reversible treatments. As
seen in Chapters 5 and 6 (i.e. PRL) in comparison to Chapters 3 and 4 (i.e. VPVD), rats
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learn the spatial PRL task faster and can perform multiple reversals within the same session,
whereas in the VPVD paradigm they need more weeks to reach the discrimination criterion
and subsequently multiple sessions to complete one reversal. A potential explanation for this
is that in touchscreens, animals are removed from their standard habitat and context to train or
test, hence potentially raising problems related to the ethological validity of the methodology.
Specifically, due to the artificial nature of the setting, subjects may rely on processes to solve
the task that are not standardly recruited in their natural environments. During the PRL
task, animals are also tested in operant chambers, but they rely on spatial, instead of visual,
abilities, which are highly developed in rodents. In addition, this dissociation in learning
span might depend on the speed in which the neural circuits form S-R associations following
Pavlovian conditioning within the striatum, and its transfer to other striatal regions to develop
operant behaviour (see section 7.3 within this chapter) within this chapter). Hence, although
assessing sensitivity to feedback with the PRL task might be misleading, this task provides
a platform to test reversal learning, with other pragmatic/convenient advantages such as
reduced time-frames, as it can be rapidly trained.
7.7.2 Computational modelling
The experimental work in this thesis was performed in rats, but the ultimate goal was to
provide an understanding of the human brain. While human and rodent brains share structural
and functional similarities, it remains unclear whether our findings have any relevance for
humans. The use of analogous paradigms of reversal learning in animals and humans
contributes to making the translation possible, but different aspects of behavioural responses
are still challenging to reliably relate across species.
Computational modelling of behavioural data enables us to further understand behavioural
results and increase the translational value of animal studies by assessing subtle changes in
the employed strategy to solve the reversal-learning paradigm. The parameters that can be
derived from computational models provide insight into the mechanisms that form the basis
for complex and dynamic decision-making behaviour, including learning from delivery or
omission of reward, and perseverative behaviour. In Chapter 6, the computational model
revealed that animals with impaired performance were not modifying their learning rate
depending on reward or lack of it, neither that they changed their behaviour by exploring
or exploiting the stimuli according to their accumulated evidence of reward. Instead, they
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were less likely to repeat previous choices during the "after loss" condition. This provided
insight not only into the behavioural trait – and its underlying neural mechanism –, but also
into the task, since, as discussed, it revealed that the traditional way of interpreting win-stay
and lose-shift probabilities as sensitivities to feedback may be incorrect.
However, computational modelling is not exempt from downsides. Choosing the wrong
model or data over-fitting can lead to false conclusions. Care and preparation must be taken
to implement the appropriate model for each situation depending on the context of the results.
Data availability might be restraining to obtain accurate and reliable results as experimental
approaches use small group sizes (n < 100), whilst these studies would most benefit from
larger datasets. Nonetheless, despite computational modelling still being relatively nascent,
it has real potential as a translational bridge to inter-relate behavioural and psychological
constructs in humans and other animals.
7.8 Limitations and alternative approaches
A number of limitations should be taken into account when interpreting the present results,
in addition to those mentioned in each chapter. First, the D2R agonist, quinpirole, and
antagonist, raclopride used in Chapters 3, 4, and 5 also have affinity for D3R, D4R and
serotonergic receptors (Knight et al., 2004; Millan et al., 2002). Although serotonergic
receptors and D4R are less abundant in the NAc, D3R are highly expressed in the NAcS
(Schwartz et al., 1994) and it is not possible to clearly distinguish if the observed effects were
due to D2R or D3R actions, which could account for the unpredicted findings in the studied
subregions. For example, antagonising D3R in the NAcS has been reported to increase
impulsivity in rats, hence their agonism may have the opposite effect: decrease impulsivity
and improve flexible performance (Besson et al., 2010). To surmount this limitation, I could
repeat the experiments using a more selective D2R agonist, such as sumanirole, or assessing
the role of D3R in behaviour by combining D2R agonism with selective D3R antagonists
such as nafadotride (Sautel et al., 1995).
Second, in rodents, chronic administration of quinpirole induces sensitization, which
generates compulsive-like behaviour (Amato et al., 2006; de Haas et al., 2011; Szechtman
et al., 1998), and increased locomotion activity (Escobar et al., 2017). Sensitization to the
D2R agonist quinpirole seems to be induced by reduced DA release, especially in the NAcC
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(de Haas et al., 2011; Escobar et al., 2017), increased post-synaptic D2R sensitivity (Escobar
et al., 2017), increased D2R binding, and reduced glucose consumption (Culver et al., 2008).
Whereas quinpirole-induced compulsive-like behaviour could have an impact in reversal
learning, such behavioural traits would impair animals’ performance. Nevertheless, when
repeatedly administering quinpirole into the NAc, I observed an improvement in performance
selective for the early perseverative phase of reversal learning. In addition, a recent study
by Eagle et al. (2020) showed that chronic quinpirole only increased functional, but not
dysfunctional checking behaviour in an observing response task in rats, suggesting that
it might not accurately replicate OCD behaviours. To control for accumulative effects in
locomotion in future experiments, I could run a locomotor activity test with freely moving
rats before and after the testing period (i.e. before the first, and after the last testing day).
Third, comprehending and dissecting the role of DA transmission is intricate since D2R
are expressed in both pre- and post-synaptic striatal neurons, and on striatal GABAergic
and cholinergic interneurons (De Mei et al., 2009). Pre-synaptic D2R or autoreceptors
mediate auto-inhibition to control DA release into the cleft in conditions of high extracellular
DA levels. For example, in drugs of abuse such as cocaine that block the DA transporter,
pre-synaptic D2R are the only factor left to counteract the hyperdopaminergic effect, which
explains why D2R play a critical role in drug abuse disorder (Centonze et al., 2002; De Mei
et al., 2009). Pre-synaptic D2R are expressed in striatal neurons not only projecting from the
midbrain, but also from the cortex, and are implicated in GABA, glutamate and acetylcholine
release (Bamford et al., 2004; Centonze et al., 2004; Wang et al., 2006). Therefore, we cannot
exclude the possibility that altered concentrations of these neurotransmitters impacted on our
results.
Autoreceptors mainly belong to the short isoform of the D2R (i.e. D2S), which is more
sensitive to DA than the long isoform (i.e. D2L) and interacts with different signalling
pathways, whereas post-synaptic receptors are mainly D2Ls and modulate activity of stri-
atopallidal neurons (Lindgren et al., 2003; Usiello et al., 2000). However, it has been reported
that D2S can also be expressed in post-synaptic neurons and inhibit D1R responses, while
acting in synergy with post-synaptic D2L (Usiello et al., 2000). Thus, the effects induced
by quinpirole and raclopride in Chapters 3, 4 or 5 might not be exclusively mediated by
D2R, but also by D1R via D2S, in addition to the potential interacting mechanisms discussed
in the relevant chapters such as lateral inhibition. To dissociate the modulation related to
different D2R-expressing neurons and their isoforms, we could use selective or conditional
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knockdowns of D2R, for example using the Cre-loxP system (Sato et al., 2004), and replicate
the experimental designs presented in this thesis.
Another factor to bear in mind is that performance in reversal learning may rely on
other cognitive processes in addition to or instead of cognitive flexibility, such as attention,
motivation or locomotion. Although throughout testing I aimed to control for these processes
(e.g. using latencies to collect the reward or to respond to the stimuli), a direct approach
would be necessary to weigh their influence in observed behaviour. A possibility would be to
test animals’ behaviour in different tests e.g. effort-related choice for motivation (Salamone
et al., 2018), 5-choice serial reaction time test for attention and response control (Carli et al.,
1983), or infrared detection for spontaneous locomotor activity. A better alternative would be
to assess a wider range of cognitive processes within each task, for which additional task
development would be necessary. Furthermore, animals are typically removed from their
habitual environment to train and test, arising potential problems related to the ethological
validity of the methodology. In response to this limitation, different automated systems are
being developed to assess cognitive abilities while animals remain in their home cage (Aarts
et al., 2015; Galsworthy et al., 2005; Redfern et al., 2017).
Finally, all the studies presented in this thesis were performed with male rats and bilateral
manipulations. It is conceivable that future studies with females will reveal sex differences
in the impact of DA receptors and the neural circuitry on reversal learning, as unilateral
manipulations might expose compensatory, competing effects within hemispheres or reveal
intricacies in regional dynamics and inter-communication.
7.9 Future directions
One prominent question that remains to be answered is how the dynamics of DA release,
neuronal firing and RPEs during flexible decision-making relate to one another. To determine
the link between these phenomena, tracking DA fluctuations with high temporal and spatial
resolution is key. The recently developed neurotransmitter sensor dLight1 (Patriarchi et al.,
2018) would allow to monitor DA modulatory signal dynamics while animals performed
in a reversal-learning task. Alternatively, in-vivo microdialysis or electrochemical sensors
could provide an understanding of DA release, but lack spatial and/or temporal resolution
and cannot target specific cells of interest (Jaquins-Gerstl and Michael, 2015; Muller et al.,
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2014). To better understand the DA connection between brain regions, DA release should be
compared with DA neuronal activity. For this, fibre-photometry could be used to characterise
the dynamics of population-defined neural activity, and test how manipulating DA activity
with optogenetics affects the dynamics of DA release and the choice process. All these ma-
nipulations could be applied while animals perform in a reversal-learning task that dissociates
learning from positive or negative feedback – such as the VPVD task – to differentiate the
effect on positive and negative RPEs.
There is supporting evidence that DA concentrations in the striatum do not always reflect
the activity of midbrain DA neurons (Mohebi et al., 2019). Unlike positive RPEs, which
induce a large increase in neuronal activity, negative RPEs induce a small pause in spiking in
the midbrain. Some have suggested that this small pause translates into a larger decline in
DA release in post-synaptic regions, potentially mimicking the magnitude of the increased
efflux following positive RPEs (Hart et al., 2014), again reflecting the fact that neuronal
activity and DA release do not necessarily correlate. It is unclear how small pauses after
negative RPEs are sufficient to encode teaching signals, but when inhibiting midbrain neurons
with optogenetics, brief pauses proved sufficient to serve as RPE, although the observed
behavioural results were modest (Chang et al., 2015). It is plausible that, instead of magnitude,
negative RPEs are encoded by extended pauses in neuronal activity. Therefore, longer pauses
in neuronal spiking could induce a larger effect. Testing if the duration of pauses in midbrain
DA firing serves as a teaching signal in negative RPEs could be achieved by assessing how
manipulating DA neuronal activity affects DA release dynamics and behaviour. Specifically,
using optogenetics would allow testing of the impact of inhibiting selective VTA DA neurons
for different durations and measuring the effect on behaviour and DA release with fiber
photometry (Saunders et al., 2018).
The present thesis has mainly focused on systemic or ventral striatal manipulations
(apart from manipulation of nigrostriatal projections to the DMS in Chapter 6). However,
cognitive flexibility is not only modulated by the ventral striatum and greatly relies on the
interconnectivity between this and other brain regions, including the PFC, the OFC, and
the dorsal striatum (Hervig et al., 2019; Izquierdo et al., 2017; Turner and Parkes, 2020).
Further elucidation of cortico-striatal circuits using new methodology such as optogenetics
and chemogenetics, or the recently developed behavioural tasks (Alsiö et al., 2019) could
contribute to target specific projections from different subregions in the cortex to the basal
ganglia. In addition, there are many understudied circuits within each region and it is likely
that subregions not only receive inputs from and send outputs to other subregions, but that
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they act as cooperative and interconnected hubs before communicating with other parts of
the brain. Thus, microcircuits could be a potential avenue for future research.
If preclinical research aims to provide insight into the neural mechanisms underlying
cognitive disorders in humans, it is of vital importance that behavioural parameters used in
animal studies appropriately relate to and reflect the relevant system involved in patients.
Further efforts should be placed on developing new or optimising current tasks to (1) dissoci-
ate parameters and processes that might be underlying behaviour to refine the results and
our understanding; (2) provide more naturalistic approaches to animals’ behaviour, which in
turn contributes to the last point; (3) assess behaviour with high construct and validity, and
provide translational power to transfer findings in animals to humans with as little ambiguity
as possible.
Finally, computational modelling can increase translational value of preclinical studies
by assessing subtle changes in behavioural strategies employed by animals and humans
when performing in the task, as discussed in section 7.7 and observed in Chapter 6. These
models can also relate behavioural findings with neurophysiological data by encoding the
dynamic nature of neurons, as shown by the drift-diffusion model (Wiecki et al., 2013). Thus,
future preclinical and clinical studies should ideally include computational tests as part of
their systematic analysis, where appropriate. In addition, novel statistical approaches arising
from machine and deep learning could be particularly informative in identifying complex
patterns or relationships not captured by traditional methods, leading neuroscience to a highly
promising future that is about to come.
7.10 Conclusions
The findings reported in this thesis collectively show that behavioural flexibility is differen-
tially affected by sensitivity to positive or negative feedback, and its modulation relies on
distinct neural circuits, striatal subregions, and dopamine receptors.
By combining in different experiments systemic, local pharmacology and optogenetic
approaches while animals performed in three different reversal-learning tasks, this thesis
revealed several novel mechanisms that underpin behavioural flexibility. First, I provided
experimental evidence that D2R mediate learning from negative feedback, potentially by
acting on striatopallidal neurons. Second, I showed that systemic D2R agonism impairs
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reversal learning, whilst hyper-activation of D2R in the NAc leads to an improvement,
suggesting that different regions act in synergy or compete to modulate behaviour. Third,
NAcC and NAcS utilise dissociable mechanisms to regulate flexibility: whereas the NAcS
mediates sensitivity to positive feedback potentially via pre-synaptic D2R, the NAcC mediates
negative feedback possibly via post-synaptic receptors. Fourth, levels of D2R agonism in
the NAc alter the balance of DA function and can switch from inducing improvements to
impairments in reversal learning. Fifth, although the effects of manipulating the NAc might
be expressed in later sessions in the VPVD task, the NAc modulates performance in early
stages of serial reversal learning, suggesting it plays a critical role in disengaging from
previous strategies to develop a new approach. Sixth, hyper-activation of the mesoaccumbal,
not nigrostriatal, pathway impairs reversal learning when timed with lack of reward, not
with the delivery of reward or up until making a choice. Finally, by comparing our results
from the VPVD task with those obtained in the PRL task and analysing the latter with
computational models, I demonstrate that the canonical measure of positive and negative
feedback in animals and humans (i.e. win-stay/lose-shift probabilities in the PRL task) is not
necessarily accurate and can, in fact, be misleading.
The results from this thesis demonstrate with unprecedented detail how striatal DA
modulates feedback sensitivity, bringing the field closer to a comprehensive understanding of
the role of DA, its receptors, and cortico-striatal circuits in cognitive flexibility. These studies
enhance our knowledge of the neural circuits underlying visual reversal learning and could
be relevant for cognitive inflexibility in DA-related disorders, such as Parkinson’s disease
(Cools et al., 2007), OCD (Denys et al., 2004) or drug-use disorder (Volkow et al., 2009).
Future research should aspire to provide refined detail of the factors involved in behaviour,
which could contribute not only to our understanding of the mechanisms, but also to the
reproducibility of results. It should also seek to improve the congruence of experimental
designs and methods between preclinical and clinical research, and to expose subtle mech-
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